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ABSTRACT 
 
EVALUATING THE ROLE OF THE STRINGENT RESPONSE IN CLOSTRIDIOIDES 
DIFFICILE SURVIVAL AND PATHOGENESIS  
 
Astha Pokhrel  
Old Dominion University, 2021 
Director: Dr. Erin B. Purcell  
 
 
The human pathogen Clostridioides difficile is increasingly tolerant of multiple antibiotics 
and causes infections with a high rate of recurrence, creating an urgent need for new 
preventive and therapeutic strategies. The stringent response, a universal bacterial 
response to extracellular stresses, governs antibiotic survival and pathogenesis in diverse 
organisms but has not previously been characterized in C. difficile. This dissertation 
explores the ability of C. difficile to mount the stringent response. The bacteria encode a 
full-length, canonical bifunctional Rel/Spo Homolog or RSH enzyme. C. difficile RSH is 
incapable of utilizing GTP as a substrate but readily synthesizes putative 5’-pGpp-3’ 
alarmones. Transcription of rsh is stimulated by bacterial stationary phase onset, nutrient 
limitation, and exposure to the antibiotics clindamycin and metronidazole. Transcriptional 
suppression of rsh increases bacterial antibiotic susceptibility, suggesting that RSH 
contributes to bacterial antibiotic tolerance and survival. Chemical inhibition of RSH by the 
5’-ppGpp-3’ analog Relacin similarly increases antibiotic susceptibility in epidemic C. 
difficile, indicating that RSH inhibitors are a viable strategy for drug development against 
Clostridioides difficile infection. Finally, mechanisms contributing to C. difficile host 
colonization and aspects of bacterial behavior during infection remain unclear. Therefore, 
this dissertation also explores nutrient-derived motility regulation of the pathogen during 
host intestinal mucus colonization. An epidemic C. difficile strain suppresses motility in the 
presence of high unchained N-acetylneuraminic acid, an intestinal mucus component. The 
observed motility suppression is independent of bacterial tumbling but robust single-
species biofilm formation by R20291 and motility suppression in response to high NEU5A 
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CLOSTRIDIOIDES DIFFICILE INFECTION  
 
Clostridioides difficile (C. difficile), previously known as Clostridium difficile is a 
Gram-positive, obligate anaerobic bacillus that was discovered in 1935 and identified as 
a severe pathogen only in the late 1970s (1). Today, C. difficile is the most common cause 
of hospital-acquired infection and C. difficile infection (CDI) in several developed countries 
(2). The pathogen contributes to approximately 500,000 cases and 29,000 deaths 
annually in the United States alone and in 172,000 cases annually in Europe (3-6). 
According to the Antibiotic Resistance Threats in the United States 2019 report issued by 
the US Center for Disease Control and Prevention (CDC), C. difficile was responsible for 
~223,900 hospital admissions cases and ~12,800 deaths in 2017. The economic impact 
of CDI is enormous. It has led to health care and medical expenditures of over one billion 
dollars and three billion euro per annum in the US and within the European Union, 
respectively (6-8). The CDC currently recognizes the pathogen as an urgent public health 
threat (9). 
C. difficile persist as aerotolerant spores in aerobic environments (10). The spore is 
a metabolically dormant form of the bacterium that houses genetic entities preserved in 
a dense hydrophobic core, externally protected by a thick proteinaceous coat (11). Due 
to their dormancy and highly complex structure, C. difficile spores are intrinsically 
resistant to antibiotics, and defenses from the host’s immune system (11). They are also 
tolerant to bleach-free as well as alcohol-based disinfectants commonly used in 
healthcare settings (11). Furthermore, C. difficile spores also survive heat assault, making 
their eradication extremely challenging from contaminated surfaces (12).  
 
 




Surfaces most frequently contaminated by C. difficile spores include toilet seats, 
sinks, call buttons, bed rails, and telephones, along with medical devices such as 
stethoscopes, blood pressure cuffs, and pulse oximeters (9). Other reservoirs for the 
bacteria include asymptomatic carriers, infected patients, and the animal intestinal tracts 
(13). Around 5% of adults and 15 to 70% of infants are colonized by C. difficile, with 
colonization prevalence being significantly higher in institutionalized patients,  including 
adults with underlying health conditions (6,13). Notably, the community-acquired 
incidence of C. difficile infection has been increasing with an associated increase in 
mortality, morbidity, and clinical and economic burden (14,15). According to a CDC-based 
population surveillance from 2011 to 2017, the estimated burden of community-acquired 
CDI in the US did not decrease like healthcare-associated CDI and contributed to ~50% 
of CDI’s total national burden in the year of 2017 (16).  
Upon ingestion by susceptible hosts, C. difficile spores germinate into actively 
reproducing vegetative cells in the anaerobic mammalian gut. Spore germination is 
triggered in response to host-derived bile salts, including taurocholate, glycocholate, 
cholate and deoxycholate, and L-glycine, which is a more effective germinant than the 
other naturally occurring amino acids (11,17,18). Germination into oxygen-intolerant 
vegetative cells further leads to the secretion of exotoxins, toxin A (TcdA) and toxin B 
(TcdB) that are internalized by host intestinal epithelial cells (10). TcdA (308 kilodalton) 
and TcdB (270 kilodalton) are members of the large clostridial toxin family, encoded by 
tcdA and tcdB genes, respectively (10,19). These genes are part of a highly conserved 
19.6-Kb pathogenicity locus (PaLoc) of toxigenic strains (19,20). In addition to tcdA and 
tcdB genes, three other open reading frames are associated with the PaLoc, including 
tcdC, tcdD/tcdR, and tcdE (19). TcdC is suggested to function as a negative regulator of 
toxin A and B production whereas TcdR acts as a DNA binding protein that positively 
regulates toxin gene expression and production (19,21). Finally, the gene encoding TcdE 
is homologous to holin proteins and is suggested to contribute to the release of the toxins 
through permeabilization of the bacterial cell wall (19,22).  
After receptor-mediated endocytosis, both toxins transfer a UDP-glucose to Ras 
superfamily GTPases (Rho, Rac, and Cdc42), resulting in host cell morphological 
changes, inhibition of cell division, and blocking of membrane trafficking (19). Rho 
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GTPase is the primary regulator of the cellular actin cytoskeleton, which plays a critical 
role in forming and localizing stress fibers at the focal adhesion sites (19). Rho also 
regulates the formation of prejunctional rings at the apical side of epithelial cells such that 
inactivation causes epithelial cell rounding from disaggregation of the actin cytoskeleton 
as well as disruption of the epithelial tight junction (19,23). Consequently, neutrophils are 
recruited to the intestines, macrophages are activated, and pro-inflammatory cytokines 
are rapidly released to cause a massive host acute inflammatory response (19). In more 
severe cases, microulcerations covered with pseudomembranes made of destroyed 
intestinal cells, neutrophils, and fibrin begin to form on the intestinal mucosal surfaces 
(13). Unlike Rho, Rac and Cdc42 are involved in lamellipodium and filipodium formation 
that are structural extensions at the edge of migrating cells (19,24). Rac and Cdc42 
facilitate cellular movement and sensing of environmental conditions during migration. 
Interestingly, TcdA and TcdB promote cell migration despite glycosylating Rac and Cdc42 
GTPases (19). In terms of potency, initial studies based on animal models suggested 
Toxin A to be the dominant intoxicating glycosyltransferase encoded by C. difficile until 
TcdA-, TcdB+ strains became responsible for CDI outbreaks (10,13,25). Studies involving 
human colonic epithelial tissues and transplantation of human xenografts in 
immunodeficient animal models have identified Toxin B to be more potent, although both 
toxins can elicit CDI symptoms independently of one another (13,26,27).  
The incidence of CDI has markedly increased in the last 20 years, largely due to the 
emergence and dissemination of the C. difficile polymerase chain reaction ribotype 027 
(RT027) or R20291 (28). RT027, which was first isolated in North America and Europe 
back in the 2000s, is naturally hypervirulent (25,29). Hypervirulence of the strain is 
associated with reduced susceptibility to a wide array of antibiotics including 
fluoroquinolones (30). The strain also spreads more easily and rapidly within hospital 
settings as it can produce higher levels of spores and toxins (30,31). Importantly, RT027 
strain produces an additional toxin called C. difficile transferase (CDT) or binary toxin, 
which is encoded by the C. difficile transferase (Ctd) locus (CdtLoc) (10). Unlike TcdA 
and TcdB glucosyltransferases, C. difficile CDT, is an ADP-ribosylating enzyme that 
disrupts the cytoskeleton of epithelial cells by inhibiting actin polymerization (10,19,30). 
Inhibition of actin polymerization consequently leads to excessive fluid loss, cell rounding, 
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and apoptosis (10). CDT (~43 kilodalton) comprises two separate components: CDTa 
and CDTb, where CDTb binds to gut epithelial cells resulting in the uptake of CDTa (30). 
CDT also induces the formation of thin microtubules that promote Clostridia adherence 
to host intestinal epithelial surfaces along with increasing TcdA and TcdB uptake (30,32). 
In the last decade, the percentages of CDI caused by the RT027 strain is reported to be 
51% and 84% in the US and Canada, respectively (33,34).  
The clinical manifestation of CDI ranges from asymptomatic carriage, mild or 
moderate diarrhea, to life-threatening fulminant colitis and toxic megacolon (13). Most 
patients experience mild diarrhea and recover spontaneously after 5 to 10 days of 
treatment withdrawal (13). In addition to watery stool, clinical features of CDI is 
accompanied by abdominal pain, fever, weakness, nausea and vomiting, and loss of 
appetite (13). Severe clinical presentations involve symptoms such as dehydration, 
hypoalbuminemia, and subsequent circulatory shock (13). Additional complications 
include colon perforation, intestinal paralysis, kidney failure, systemic inflammatory 
response syndrome, and septicemia (13).  
The primary risk factor for CDI development is antibiotic exposure. However, other 
significant risk factors include advanced age, residence in long-term care facilities 
(hospitals and nursing homes), and prior medical conditions such as immunosuppression, 
inflammatory bowel diseases, and chronic kidney disease, and/or gastrointestinal 
procedures (6,13,35,36). Antibiotics have serious and long-lasting effects on the bacterial 
ecosystem of the host gut. The highly organized intestinal ecosystem comprises 
numerous bacterial species, mainly those belonging to the Firmicutes and Bacteroidetes 
phyla, whose concentration is heightened in the colon (6,37-39). The commensal 
microbiota plays a crucial role in maturating the immune system and protecting against 
enteric pathogens. Disruption of this well-balanced ecosystem via antibiotic exposure 
alters microbial diversity and composition, promoting C. difficile colonization (6). 
Antibiotics associated with the development and increased frequency of CDI include 
metronidazole, vancomycin, broad spectrum penicillins and cephalosporins, clindamycin, 
and fluoroquinolones (6,13). Cephalosporins are known to decrease members of the 
healthy Clostridia, Lactobacilli, and Bifidobacteria taxa, whereas clindamycin decreases 
species of the anaerobic Bifidobacterium, Clostridium, and Bacteroides genera (40,41). 
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Another significant role of commensal bacteria, particularly those in the Lachnospiraceae, 
Ruminococcacae, and Blautia families of Firmicutes as well as Clostridium spp., is to 
metabolize primary bile acids into secondary bile acids via deconjugation and 7-α-
dehydroxylation mechanisms (42,43). As mentioned previously, C. difficile spores 
germinate into replicating vegetative cells in the presence of primary bile acids such as 
taurocholate and cholic acid to promote vegetative cell outgrowth (43). Secondary bile 
acids, on the other hand, inhibit C. difficile growth (44,45). Antibiotic-induced alterations 
of the intestinal microbiota cause an increase in the primary bile acids concentration and 
a concurrent decrease in secondary bile acids concentration, enhancing colonization. The 
commensal Bacteroidetes and Firmicutes phyla are depleted and changed, respectively, 
with a concurrent increase in pathogenic Enterobacteriales and Proteobacteria diversity 
in CDI patients (42,46).  
C. difficile colonization is very common in the elderly population due to inadequate 
innate or humoral immune responses and loss of commensal bacterial diversity in this 
age group (6,47-51). Patients above 65 years of age carry an increased risk for CDI 
development, ~5 to 10-fold higher relative to younger patients (13). Although a significant 
portion of CDI incidence also occurs in the younger age group, the poor clinical outcome 
of the disease (higher severity and mortality) is directly associated with advanced age 
(13). Prolonged stay in healthcare institutions also corelates with CDI incidence. The 
incidence of bacterial colonization during the first few days of hospitalization ranges from 
2.1 to 20% and gradually increases with extended stay (52-56). Furthermore, nursing 
home residents are also at high risk for CDI possibly due to older age, health 
comorbidities, frequent hospitalizations, and antibiotics exposure compared to the non-
institutionalized population (13).  
Prevention of CDI has mostly included the use of gloves and disposable gowns in 
healthcare settings since C. difficile spore transmission occurs from person to person 
contact and through the fecal oral route (13,35). After direct contact with CDI patients, it 
is recommended to wash hands with soap and water (57). Since alcohol-based 
disinfectants are ineffective at killing C. difficile spores, it is ideal to use chlorine-based 
solutions such as sodium hypochlorite for environmental cleaning (58). Treatment wise, 
primary therapy of moderate and severe CDI has included the use of metronidazole and 
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vancomycin (59). While the Infectious Diseases Society of America (IDSA) and Society 
for Healthcare Epidemiology of America (SHEA) guidelines issued in 2018 no longer 
recommends the use of metronidazole as a first-line treatment, multiply recurrent CDI 
(rCDI) is a significant problem associated with the use of vancomycin (4,29,36,60-63). 
The recurrence rate after the first bout of CDI treatment (or second episode within 8 weeks 
of discontinuing antibiotic therapy for primary infection) using vancomycin is ~10 to 35%, 
and that the risk for subsequent recurrences is at least 40% (36,59,64). Patients with 
three or more relapses often experience consecutive relapse episodes, leading to low 
quality of life with minimal therapeutic options (57,59). Unlike vancomycin, fidaxomicin is 
associated with a lower recurrence rate via the inhibition of C. difficile spore formation 
and toxin production (65,66). Fidaxomicin targets exosporium and spore coat proteins to 
inhibit germination and internalizes vegetative C. difficile cells (67). Furthermore, the use 
of fidaxomicin is also advantageous over vancomycin due to the twice-daily dosing 
regimen of the former antibiotic over quadrice-daily dosing (36). However, fidaxomicin is 
expensive, preventing its widespread use and resistance of the epidemic strains to the 
antibiotic has been reported in clinical trials (59,65,66,68). As C. difficile demonstrates 
high survival rates when treated with multiple classes of antibiotic, including beta-lactams, 
cephalosporins, clindamycin, and fluoroquinolones, microbiome restoration through fecal 
microbiota transplantation (FMT) continues to be the most effective therapy for rCDI 
(7,36,63,69,70). The introduction of suppressive bacterial species from screened and 
healthy donors to C. difficile colonized gastrointestinal tracts of infected patients has 
demonstrated between 80 to 90% success rate (57,71,72). Unfortunately, the technique 
carries an inherent risk of transmitting undetected pathogens and chemical agents to the 
recipient (73,74). Additionally, the long-term effect of the therapy remains to be 
determined (74). In 2019, two immunocompromised patients were reported to develop 
extended spectrum β-lactamase producing Escherichia coli infection post-FMT, which 
lead to the demise of one of the patients (75).  
Another significant drawback of FMT is the heterogeneity associated with the 
methodological components of the procedure, including donor screening, donor and stool 
sample preparation, and instillation as well as patient follow-up (36). To establish 
standardization of the FMT technique for universal therapeutic usage, capsule-based 
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products such as CP101 (Phase II), RBX7455 (Phase I), SER-109 (Phase III), and 
enema-based RBS2660 (Phase II and III) have demonstrated appreciable efficacy in 
double-blinded randomized-controlled trial (36). Nevertheless, replacement of the 
conventional FMT with standardized microbiome restoration products appears to be 
encouraging also because patients’ experience with and perception regarding traditional 
FMT is reportedly unpleasant (36,76). 
 Newer approaches to managing CDI and multiply rCDI have included the 
administration of monoclonal antibodies directed against C. difficile toxins in conjugation 
with antibiotic therapy. Bezlotoxumab is the United States Food and Drug Administration 
(FDA)-approved human monoclonal antibody that targets toxin B, and that is associated 
with a substantially lower rate of rCDI (63,77). Notably, some vaccines that have entered 
late-stage clinical trials include injectable anti-toxin vaccines and formalin-inactivated 
toxin A and B by Sanofi Pasteur (63). Genetically and chemically inactivated toxin A and 
B vaccine by Pfizer and a single recombinant fustian protein with segments of the 
bacterial toxins by Valneva have also entered Phase 3 clinical trials (63). The use of 
probiotics as an alternative to antibiotics and FMT is also being largely explored in the 
field. Much like the native intestinal microbiota,  probiotics stimulate the host immune 
system, compete with enteric pathogens for nutrients, and inhibit colonization of foreign 
species (78,79). Bifidobacterium as well as the combination of B. longum and B. bifidum 
with prebiotics are known to be protective against C. difficile (80,81). Widely used 
Lactobacilli probiotics also inhibit C. difficile growth where Lactobacillus rhamnosus GG 
interfere with key metabolic pathways in the bacteria such as Stickland reactions and 
butyrate metabolism, resulting in the negative regulation of toxin production (82,83).  
 In summary, diverse approaches are available and under development for the 
management of CDI and rCDI. However, the development of more effective prevention 






FACTORS PROMOTING CLOSTRIDIOIDES DIFFICILE VIRULENCE 
 
Adhesion of bacteria to target cells is the first step in colonization and the 
establishment of pathogenesis. Therefore, it is imperative for C. difficile to find a way to 
get through the host intestinal lumen and into the mucosa to the epithelial cells for 
attachment and infection. Notably, mammalian epithelial mucosal tissues are coated by 
a high viscosity mucus layer composed of water and glycosylated mucin components 
(84). Hence, movement or motility through the mucus barrier to the epithelial lining is 
essential for successful colonization. The secretion of flagella provides many species with 
ability to be motile, to colonize abiotic and/or biotic surfaces, to optimize growth, and to 
survive attacks from the host (85,86). In a few gastrointestinal pathogens, including 
Campylobacter jejuni and Vibrio cholerae, flagella play roles in bacterial motility, 
adherence, and colonization (87-90). Therefore, flagellar mutations cause these bacteria 
to become less adherent and less pathogenic in nature (91-95).  
The flagellum is constituted of a basal body which contains the reversible motor that 
anchors the structure to the cell membrane while powering organelle rotation, a hook that 
extends out from the top of the basal body, and the filament which extends ~20 µm from 
the hook to form the helical propeller when rotated (Fig. 1) (86,87,96). Self-assembly of 
the flagellum is a multi-stage hierarchical process that begins with the coordinated 
assembly of the flagellar type III secretion system (T3SS), the MS-ring in the cytoplasmic 
membrane, and the C-ring at its cytoplasmic face (87). In Gram-negatives, the MS- and 
C-rings form a scaffold for the assembly of the flagellar T3SS first followed by the 
assembly of the peptidoglycan-spanning P-ring and lipopolysaccharide-spanning L-ring 
(87). Notably, the L- and the P-rings are lacking in the structure of a Gram-positive 
flagellum (Fig. 1). Consequently, the activated T3SS recruits, unfolds, and exports 
proteins through the axial structure’s hollow core in order to assemble the periplasm-
spanning rod, the flagellar hook, and the filament in a highly coordinated fashion (87). As 
mentioned previously, the motor of the flagellar basal body is responsible for fueling 
flagellar rotation. This transmembrane protein complex transduces energy from the flow 
of H+ or Na+ ions across the inner membrane, causing a conformational change in the C-
ring torque that is coupled to the rod, the hook, and the filament (87). The propulsive force 
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generated by the flagellar rotation subsequently leads to bacterial movement at speeds 
ranging from 25 to 160 µm/sec (87,97,98). Due to flagellar rotation that propels bacteria 
forward in the direction of suitable niches (swimming motility) and/or for adhesion and 




Several genes governing the structural integrity and function of the flagellum in 
relevant flagellated species have also been identified in different C. difficile strains (86). 
These genes are organized into three distinct loci called F1, F2, and F3 (61,86). The 
hierarchical transcription of flagellar genes is firstly initiated in the F3 regulon or ƒlgB 
operon, which comprises early flagellar genes such as the ƒliA (86). This operon mainly 
encodes motor and structural components of the organelle along with the alternative 
sigma factor SigD necessary for flagellar assembly and bacterial movement. The SigD 
alternative sigma factor regulates the transcription of flagellar genes in the late-stage F1 
 
Figure 1. Diagram of a Gram-positive flagellum. Gram-positive flagellum showing 





Basal body  
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and F2 operons (99,100). The F1 regulon houses three ƒliA promoter regions (86). The 
same operon also encodes flagellin FliC and the protein cap FliD, both of which are 
structural proteins critical for attaining complete flagellar functionality (86,101). 
Interestingly, variation in the F1 regulon between C. difficile strains have been recorded, 
supporting the findings that the R20291 strain is more motile with higher flagellar counts 
in comparison to the non-epidemic or historical strain C. difficile 630 (61,86,102). Lastly, 
genes in the F2 regulon encode proteins that play parts in filament glycosylation (86,90). 
Notably, the F2 operon of C. difficile 630 strain carries four genes encoding glycosyl 
transferases, whereas that of R20291 carries six (61). 
Post-translational modification (PTM) of C. difficile flagella is critical for flagellar 
assembly and bacterial motility. In 2009, Twine and group determined that C. difficile 
flagellin undergoes modification by O-linked glycans and that this modification varies 
between C. difficile strains (103). According to Twine et al., the addition of N-acetyl 
hexosamine is dependent on the specific glycosyltransferase gene (CD0240) from C. 
difficile 630 F1 operon such that inactivation results in the loss of surface-associated 
flagellin protein and in impaired bacterial motility (103). Years later, Faulds-Pain et al. 
showed that a β-O-linked N-acetylglucosamine (GlcNAc) glycan is attached to either 
serine and/or methylated phosphor-threonine of the flagellin to induce PTM (104). 
Nevertheless, mutations in the CD0240 gene and those downstream of CD0240 in the 
F2 operon (with putative roles in flagellin modification) lead to bacterial autoagglutination, 
increased cellular binding to abiotic surfaces, and reduced colonization in a relapsing 
model of CDI (104). Autoagglutination is a process of bacterial cells either clumping 
together or with host cells. Several surface structures in bacteria influence 
autoagglutination. For instance, C.  jejuni employs a flagellin-dependent autoagglutination 
strategy to promote virulence (86,105). The degree of autoagglutination in C. difficile is 
strain-specific and that this dependency is majorly due to differences in flagellar 
glycosylation pattern (61,86). Valiente et al. studied genes in RT027 with predicted roles 
in flagellar glycosylation and PTM (106). Mutation of two putative glycosyltransferase 
genes, GT2 and GT3 as well as those with predicted coding sequences of the F2 operon, 
immediately downstream of ƒliC gene demonstrated reduced motility but an increase in 
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autoagglutination (106). This suggests that the PTM of C. difficile flagellin influences 
pathogenesis.  
Flagellum-mediated motility contributes to bacterial colonization and virulence in 
many species. Flagellar filaments are responsible for probing the host cell surface for 
contact and interaction with polymeric proteins, proteoglycans, glycolipids, and 
phospholipids (84). Flagella contributes to C. difficile adherence to epithelial cells in vitro 
and host colonization in a strain-specific manner. Mutation in the ƒliC gene of the RT027 
strain has been shown to reduce bacterial adherence to mammalian cell lines and 
colonization in mouse models (107). Surprisingly, a mutation in the same gene from C. 
difficile 630Δerm (RT012) strain, an erythromycin sensitive variant of the non-epidemic 
630 isolate, increased bacterial adherence to mammalian cells without affecting 
colonization (107,108). This indicates that flagella-driven motility is not necessary for 
colonization in all genetic variants of C. difficile, but the flagellum can function as an 
adhesin is some, promoting bacterial interactions with the host (90). Aubury et al. also 
used 630Δerm strain to generate early-stage flagellar gene mutants and late-stage ƒliC 
and ƒliD mutants (109). They found mutations in early stage flagellar genes to attenuate 
virulence in hamster models of infection, whereas ƒliC and ƒliD mutations lead to 
increased virulence and quick transitioning of infection models to a moribund state (109). 
The same study also recorded a decrease in toxin production due to early-stage flagellar 
gene mutations (109). The association between flagellar genes and toxin production can 
be explained by the role of the flagellar alternative sigma factor SigD. SigD regulates tcdA 
and tcdB gene expression and toxin production in C. difficile via tcdR activation such that 
sigD mutations lead to decreased toxin expression, production, and virulence during 
infection (109). Nevertheless, the flagellum is an essential organelle of C. difficile 
physiology with roles in bacterial motility and colonization, even motility-driven dispersal 
of cells to find new surfaces to colonize (87).  
Another surface-associated protein encoded by many Gram-negative and select 
Gram-positive species is the Type IV pili (TFP) that regulate bacterial movement, 
adherence to host cells, DNA uptake, transformation, and protein secretion (Fig. 2) (110-
112). TFP can also act as nanowires carrying electric current and that pilus biosynthesis 
occurs through the type II protein translocation pathway (112,113). This surface-
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associated macromolecule is polymerized from an inner membrane-bound pool of pilin 
monomers (PilA) via the PilB ATPase, and is held to the pilus filament via hydrophobic 
interactions and assembly of the PilM, PilN, and PilO proteins required for extension (Fig. 
2) (112).  Retraction of the pilus, on the other hand, is controlled by the disassembly of 
the PilA pilin subunits into the inner membrane, a mechanism powered by the PilT 
ATPase (113).  
In contrast to the flagellar filament, TFP make thinner and shorter filaments that 
extend from the bacterial surface (Fig. 3) (110). Interestingly, both flagellum and TFP can 
coordinate with each other to facilitate bacterial adhesion and colonization. In some 
cases, for instance, TFP reinforce flagella-mediated transient and reversible interactions 
of bacteria, resulting in more robust and permanent associations (110,114). 
Mechanistically, TFP promotes bacterial motility through the extension, attachment, and 
retraction of the pilin fiber along a solid surface (110). The TFP-based motility that aid in 
bacterial propulsion to reach target sites has been described in many species including, 
Neisseria, Pseudomonas, Myxococus xanthus, C. difficile, and Clostridium perfringens 
(115,116). Furthermore, in C. difficile, TFP contributes to in vitro cell aggregation in a 3’-
5’ cyclic diguanylate (c-di-GMP)-dependent manner (117). Inactivation of pilA1 (encoding 
PilA monomer) and pilB1 (encoding PilB ATPase) genes from the primary TFP loci 
hinders pilus formation and reduces C. difficile autoaggregation (117). c-di-GMP is a 
bacterial second messenger that regulates the switch of cells from motile, free-living, or 
planktonic state to sessile while playing multifaceted roles in bacterial physiology and 
virulence. The cytoplasmic levels of c-di-GMP is regulated by GGDEF-domain containing 
diguanylate cyclases and EAL or HD-GYP-domain containing phosphodiesterases that 
synthesize and hydrolyze the signaling molecule, respectively (110). In Gram-positives, 
two protein receptors for c-di-GMP have included the PilZ-domain protein and the 
transcription factor BidD. Furthermore, class I and II types of riboswitches have also been 
identified in different bacterial groups that bind c-di-GMP and regulate gene transcription 
(110). Importantly, the C. difficile 630 genome encodes 37 predicted c-di-GMP cyclases 
and phosphodiesterases (31 of which are conserved in R20291), one PilZ domain, 12 
predicated class I, and four class II riboswitches (110). An increase in the intracellular c-
di-GMP concentration via the overexpression of DccA synthetase (GGDEF-domain 
13 
 
carrying diguanylate cyclase) inhibits flagellar-driven motility and induces C. difficile cell 
clumping (117-119). According to Purcell and colleagues, repression of flagella-mediated 
motility at elevated c-di-GMP levels is due to the binding of c-di-GMP to the type I 
riboswitch located upstream of the ƒlgB flagellar biosynthesis operon (119). As mentioned 
previously, the ƒlgB or F3 operon includes sigD, which regulates tcdA and tcdB gene 
expression and toxin production via the tcdR of the PaLoc. Therefore, increased 
concentration of cytoplasmic c-di-GMP also inhibits C. difficile toxin production via 
premature transcription termination of the sigD (99). c-di-GMP-dependent motility 
suppression and induction of cell aggregation via the TFP has been reported to involve a 
c-di-GMP riboswitch that transcriptionally regulates TFP biosynthesis genes (117). 
Binding of c-di-GMP to the class II_4 riboswitch located upstream of the TFP primary 
locus facilitates C. difficile autoaggregation, which contributes to biofilm formation (117). 
In 2018, McKee et al. evaluated the role of TFP in the ability of C. difficile to adhere to 
and colonize the intestinal epithelial cells (120). Based on their observations, c-di-GMP 
promotes TFP-mediated attachment of C. difficile to colonic epithelial cells such that 
mutations in TFP genes (pilA1 and pilB1) result in reduced bacterial adherence (120). 
Overall, these findings suggest that c-di-GMP signaling regulates virulence in C. difficile 
by inhibiting flagella-dependent swimming and enhancing TFP-dependent aggregation 











Figure 2. Diagram of Gram-positive Type IV Pili. PilB ATPase assembles PilA pilin 
subunits from the base to allow pilus extension. PilM, PilN and PilO form a membrane 
complex for pilus extension. Adapted from Purcell et al. 2016. 
 
Figure 3. Comparison of C. difficile flagella and Type IV Pili using transmission 
electron microscope (TEM). Shown are the C. difficile flagella (black arrowheads) 
and TFP (white arrowheads). Image scale from left to right is 5 µm, 5 µm, and 100 







Biofilms are the predominant state of most bacteria in natural environments (110). 
Biofilm formation is initiated by bacterial interaction with a surface where surface-
adhesion is facilitated by flagella and TFP (121). Post-surface attachment, adherent cells 
secrete a dense and very protective extracellular polymeric substance or matrix (ECM) 
(121,122). The ECM comprises polysaccharides, proteins, lipids, complex sugars, 
extracellular DNA, and ions such as Ca2+ (121,123). The surface-attached cell mass also 
harbors many pathogenic species that are inherently more drug-tolerant than planktonic 
species, suggesting that biofilm plays a crucial role during host infection (122,124). 
Irreversible attachment and maturation of the biofilm through development of 
microcolonies ultimately results in a robust three-dimensional community of 
microorganisms (122). The major roles of the ECM include securing the biofilm 
community to the surface, trapping nutrients within, providing structural support, and 
protecting the community from host immune defenses as well as antimicrobial agents 
(122). Furthermore, the ECM is responsible for enabling cell-to-cell communication via 
autoinducer molecules and the exchange of genetic materials via horizontal gene transfer 
mechanism within the community (122). Upon maturation, to disperse bacterial infection, 
mature biofilms release cells from the main community so that free cells can swim to new 
locations for surface attachment (122).  
Mechanisms contributing to bacterial drug tolerance and survival within a biofilm 
community include occlusion of the penetration of chemical agents by the thick ECM, 
sequestering of antimicrobial agents within the matrix, and the inner hostile environment 
of biofilms that reduce growth rate and render bacteria metabolically inactive (122,124). 
In humans, 80% of bacterial infections are due to biofilm-producing pathogens such as 
those belonging to the Staphylococcus, Pseudomonas, Enterococcus, and Streptococcus 
genera (124). Furthermore, biofilms also contribute to bacterial persistence and infection 
recurrence (90). Bacterial persistence is an antibiotic stress-response phenomenon in 
which a subpopulation of cells survives antibiotic exposure without acquiring genetic 
alteration(s) in their genome that can otherwise confer antibiotic resistance (125,126).  
Over the years, biofilm formation has been characterized in a handful of anaerobic 
species that colonize the gut. Both C. difficile 630 and R20291 strains can form well-
structured and thick biofilms in vitro, with the latter strain forming substantially more 
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biofilm (127). The biofilm matrix of C. difficile is mainly composed of glycoproteins, 
lipoproteins, phosphoproteins, and extracellular DNA in addition to fiber-like structures 
(127). The surface-structures flagella and TFP, and members of the S-layer regulate 
biofilm formation in C. difficile. The C. difficile S-layer is composed of S-layer proteins 
(SLPs) that present as heterodimeric complex with putative functions in bacterial 
adherence and evasion of the immune system (128). The maturation of the S-layer 
proteins is dependent on proteolytic cleavage by Cwp84. Therefore, isogenic mutants of 
cwp84 and ƒliC dramatically suppress biofilm formation during the early and late stages 
of biofilm maturation, respectively (127). Quorum sensing, which is a process that permits 
bacteria to coordinate group behaviors for sharing information about cell density and gene 
expression, also influences biofilm formation (129). The role of quorum sensing regulators 
in biofilm production, such as luxS has been documented in B. subtilis and C. perfringens 
(130,131). Notably, luxS mutants in C. difficile also cause dramatic defects in biofilm 
formation, suggesting that the luxS-mediated quorum sensing system contributes to 
mature biofilm formation in this organism (127). Furthermore, the master regulator of the 
sporulation pathway called Spo0A is also involved in C. difficile biofilm formation in vitro 
(127). The biofilm environment is known to support sporulation processes making spores 
one of the members of the biofilm ecosystem, particularly under nutrient-limiting 
conditions (127,132). While Dapa et al. found C. difficile biofilms to contain significantly 
lower numbers of spores in vitro, other studies have found C. difficile biofilms to be 
densely populated with spores harnessing reduced germination efficiency (127,133). In 
agreement with precedent findings, Dawson and group recently demonstrated that both 
R20291 and 630 strains have significantly increased spore titers within the biofilm matrix 
compared to the planktonic phase (134). The discrepancy between these findings can be 
attributed to differences in strain types and growth conditions used in the studies (90).  
Nevertheless, field emission scanning electron microscopy (FESEM) and confocal 
laser scanning microscopy (CLSM) based studies have revealed biofilms produced by C. 
difficile to contain mats of rod-shaped vegetative cells, spores, and sporulating cells 
interconnected through a network of ECM, and string-like materials connecting the cells 
(135). Arguably, it is reasonable for C. difficile biofilms to constitute a higher proportion of 
non-germinating spores since germination suppression enables more spore 
17 
 
dissemination and transmission. Spores are highly resilient to a vast range of 
environmental insults and it can persist in the gut to cause recurrent infection (136,137). 
Garth et al. have found fidaxomicin, an inhibitor of the sporulation process, to be more 
potent than metronidazole and vancomycin at penetrating and disrupting C. difficile 
biofilms in vitro, indirectly supporting precedent findings that C. difficile biofilms constitute 
a significant number of spores (137). Additionally, their study revealed surotomycin to be 
effective at disrupting C. difficile biofilms by killing vegetative cells within this community 
(137). Unfortunately, the development of surotomycin remains incomplete due to poor 
outcomes in a reported Phase 3 clinical trial (137,138). Nonetheless, the establishment 
of persistent cells and spores within the biofilms potentially cause rCDI. In vivo, C. difficile 
associates with commensal microbes within the mucus during CDI (139-141). Clumps or 
aggregates (containing polysaccharides and extracellular DNA consistent with a typical 
biofilm matrix) of C. difficile cells have also been observed in mouse models with 
damaged intestinal tissues (86,90,139,141,142). In support of these findings, Normington 
and group, using a model reflective of human colon, recently showed that C. difficile cells 
and spores associate with polymicrobial biofilm communities, which leave vancomycin 
and FMT treatments ineffective at depleting bacterial load (143). Composed of synergistic 
species, including Candida parapsilosis, Staphylococcus warneri, and Bacteroides 
thetaiotaomicron, the polymicrobial biofilms encase C. difficile via species-specific ECM 
and facilitate bacterial growth (143). Since 8 to 18% of FMT patients are reported to 
experience relapsing episode of CDI, it can be suggested that C. difficile within multi-
species biofilm are responsible for causing rCDI (143).  
In summary, C. difficile encodes flagella and TFP that aid in bacterial motility and 
attachment to surfaces of the intestinal epithelial cells. Various motility modes such as 
swimming, swarming, twitching, and gliding are coupled to signaling mechanisms and 
nutritional sources that promote bacterial colonization in the host (144). Bacterial flagella 
and TFP directly influence biofilm formation as deletion of either or both surface 
appendages cause serious impairments in cell attachment, growth, and virulence 
(135,144). Biofilm formation by C. difficile is further regulated by SLPs, Spo0A and the 
luxS-mediated quorum sensing system (135).  
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THE BACTERIAL STRINGENT RESPONSE 
 
Bacteria are exposed to several adverse environmental conditions when colonizing a 
potential host, including nutrient limitation, heat, and pH changes, high osmolarity, 
reactive oxygen species, and antimicrobial peptides of the host innate immune system 
(145-147). Bacteria must respond and adapt to these conditions efficiently to maintain 
growth and survival (147). Therefore, bacteria have evolved several stress response 
pathways that enable adaptation and survival, including the ubiquitous stringent response 
(SR) mechanism (147). The SR is mediated by the nucleotide alarmones GDP-3’-
diphosphate (5’-ppGpp-3’) and GTP-3’-diphosphate (5’-pppGpp-3’) produced from GDP 
and GTP, respectively (147-149). These nucleotides are produced by the members of the 
RelA/SpoT homolog (RSH) protein superfamily (149). Synthesis involves transferring a 
pyrophosphate group of ATP to the 3’OH group of the ribose moiety of GDP or GTP via 
a nucleophilic attack of the β-phosphate of ATP by the 3’OH group of the substrate 
(149,150). Furthermore, the presence of guanosine GMP-3’-diphosphate (5’-pGpp-3’) 
has also been confirmed in numerous species, including Mycobacterium tuberculosis, 
Enterococcus faecalis, Staphylococcus aureus, Mycobacterium smegmatis, 
Corynebacterium glutamicum, and Bacillus subtilis (151-157). To produce pGpp, bacteria 
can directly utilize primary GMP and/or GMP that result from phosphatases-induced ester 
hydrolysis of GTP (151). All three nucleotides or small nucleotide messengers are 
collectively known as (pp)pGpp (149).  
Three main groups of enzymes in the RSH superfamily regulate the intracellular levels 
of (pp)pGpp, including long RSH or full-length RSH enzymes, small alarmone 
synthetases (SAS), and small alarmone hydrolases (SAH) (148,149,158). Long RSH 
enzymes have a hydrolase domain (HD) and a synthetase domain (SD) in their N-terminal 
domain (NTD), and a regulatory C-terminal domain (CTD) (158). The CTD is comprised 
of ThrRS, GTPase, and SpoT (TGS), helical, conserved cysteine (CC), and aspartate 
kinase, chorismate, and TyrA (ACT) domains (158). The NTD contains RSHs’ catalytic 
region where the hydrolase and synthetase domains act coherently to maintain an 
optimum level of cytoplasmic (pp)pGpp based on immediate environmental conditions 
(149,159-161). Binding of the substrate (GXP) and the ATP precursor to the synthetase 
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domain of long RSH enzymes alters protein conformation, resulting in the activation of 
the SD (149,162). Binding of ppGpp to the HD domain, on the other hand, induces 
conformational changes that inactivates the SD while activating the HD to facilitate 
nucleotide hydrolysis (149,162). Notably, the switch between domain activities is 
presumed to occur via protein-protein interactions or small-molecule binding by the 
enzymes’ non-catalytical CTD (147,159,160,163-166). The model Gram-negative 
organism, E. coli, contains two long RSH enzymes. The monofunctional RelA has a 
catalytically inactive pseudo-HD domain, while the bifunctional enzyme SpoT exhibits 
weak synthetase activity and strong hydrolase activity (148,149). Gram-positive species 
such as B. subtilis, Streptococcus equisimilis, S. mutans, and bacteria outside the β-
proteobacteria and γ-proteobacteria group also encode a single long RSH enzyme 
bearing great sequence homology to E. coli RelA and SpoT (149). Gram-positive bacteria 
also oftenly possess one or two monofunctional synthetases (167,168). The SASs lack a 
hydrolase domain and are divided into several subfamilies that are spread across species 
(169). RelQ and RelP from Firmicutes such as B. subtilis and S. aureus are the most 
extensively characterized SASs. Other SASs that have been studied include RelV from 
the Proteobacterium V. cholerae, and RelS as well as RelZ from the Actinobacterium 
group (155,170). RelZ encoded by M. smegmatis is the only SAS enzyme whose 
synthetase domain is fused to an RNase HII domain that separates RNA-DNA hybrid 
structures during DNA replication, repair, and transcription (171). The last group of RSH 
superfamily proteins is the SAH recently identified in C. glutamicum (172). C. glutamicum 
RelH is a member of the metazoan SpoT homolog 1 L (Mesh1-L) subgroup that lacks a 
SD and can hydrolyze (pp)pGpp in vitro (172). Interestingly, genes encoding for (pp)pGpp 
synthetases and hydrolases are conserved in a few plants, including green algae, 
Physcomitrella patens moss, Oryza sativa, and dicotyledon Arabidopsis thaliana, 
Nicotiana tabacum, and Capsicum annnum (173). According to Ito et al., RSH encoding 
genes were first introduced in proto-plant cells via the lateral gene transfer mechanism 
from different bacteria (173,174). Very recently, Ito and colleagues demonstrated that 
ppGpp accumulates in Mesh1 encoding Drosophila at all stages of metazoan 
development (175). As in bacteria, overaccumulation of ppGpp in Drosophila causes 
changes in cellular metabolome and cell death (175).  
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Proteins that are not members of the RSH superfamily can also metabolize (pp)pGpp 
in bacteria. For instance, E. coli encodes guanosine pentaphosphate phosphohydrolase 
(GppA) that lacks the enzymatic domains of the long RSH NTD (176). GppA converts 
pppGpp to ppGpp through its guanosine pentaphosphate phosphohydrolase activity, 
presumably to refine ppGpp potency (176-178). In B. subtilis and Bacillus anthracis, a 
nucleoside diphosphate linked moiety X (NuDiX) hydrolase called NahA degrades 
pppGpp and ppGpp to pGpp in vitro and in vivo (156,157). Hydrolysis of pppGpp and 
ppGpp between the 5’-α and 5’-β phosphate groups is postulated to fine-tune alarmone 
regulation in the bacterial cells (157). Interestingly, Gram-negative E. coli also encodes 
for NuDiX hydrolases such as MutT, NudG, and RppH to cleave pppGpp and ppGpp to 
5’-pGp-3’ in vivo (179,180). However, Gram-positive species are not yet reported to 
encode for GppA homolog(s) or enzyme(s) with identical GppA functionality (181).  
Long RSH enzymes are regulated at the transcriptional level, with transcription 
increasing during the late exponential or stationary phase of bacterial growth or upon 
induced nutrient depletion by inhibitors of biosynthetic pathways (147,158,182-184). The 
specific nutrients that trigger (pp)pGpp synthesis also vary between bacteria (182,185-
187). In E. coli, the relA gene is under the control of four promoters, two σ70-dependent 
promoters, relAP1 and relAP2, and σ54-dependent P3 and P4 promoters (158,188). 
Transcription from relAP1 is constitutive throughout growth, and activity is dependent on 
a UP element (158,188). Transcription from relAP2 is induced when bacteria transition 
from exponential growth to stationary phase (158,188). Conversely, transcription from 
relAP3 and relAP4 is activated from nitrogen starvation in an NtrC-dependent manner 
where NtrC is a master regulator of nitrogen limitation in the niche (158,188). E. coli relA 
is further transcriptionally regulated by HipB, and 6S RNA. HipB is an anti-toxin 
component of the type II toxin-antitoxin module HipAB involved in E. coli persister cells 
formation (189,190). HipB negatively regulates relA transcription in E. coli by binding to a 
sequence upstream of the P3 promoter (189,190). 6S RNA is a small non-coding RNA 
that binds σ70-RNA polymerase (RNAP) to suppress E. coli relA transcription (190). Amy 
et al. demonstrated that E. coli cells lacking 6S RNA present with increased transcription 
of E. coli relA and subsequent accumulation of cytoplasmic ppGpp (191).  
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Transcriptional regulation of Gram-positive long RSHs have not been characterized 
as extensively as that of E. coli RelA. Swantjie et al. evaluated the response of S. aureus 
to mupirocin or pseudomonic acid, which is a structural analog of isoleucyl-adenylate that 
binds eubacterial and archaeal isoleucyl-tRNA synthetases (192). Binding of mupirocin 
to isoleucyl-tRNA synthetases (which otherwise bind isoleucyl-tRNA-isoleucyl adenylate) 
restricts the charging of isoleucyl-tRNA with isoleucine, resulting in the accumulation of 
uncharged isoleucyl-tRNA (193,194). The increased concentration of uncharged tRNAs 
represents amino acid starvation in cells that triggers the stringent response. Therefore, 
the treatment of cells with mupirocin mimics amino acid limitation stress. According to 
Swantjie et al., mupirocin induces S. aureus rel transcription in the S. aureus background 
(192). In M. tuberculosis, rel gene encoding the long RSH enzyme is a part of the σE 
regulon, which is positively regulated by polyphosphate chains that serve as a phosphate 
donor to histidine Kinase MprB (158). MprB senses polyphosphate chains to 
phosphorylate MprA, resulting in the upregulation of SigE transcription (158). SigE is an 
alternative sigma factor, one of the master regulators of bacterial gene expression 
involved in bacterial survival during stressful conditions. In M. tuberculosis, SigE 
contributes to increased bacterial tolerance and persistence to antitubercular drugs (195). 
Based on a study conducted by Kamakshi and colleagues, MrpA-P-driven activation of 
SigE positively regulates M. tuberculosis rel transcription (196).  
Transcriptional control of SASs has been elucidated for some Gram-positive bacteria. 
Under stresses, SAS genes from B. subtilis are differentially regulated during growth 
phases (158). The gene encoding B. subtilis RelQ (relQ) is transcriptionally regulated 
during exponential growth, with mRNA transcript levels decreasing as cells transition into 
the stationary growth phase (168). Conversely, the RelP encoding gene (relP) is induced 
in the late exponential phase when there is a concurrent decrease in relQ transcription 
(168). Of the seven identified sigma factors in the genome of B. subtilis, relP is part of the 
σM and σW-induced regulons (158,197,198). Both sigma factors respond to cell wall 
stresses, including vancomycin and alkaline shock, suggesting that SAS enzymes in this 
organism are activated from extracytoplasmic stresses (158,168). Transcription of S. 
aureus relP and relQ is also induced by vancomycin and exposure to ethanol, increasing 
relP transcription by more than 20-fold (199,200).  
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The intracellular accumulation of (pp)pGpp has a diverse range of biological 
consequences in bacteria. (pp)pGpp can control critical metabolic pathways and 
processes in a cell such as DNA replication, transcription, nucleotide synthesis, and 
translation or protein synthesis. In E. coli, ppGpp directly binds to and inhibits the priming 
activity of DnaG, a DNA primase that synthesizes RNA primers needed for DNA 
replication (201,202). In B. subtilis, pppGpp not ppGpp binds DnaG primase to inhibit 
replication elongation (203). Another consequence of (pp)pGpp accumulation during the 
SR is a rapid change in gene transcriptional profiles. Ribosomal RNA (rRNA) synthesis, 
tRNA synthesis, and transcription of genes involved in the metabolism of DNA and 
phospholipids are dramatically suppressed with a coincident increase in the transcription 
of amino acid biosynthesis genes and nutrient transporters (149,204). In all studied 
Proteobacteria, ppGpp directly interacts with RNAP to influence gene transcription (178). 
In E. coli, binding of ppGpp to RNAP σ70 holoenzyme in the presence of DksA 
transcription factor allosterically potentiates alarmone-mediated inhibition of gene 
transcription (204).  
 In contrast to Proteobacteria, (pp)pGpp in Firmicutes, Actinobacteria, and 
Deinococcus Thermus do not bind RNAP but indirectly contribute to transcriptional 
regulation (205). During the SR, the GTP nucleotide pool decreases due to the production 
of (pp)pGpp via RSH enzyme-catalyzed pyrophosphoryltransferase reaction. A decrease 
in the GTP pool is also attributable to the inhibition of GTP biosynthesis enzymes, 
including inosine monophosphate dehydrogenase (GuaB) and guanylate kinase by 
(pp)pGpp (157,206,207). In B. subtilis, a decrease in GTP levels reduces the transcription 
frequency of σA -dependent promoters at the +1 position during amino acid starvation that 
otherwise use GTP as a transcription initiating nucleotide (205,208). Similarly, GTP at +1 
to +4 positions also have a role in S. aureus gene transcription during SR activation, 
suggesting that initial mRNA elongation step is also sensitive to the intracellular GTP pool 
(209). A global transcriptional repressor called CodY is also able to utilize GTP along with 
branched-chain amino acids as cofactors to regulate gene expression (210). Present only 
in Gram-positive species with low G + C content in their genomes, this nutritional regulator 
senses changes in nutrient availability such that when the GTP concentration is high, 
CodY binds the promoter regions of target genes to block the transcription of genes 
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involved in carbon and nitrogen metabolism as well as in amino acid biosynthesis and 
transport (210-212). When GTP levels are low, CodY-mediated repression of genes are 
de-repressed enabling the transcription and adaptation of bacteria to the immediate 
environment. In 2012, Geiger et al. demonstrated a direct association between the 
stringent response and the CodY regulon (213). They found that out of 150 genes in S. 
aureus that are upregulated during leucine and valine starvation, 143 are positively 
regulated from CodY de-repression (213).  
(pp)pGpp alarmones also inhibit protein synthesis. During the SR, (pp)pGpp targets 
the guanine binding domain of translational GTPases initiation factor 2 (IF2) to prevent 
30S initiation complex (30SIC) formation and translation (149,214,215). IF2 is the only 
initiation factor that binds ribosome to facilitate 30SIC formation and subsequent 
assembly of the 70S initiation complex (70SIC), which results in the formation of the 
initiation dipeptide and the ribosomal pretranslocation complex (215). (pp)pGpp also 
suppresses translation by targeting elongation factors EF-TU and EF-G. These 
elongation factors are essential for charged tRNA delivery and translocation of the peptide 
chain during protein synthesis (149). Additionally, (pp)pGpp inhibits the termination factor 
F3, which during termination plays a critical role in the removal of release factors (RF) 1 
and 2 (that hydrolyze and release the completed nascent chain from the P-site tRNA) 
from the ribosome (149,216). Binding of ppGpp to RF3 reportedly slows down translation 
(216). Finally, (pp)pGpp halts protein synthesis via inhibition of ribosomal maturation. 
(pp)pGpp targets GTPases such as RsgA, RbgA, Era, HfIX, and Obg that function in the 
maturation of individual 50S and 30S ribosomal subunits prior to the formation of mature 
70S ribosomes (149,217).  
Despite interfering with protein synthesis at different stages, (pp)pGpp can still 
activate the transcription and translation of several genes required for the SR cascade. 
Recently, Vinogradova and group showed that 30S-bound IF2 exhibits different tolerance 
to 5’-ppGpp-3’ based on the mRNA present in the 30S pre-IC state (218). In E. coli, 
structured enhancer of translational initiation (SETI) confers ppGpp tolerance for tuƒA 
(encoding elongation factor EF-TU) and rnr (encoding RNase R) mRNA under 
physiological concentrations of GTP (218). According to Vinogradova and group, SETI-
mRNA binds to 30S pre-IC complexed with ppGpp and enables the substitution of ppGpp 
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for GTP to allow translation (149,218). Furthermore, pppGpp bound to IF2 also enables 
the permissive synthesis of proteins, albeit at higher IF2 concentrations (149,218).   
One of the most intriguing aspects of the stringent response is its association with 
virulence phenotypes (motility, adhesion, and invasion) and traits such as biofilm 
formation, sporulation, toxin production, and antibiotic survival (Table 1) (147,149,219). 
For instance, ppGpp is required for host cell invasion and regulation of virulence gene 
expression in Salmonella typhimurium. Using a (pp)pGpp-null mutant of Salmonella 
enterica subsp. enterica serovar Typhimurium, Pizarro et al. demonstrated that bacterial 
invasion of intestinal epithelial cells is attenuated in the animal infection model (220). 
Based on their study, a (pp)pGpp-null mutant exhibited reduced expression of hilA and 
invF that encode two essential transcriptional activators of the Salmonella pathogenicity 
island 1 (SPI-1) operon (220). SPI-1 encodes a type III secretion system responsible for 
secreting factors that support bacterial uptake and invasion (220). (pp)pGpp also binds 
to S. typhimurium SlyA transcriptional activator leading to SlyA dimerization in vivo (221). 
The SlyA dimers subsequently bind to the target promoter DNA and influence the 
transcription of the pagC virulence gene (221). PagC is an outer-membrane protein that 
confers an appreciable degree of serum resistance to S. enterica serovar Choleraesuis 
enabling infection establishment (222). The importance of (pp)pGpp to Salmonella 
invasion was further explored by Dasgupta and colleagues who discovered that a 
(pp)pGpp-null mutant strain displays decreased flagellar-motility and phagocytic uptake 
by macrophages owing to diminished bacterial adhesion (223). Additionally, the role of 
(pp)pGpp in bacterial invasion and intra-epithelial survival has been evaluated in C. jejuni. 
In C. jejuni, the stringent response is specifically regulated by SpoT, and according to 
Gaynor et al., a SpoT mutant strain exhibits poor invasion of human epithelial cell lines, 
along with defects in host cell survival (224). Interestingly, the ΔSpoT strain also exhibits 
higher susceptibility to rifampicin in comparison to the WT strain, suggesting that the SR 
contributes to antibiotic resistance in C. jejuni (224).  
The stringent response is critical for pathogenesis in P. aeruginosa as well. A relA 
spoT double mutant strain of P. aeruginosa is severely attenuated in virulence in animal 
models (225,226). According to Vogt et al., the double mutant strain secretes a reduced 
amount of virulence factors, including pyocyanin, elastase, and the siderophore 
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pyoverdine (225). Reduced production of these virulence factors is presumably due to 
altered expression of the Las and/or RhI quorum sensing systems, suggesting that 
quorum sensing signaling also contributes to the ability of P. aeruginosa to cause chronic 
infection (225). The contribution of ppGpp in antibiotic tolerance to quinolone in P. 
aeruginosa has also been evaluated. Knockout mutants of P. aeruginosa SpoT and dksA 
appear to show higher survival rate in the presence of ofloxacin and ciprofloxacin 
compared to relA knockout strain, suggesting that lower levels of ppGpp in the later strain 
renders the mutant less tolerant to quinolones (227). Furthermore, the relA spoT double 
mutant displays impaired flagellum-mediated swarming and TFP-mediated motility 
compared to the WT strain, suggesting that (pp)pGpp is required for P. aeruginosa 
adhesion (225). Since biofilm formation is dependent on bacterial motility, adhesion, and 
translocation, the relA spoT double mutant strain of P. aeruginosa also exhibits reduced 
biofilm formation and cell viability (226).  
The contribution of (pp)pGpp in biofilm formation has also been implicated in other 
species, including E. coli, V. cholerae, and S. mutans (228-230). In E. coli, fimbriae are 
important factors for bacterial attachment to host cells (149). The expression of type 1 
fibrial genes in uropathogenic E. coli is upregulated by (pp)pGpp via transcriptional 
activation of the ƒimB gene whose protein product acts as a recombinase switch to turn 
on the ƒimAICDFGH operon (149,228). Activation of the ƒimAICDFGH operon promotes 
transcription of many fimbria-encoding genes with roles in bacterial adhesion and initial 
steps of biofilm formation (228). (pp)pGpp-null uropathogenic E. coli mutants fail to 
display fimbriae on their surface, resulting in impaired biofilm formation (228). In V. 
cholerae, genes involved in biofilm formation are regulated by the transcriptional 
activators vpsR and vpsT of the Vibrio exopolysaccharide operon, which in turn are 
regulated by the stationary phase sigma-factor σS (rpoS) (229). According to He et al., all 
three SR-mediating synthetases play a distinct role in the positive transcriptional 
regulation of vpsR and vpsT, suggesting that biofilm formation is controlled by (pp)pGpp 
(229). S. mutans form biofilms to tolerate pH changes and nutrient limitation in the human 
oral cavity (230). S. mutans relA insertional mutants also show a significant reduction in 
biofilm formation (230). Interestingly, Lemos and group found the biofilms of the relA 
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mutants to be more resistant to acid killing, suggesting that the physical barrier of biofilms 
contributes minimally to acid diffusion in this organism (230).  
Apart from adhesion, antibiotic tolerance, and biofilm formation, (pp)pGpp also 
regulates sporulation and toxin production in bacteria. During amino acid starvation, a 
relA deletion mutant of B. anthracis demonstrates significantly reduced sporulation, 
notably, without affecting bacterial virulence in animal models of infection (231). Upon 
germination, B. anthracis produce toxins and a capsule where the toxin-form constitutes 
of a protective antigen (encoded by pagA) with either the lethal factor (encoded by lef) or 
oedema factor (encoded by cya) (231). The capsule, which is composed of poly-γ-D-
glutamate aids in inhibiting bacterial phagocytosis during infection (231). Both toxins and 
capsule formation in the organism are regulated by AtxA (231). However, relA deletion 
does not impact pagA and atxA transcription, suggesting that the SR in B. anthracis is 
more critical in priming cells to sporulate than in virulence factors production during 
nutrient limitation (231). In V. cholerae, the toxin-coregulated pilus (TCP) and cholera 
toxin are major virulence factors responsible for host colonization and symptomatic 
infection (232). Expression of genes encoding these virulence factors is controlled by the 
ToxR regulon, which includes ToxR (encoded by toxRS), TcpP (encoded by tcpPH), and 
ToxT (encoded by toxT) transcriptional activators (232). Where ToxT directly initiates 
cholera toxin and TCP genes transcription, TcpP and ToxR control the expression of ToxT 
(232). TcpP is needed for bacterial colonization of the small intestine during early stages 
of infection so that toxin production can be enabled (232). Recently, Raskin and group, 
using ΔrelAΔspoTΔrelV strains demonstrated that tcpPH and toxT expression are 
decreased in cells devoid of (pp)pGpp with a corresponding defect in bacterial 
colonization and toxin production, suggesting that the SR regulates cholera toxin and TCP 











Due to the role of (pp)pGpp in bacterial virulence factor production, antibiotic 
tolerance, infection, and persistence, there has already been some interest in inhibiting 
the SR cascade. One of the first molecules to be synthesized for the targeted inhibition 
of the SR-regulating RSH enzymes is Relacin (233). Relacin is a ppGpp analog in which 
the molecule’s pyrophosphate moieties at positions 5’ and 3’ are substituted with a glycyl-
glycine dipeptide linked to the sugar ring by a carbamate bridge (Fig. 4) (233,234). 
Functionally, Relacin perturbs stationary phase onset and viability of Gram-positive B. 
subtilis, Deinococcus radiodurans, and Streptococcus pyogenes (233). In vitro analyses 
by Wexselblatt et al. also demonstrated that Relacin inhibits (pp)pGpp synthesis driven 
by B. subtilis RelA and D. radiodurans RelA in a dose-dependent manner (233). 
Furthermore, in B. subtilis and B. anthracis, Relacin largely inhibits sporulation by 
lowering the number of cells expressing sporulation-specific enzymes required in different 
Table 1.  
Stringent response is widely conserved in bacterial groups. Summary of components 
of the stringent response that contribute to virulence traits and phenotypes in diverse 
bacterial species. Adapted from Dalebroux et al. 2010. 
Pathogen RSH enzyme(s) Phenotypes/traits 
Yersinia pestis RelA, SpoT, DksA Infection, dissemination 
Legionella pneumophila RelA, SpoT, DksA Macrophage transmission 
Shigella flexneri RelA, SpoT, DksA Intracellular spread 
Mycobacterium tuberculosis RelA Persistence 
Listeria monocytogenes RelA, RelQ, RelP Adherence, survival 
Staphylococcus aureus RelA, RelQ, RelP Viability 




stages of the sporulation process (233). Relacin also reduces B. subtilis biofilm formation 
(233). E. coli RelA-mediated (pp)pGpp synthesis is also inhibited by Relacin in vitro, 
although the compound fails to inhibit E. coli growth and survival (233). Furthermore, 
Relacin has no effect on the (pp)pGpp synthetase activity of SAS family synthetases, 
indicating that the compound’s activity is specific for long RSH enzymes (152).  
Employing the crystal structure of the N-terminal catalytic fragment of the long RSH 
enzyme encoded by S. equisimilis, Wexselblatt and group also modeled the interaction 
of Relacin with the enzyme’s SD to determine the molecule’s mechanism(s) of inhibition 
(233). Based on their putative model, Relacin adopts an optimal conformation upon 
binding to the extremely polar Rel/Spo synthetase domain active site (233). In this 
conformation, Relacin forms a net of hydrogen bonds and strong hydrophobic interactions 
with relevant amino acid residues within the domain’s GDP-binding pocket (233). 
Additionally, the hydrophobic isobutyryl group of the compound at position N2 of the 
guanosine base (Fig.  4, black dashed circle) makes contact with a defined hydrophobic 
patch within the SD active site, ensuring high-affinity interaction and effective occlusion 




Figure 4. Chemical structure of Relacin. Relacin contains an isobutyryl group 





Despite its efficacy at inhibiting RSH/Rel-mediated (pp)pGpp synthesis in vitro and 
in vivo, and the long-term survival strategies employed by some deadly pathogens, 
Relacin is only effective at millimolar concentrations. Therefore, efforts have been made 
to increase the potency of Relacin by synthesizing analogs of the molecule (235,236). 
Wexselblatt et al. synthesized a series of analogs that were symmetrically substituted 
with several amino substituents (Fig. 6) in place of the moieties at positions 5’ and 3’ 
deoxyribose ring of Relacin (Fig. 5) (235). The activity of the inhibitors was also tested in 
vitro using Rel enzymes encoded by B. subtilis, D. radiodurans, and E. coli.  According to 
Wexselblatt et. al., of all the symmetrically substituted analogs, compounds 2a and 2d 
demonstrated highest inhibitory activity, potentially due to the replacement of basic 
dimethylamino groups with carboxylic acid(s) (Fig. 6) (235). Between compounds 2a and 
2d that only differ in the number of negatively charged species and in bulkiness, 
compound 2a reduced intracellular levels of serine hydroxamate (SHX)-induced 
(pp)pGpp levels in B. subtilis (235). SHX is a derivative of L-serine that serves as a 
completive inhibitor of seryl-tRNA synthetases, mimicking amino acid starvation in 
bacterial cells and evoking the SR (237). Compound 2d deemed significantly more 
effective at reducing B. subtilis (pp)pGpp levels in vivo (235). Furthermore, compound 2d 
was more effective at inhibiting (pp)pGpp synthesis via E. coli RelA and D. radiodurans 
Rel/Spo in vitro (235). The efficacy and potency of compound 2d are directly attributable 
to the two glutamyl-glutamic acid moieties of the analog (235). The six-total number of 
carboxylic acids in this analog makes it more acidic and voluminous than the parent 
Relacin molecule, enabling more hydrogen bonding and electrostatic salt bridges 











Figure 5. Schematic representation of the synthetic route employed for 
symmetric compounds analogous to Relacin. Reaction conditions as mentioned in 
the reference Wexselblatt et al. 2013 from which the figure has been adapted.  
 
 
Figure 6. Summary of symmetric substituents on the 3’ and 5’ positions of Relacin 







Syal et al. substituted the isobutyryl group at the second position of Relacin 
guanosine base with either a bulkier benzoyl group or a less bulkier acetyl group called 
acetylated benzoylated compound (AB) and acetylated compound (AC), respectively 
(Fig. 7) (236). They found  both compounds to inhibit M. smegmatis Rel-driven pppGpp 
synthesis in vitro and in vivo, with compound AB being a more potent inhibitor of the 
bacterial Rel protein (236). The group further demonstrated that both synthetic 
compounds affect long-term M. smegmatis survival and biofilm formation (236). These 
nontoxic and cell permeable agents also disrupt preformed biofilms produced by M. 
smegmatis and arrest biofilm formation in M. tuberculosis (236). Overall, the chemical 
modifications of Relacin render the molecule more potent, providing further modification 
opportunities so that inhibitor activity in the nanomolar range can be attained for use in 
the clinical settings.  
Apart from Relacin and its structural analogs, molecules that interfere with the 
bacterial SR have included vitamin C and an inhibitor peptide called peptide 1018 (234). 
Vitamin C is an antioxidant agent that has roles in strengthening host immune system, 
speeding recovery from a tuberculosis infection, and impeding pathogen progression, 
 
Figure 7. Modification of Relacin isobutyryl group. Analogs of Relacin where the 
isobutyryl group have been substituted with (A) acetylated compound and (B) 









even killing M. tuberculosis (238). Vitamin C also alters regulatory pathways linked to 
bacterial stress response and dormancy (238). Structurally, vitamin C has a furan ring 
with 1,2 dihydroxy ethyl moiety that bears remarkable similarity to the chemical structure 
of GDP. Sayl et al. showed that vitamin C inhibits (pp)pGpp synthesis in vitro in a dose-
dependent manner and in vivo via direct interaction with M. smegmatis Rel enzyme (238). 
Furthermore, vitamin C lowers bacterial viability and the ability of M. smegmatis to form 
biofilms, suggesting that vitamin C affects the SR in this organism by altering the levels 
of (pp)pGpp (238). Unlike Relacin, Relacin derivatives, and vitamin C, synthetic peptide 
1018 directly targets (pp)pGpp nucleotides (239,240). Peptide 1018 is a board-spectrum 
anti-biofilm agent that prevents biofilm formation by diverse species, including P. 
aeruginosa, S. enterica, E. coli, S. aureus, Klebsiella pneumoniae, Burkholderia 
cenocepacia, and Acinetobacter baumannii at concentrations as low as 10 µg/mL (240). 
During the stringent response, peptide 1018 specifically binds ppGpp as per co-
precipitation and nuclear magnetic resonance spectroscopy (NMR)-based analyses 
(240). Peptide-bound ppGpp nucleotides in P. aeruginosa undergo rapid molecular 
degradation, leading to the inhibition of biofilm formation, cell death within biofilm 
communities, and dispersal in matured biofilms (240). This suggests that peptide 1018 
prevents (pp)pGpp signaling and the consequences of the signaling cascade, such as 
virulence factors production in pathogenic strains. The synergistic effects of peptide 1018 
against biofilms in conjugation with conventional antibiotics have also been investigated 
(239). Reffuveille et al. demonstrated that peptide 1018 in combination with ciprofloxacin, 
ceftazidime, imipenem, or tobramycin prevents biofilm formation and disrupts preformed 
biofilms in a diverse group of bacteria (239). Furthermore, interaction between the peptide 
and antibiotics results in a considerable decrease in antibiotic concentrations needed to 
inhibit biofilm production (239). Notably, the peptide and ciprofloxacin combination 
substantially increases the susceptibility of planktonic P. aeruginosa cells during SHX-
induced stringent response, suggesting that the targeted degradation of (pp)pGpp by 
peptide 1018 contributes to one, increased antibiotic susceptibility and two, decreased 
biofilm production (239).  
 Recently, a diterpene analog, 4-(4,7-Dimethly-1,2,3,4-tetrahydroNapthalene-1-
yl)Pentatonic acid or DMNP was shown to suppress M. smegmatis persistence and 
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biofilm formation at concentrations as low as 0.14 mM (~14 X less than the efficacious 
dose of Relacin) (241). The synthetic DMNP compound targets M. smegmatis Rel and 
SAS (RelZ) to inhibit (pp)pGpp synthesis while also increasing bacterial antibiotic 
susceptibility to streptomycin and rifampicin (241). Taken together, the bacterial SR 
mechanism is a largely conserved stress signaling with diverse triggering factors. The 
hallmark of the stress response, (pp)pGpp, which is metabolized by enzymes of the RSH 
superfamily and beyond, have distinct but partially overlapping functions in bacterial 
physiology. Due to the contributions of the stringent response in bacterial stress 
tolerance, survival, and pathogenesis, both RSH enzymes and small alarmone 
nucleotides catalyzed by RSHs are targets for pharmaceutical and pharmacological 
interventions.  
THE SCOPE OF THIS DISSERTATION 
 
The main objectives of the work presented in this dissertation are to:  
1. Investigate whether Clostridioides difficile can mount the stringent response using 
recombinant gene expression and protein purification techniques; confirm protein 
function and perform biochemical characterization of C. difficile full-length RSH 
enzyme using thin layer chromatography assays and high-performance liquid 
chromatography (Chapter II). This chapter is based on the publications Pokhrel et al. 
2018 and Pokhrel et al. 2020.  
2. Characterize full-length RSH-mediated (pp)pGpp signaling in C. difficile using 
quantitative reverse transcriptase-polymerase chain reaction and an oxygen-
independent fluorescent transcriptional reporter. Bacterial response to stationary 
phase onset, nutrient limitation, and antibiotics exposure was examined (Chapter III). 
This chapter is majorly based on the publication Pokhrel et al. 2020. 
3. Evaluate the effect(s) of disrupting the stringent response in C. difficile stress 
tolerance and survival using Relacin and RNA interference gene-silencing tool 
(Chapter IV). This chapter is based on the publication Pokhrel et al. 2020. 
4. Evaluate nutrient-derived motility regulation and single-species biofilm formation by 
C. difficile using a home-built rose cell chamber for single cell motility analyses and 
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plate-based biofilm production assays (Chapter V). Major aspects of this chapter are 
based on the publication Courson et al. 2019. 
 
Overall, this dissertation aims to introduce the ability of Clostridioides difficile to elicit 
the stringent response pathway via the synthetase activity of its long RSH enzyme. The 
research herein allows a greater understanding of a ubiquitous signaling system that is 
also significant for the survival and pathogenesis of C. difficile. Additionally, this 
dissertation aims at expanding the knowledge about factors contributing to C. difficile host 
colonization and virulence factors production, such as motility and biofilm. These data 
provide the foundation necessary for the synthesis and screening of small molecule 
inhibitors of the enzyme that demonstrate high specificity. The use of C. difficile RSH-
specific inhibitors in place of antibiotics or in conjugation with clinically available antibiotics 
could significantly minimize antibiotics-induced risk factor development for CDI, along 
with the side effect of bacterial antibiotic resistance in the host. The development of an 
alternative therapy will alleviate the international health and economic burden associated 























 The stringent response is a globally conserved stress signaling pathway, primarily 
characterized by the cytoplasmic accumulation of ppGpp and pppGpp alarmones. ppGpp 
and pppGpp are produced by members of the RSH superfamily from GDP and GTP, 
respectively (149,158). The presence of pGpp (formed from GMP and/or degradation of 
ppGpp and pppGpp has also been confirmed in several species (149). Together, 
(pp)pGpp regulates key physiological processes within the cells, including the inhibition 
of DNA replication, nucleotide synthesis and protein synthesis, with a concomitant 
increase in the transcription of amino acid biosynthesis and transport genes (149). 
Importantly, (pp)pGpp downregulates transcription of factors needed for growth and 
division, while upregulating stress response and virulence genes (182). Genes encoding 
proteins for (pp)pGpp metabolism are common in the genomes of Proteobacteria, 
Eubacteria, and eukaryotes as well as metazoa (160,175).  
Most Gram-positive RSH exhibit net (pp)pGpp hydrolysis activity under normal 
growth conditions. The first crystal structure of the N-terminal catalytic fragment of full-
length S. equisimilis Rel (RelSeq) revealed two conformations of the fragment, hydrolase-
OFF/synthetase-ON and hydrolase-ON/synthetase-OFF (159). Of the two conformations, 
RelSeq assumes the default (pp)pGpp-hydrolase-ON/(pp)pGpp-synthetase-OFF state 
until substrate binding to either catalytic site induces a mechanical switch of the 
conformational state; a process controlled by the enzyme’s CTD (159,160,242). The 
catalytical domain (aa residues 1- 347) and regulatory domain (aa residues 363 – 739) of 
RelSeq is presumed to be linked by a solvent-exposed, flexible hinge (160,242). When 
the two enzymatic domains of the NTD are aligned with one another and to the CTD, the 
hydrolase domain is activated (160). However, when the contact between the NTD and 
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CTD is perturbed, the NTD folds and undergoes a conformational change that leads to 
the activation of the synthetase domain (160). 
For instance, full-length RelSeq exhibits weak pyrophosphoryl transfer activity for 
basal (pp)pGpp synthesis due to its interaction with the CTD. However, the transferase 
reaction is activated ~12-fold in the absence of the C-terminal region of the enzyme in 
vitro, suggesting that the CTD of RelSeq participates in the reciprocal regulation of the 
two opposing catalytic activities of the NTD (160). Unlike RelSeq, M. tuberculosis Rel 
(RelMtb) catalyzes both transferase and hydrolase reactions at the maximal rate in vitro 
(243). But binding of full-length RelMtb to a complex containing uncharged tRNA, 
ribosome, and mRNA results in a 20-fold increase in the rate constant for the catalytic 
conversion of GXP to (pp)pGpp with a concurrent 2-fold decrease in the Kcat for (pp)pGpp 
hydrolysis (243). The presence of uncharged tRNAs, which is caused by amino acid 
limitation in bacterial cells, rapidly increases bifunctional Rel/RSH-catalyzed (pp)pGpp 
synthesis while exhibiting an opposite effect when treated with charged tRNAs (243). The 
regulation of the opposing catalytic activities of full-length RSH enzymes is extremely 
critical since equally active, unregulated hydrolase and synthetase domains would 
catalyze a futile cycle of alarmone synthesis and hydrolysis (242). Too much synthetase 
activity would elevate cytoplasmic (pp)pGpp levels provoking the SR, whereas too little 
(pp)pGpp from uncontrolled hydrolysis activity would restrict cells from responding 
appropriately to extracellular stresses (242). Gram-positive bacteria also oftenly encode 
one or two SAS enzymes that lack both N-terminal hydrolase and C-terminal regulatory 
domains of the long RSHs (158). Studies have shown that deletion of RelQ, RelP or both 
while leaving an intact RSH enzyme has minimal effects on the intracellular (pp)pGpp 
accumulation during the stringent response (167,168). However, in the absence of an 
intact long RSH enzyme, constant yet low production of alarmones by SAS results in an 
increased basal (pp)pGpp levels in E. faecalis, suggesting that SASs contribute to basal 
levels of (pp)pGpp under normal physiological conditions (244-246).  
The synthetase reactions catalyzed by RSH and SAS enzymes are universally 
dependent on Mg2+ cofactor(s) although both enzymes differ in their catalytic mechanism 
of (pp)pGpp synthesis. According to Sajish et al., a charge reversal in the highly 
conserved RXKD motif of the long RSH synthetase domain to EXDD in the SAS domain 
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contributes to the differential effect of metal cofactor and also impacts substrate 
preference (151,247). When concentrations of Mg2+ are higher than that of the total 
nucleotide pool, binding of Mg2+ to the full-length RSH enzyme presumably causes a 
protein conformational change that occludes substrate binding, resulting in the inhibition 
of (pp)pGpp synthesis (160,243,247). Using fluorescent-based nucleotide binding assays 
and circular dichroism studies, Sajish and group revealed that the RXKD motif of 
bifunctional RSH enzymes contribute to poor nucleotide binding and structural 
transitioning of the catalytic loop (α-13/β-4 loop of the SD as per the crystal structure of 
the N-terminal catalytic domain of RelSeq) strongly in favor of an alpha-helix in the 
presence of high Mg2+  (159,247).  
Of note, high Mg2+ concentrations do not affect enzyme-catalyzed reactions for 
proteins employing a dual-divalent cation mechanism (247). The closest structural relative 
to the SD of RelSeq is the palm domain of mammalian DNA polymerase β (polβ) (159). 
Of the three highly conserved aspartate amino residues that coordinate two Mg2+ ions in 
polyβ, only two carboxylic acid groups (D264 and E323) are conserved in the RelSeq 
synthetase domain, suggesting that the absence of a third carboxylic group potentially 
enables a single-divalent cation mechanism for RSH-mediated (pp)pGpp catalysis 
(159,247). In the contrary, high Mg2+ concentrations appear to have no effect on SAS-
mediated (pp)pGpp synthesis (247). The two additional negative charges in the EXDD 
motif of SAS enzymes create a second Mg2+ binding site lacking in the RXKD motif, 
suggesting that SASs follow a dual-divalent cation-mediated catalysis (247). 
Furthermore, the charge reversal in the RKXD motif of long RSH proteins to EXDD in 
SASs also influences substrate specificities. Full-length RSH proteins with an RXKD motif 
preferentially utilize GTP to produce pppGpp, whereas SASs with an EXDD motif prefer 
GDP as the primary substrate to produce ppGpp (151).  
During host colonization and infection, C. difficile encounters and adapts to 
environmental changes using different stress response pathways. We have found that C. 
difficile genome encodes a putative long RSH and a SAS, RelQ, suggesting that the 
organism is capable of mounting the SR (147). The long RSH protein contains the well-
conserved RXKD motif and we predict the enzyme to be bifunctional (147). To determine 
the substrate preference and kinetics of RSH encoded by C. difficile (RSHCd), we 
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expressed hexa-histidine tagged recombinant RSHCd in a non-native background and 
purified the enzyme using metal affinity chromatography (248). We subsequently 
performed in vitro (pp)pGpp synthesis reactions in the presence of guanosine phosphate 
derivatives and commercially available γ-32P-ATP or 32P-ATP and monitored enzyme-
catalyzed pyrophosphoryl transfer activity using thin layer chromatography (TLC) 
(147,248). While characterizing the contribution of RSHCd to (pp)pGpp synthesis in vitro, 
we found RSHCd incapable of utilizing GTP and GMP (147). Based on the enzyme’s strict 
GDP utilization unlike its Gram-positive full-length RSH homologs, we previously reported 
that RSHCd produces 5’-ppGpp-3’ (147,248). We also found GDP utilization by RSHCd 
to be independent of environmental pH and to lack metal cofactor specificity (147).  
We initially predicted that the production of ppGpp by RSHCd is either due to the 
exclusive utilization of GDP or rapid degradation of unstable pppGpp to ppGpp under the 
experimental conditions used although RSHCd binds GTP with poor affinity, indicating 
that the interaction likely doesn’t occur in vivo (147). In Gram-negative bacteria, pppGpp 
is broken down to ppGpp via GppA, whose homologs remain to be identified in Gram-
positive species. Very recently, Yang et al. identified NahA, a NuDiX hydrolase encoded 
by B. subtilis and B. anthrasis to be able to hydrolyze pppGpp and ppGpp to pGpp (157). 
Like other SR-regulating alarmones, pGpp regulate purine nucleotide biosynthesis in 
bacterial cells without interacting with GTPases (157). To confirm that the exclusive 5’-
ppGpp-3’ synthesis is a unique feature of RSHCd, we have used purified RelQ from B. 
subtilis (RelQBs) as a positive control to detect the products catalyzed by in vitro 
(pp)pGpp synthesis reactions using anion exchange chromatography. We found that 
incubation of RelQBs with GTP and GDP results in the formation of pppGpp and ppGpp, 
respectively (Poudel et al. in preparation). Unexpectedly, high performance liquid 
chromatography showed that the consumption of ATP by RSHCd occurred concurrently 
with the apparent formation of triphosphate species, leading us to hypothesize that 
RSHCd produces pGpp instead of ppGpp in the presence of GDP substrate. In support 
of this hypothesis, our thin layer chromatography assay demonstrated that incubation of 
RelQBs with GMP and 32P-ATP results in the formation of spot (representing pGpp) that 
in polyethyleneimine (PEI)-cellulose plate migrates similar distance with putative pGpp 
produced by RSHCd (Poudel et al. in preparation). The principal rule governing (pp)pGpp 
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synthesis requires a pyrophosphate moiety from ATP to be transferred to the 3’-OH group 
of GMP, GDP or GTP substrate by members of the RSH superfamily (243). Based on this 
rule, we postulate that GDP is being degraded to GMP, enabling RSHCd to catalyze an 
ATP-dependent pyrophosphate transfer to synthesize pGpp (Poudel et al. manuscript in 
preparation). Additionally, we postulate that RSHCd hydrolysis activity requires regulation 
by the CTD via interaction with branched-chain amino acids and that the enzyme 
harnesses a default synthetase activity in isolation or independent of biological effectors. 
We found that the overexpression of the monofunctional RSH-REL domain is extremely 
toxic to bacterial cells, suggesting that the CTD and the HD domain of full-length RSH 
coordinate to prevent excessive intracellular accumulation of (pp)pGpp in C. difficile.  
Overall, this chapter focuses on characterizing the synthetase activity of full-length 
C. difficile RSH, which is predicted to be regulated by the enzyme’s intact hydrolase and 
C-terminal regulatory domains. Segments of this chapter previously appeared as articles 
in the references (248) and (147). The rights and permission to use the materials of the 
publications is given in Appendix M. Published figure numbers and formats have been 
modified unless stated otherwise in the legends.  
METHODS AND MATERIALS   
 
Overexpression and purification of C. difficile RSH  
Restriction enzymes and DNA ligase used in this study were purchased from New 
England Biolabs (NEB). Phusion DNA polymerase for polymerase chain reactions (PCR) 
was purchased from Themro Fisher Scientific. rsh (CDR20291_2633) gene was amplified 
from the genomic DNA of C. difficile R20291 using primers (Appendix B) that added a C-
terminal hexa-histidine tag, ligated into the pMMBneo expression vector at the KpnI and 
PstI restriction sites, and transformed into E. coli BL21. The plasmid was confirmed by 
PCR using rsh gene-specific primers (Appendix B). 
E. coli expression strain carrying pMMBneo vector ligated with hexa-histidine 
tagged rsh gene was grown in Luria Bertani (LB) treated with 50 µg/mL kanamycin (Kan50) 
at 37 degrees Celsius (°C) to an optical density (OD) of 0.16 to 0.25 at 600 nm (if OD600 
reached above this range, cell cultures were back diluted into fresh LB-Kan50 at the 
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desired OD value or range), at which point the temperature was dropped to 30°C and 
expression was induced using 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) for 
16 hours (hrs). Cells were lysed by sonication in the lysis buffer composed of 10 mM Tris-
HCl pH 7.8, 300 mM NaCl, 5 mM MgCl2, 50 mM NaH2PO4, 10% glycerol, 0.5 mg/mL 
lysozyme, 10 mM imidazole, 0.25 mM dithiothreitol (DTT) and 5 mM 
phenylmethylsulphonyl fluoride (PMSF). After treatment with the lysis buffer, the lysates 
were clarified by centrifugation and subsequently transferred to a gravity column filled 
with 1 mL of HisPure Ni-nitrilotriacetic acid (Ni-NTA) resin (G-Biosciences). Protein 
purification was conducted according to the manufacturer’s protocol. Notably, all 
purification buffers included 5 mM MgCl2 which was found to be critical for protein 
stabilization and purification. Purification fractions were run on a Sodium dodecyl sulfate 
polyacrylamide gel (SDS-PAG) (4% stacking and 10% separating) via electrophoresis to 
resolve the elutant fractions. Purified RSHCd (elutant fraction 2) was dialyzed overnight 
(ON) at 4°C against dialysis buffer composed of 15.7 mM Tris-HCl pH 7.6, 471.9 mM 
NaCl, 15.69 mM MgCl2, 1.57 mM DTT, 1.5 mM PMSF, and 15.7% glycerol. A 30 kilodalton 
(KDa) molecular weight cutoff (MWCO) dialysis membrane (Spectra/Por Spectrum® 
Laboratories Inc.) was used for protein dialysis. Concentration of C. difficile RSH was 
determined from Beer’s law by measuring the absorbance at 280 nm and using the 
calculated molar extinction coefficient 82085 M-1cm-1. Aliquots of the protein were stored 
at -80°C for subsequent use.  
 
Purification of B. subtilis RelQ  
Plasmid bearing E. coli BL21 strain (received from the Bauer laboratory, Indiana 
University, USA) were grown to OD600 of 0.4 in LB-Kan50 before ON induction for protein 
expression at 16°C with the addition of 0.2 M IPTG. Cells were collected by centrifugation 
and resuspended in StrepTactin wash buffer (IBA Lifesciences) composed of 0.1 M Tris-
HCl pH: 8.08, 0.15 M NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), and 20% 
glycerol. Cells were lysed by sonication and the lysates were clarified by centrifugation at 
12,000 revolutions per minute (RPM) (Beckman coulter JA 12.0 rotor) at 4°C prior to 
loading onto a StrepTactin resin column (IBA Lifesciences). The column was washed with 
the wash buffer (IBA Lifesciences) followed by protein elution with elution buffer 
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composed of 0.1 M Tris-HCl pH: 7.92, 0.15 M NaCl, 1 mM EDTA, and 2.5 mM 
desthiobiotion (IBA Lifesciences). The elutants were collected in three separate fractions 
and stored at - 80°C in 5 to 10 µL aliquots to be used for subsequent enzymatic assays. 
When necessary, fractions were combined, and spin concentrated at 4,500 RPM 
(Beckman Coulter JA-12 rotor) for 15 minutes (mins) using a 10 KDa MWCO spin 
concentrator (Sartorius). Concentration of B. subtilis RelQ was determined 
spectrophotometrically.  
 
Overexpression and purification of C. difficile RSH-REL 
rsh-rel, a truncation construct of the full-length rsh gene, was amplified from 
pMMBneo::rsh expression vector using primers (Appendix B) that also added a C-
terminal hexa-histidine tag. The amplicon was subsequently digested and ligated into 
pMMBneo vector at the KpnI and PstI cut sites and transformed into E. coli DH5-α 
background. The plasmid was confirmed by PCR using rsh-rel-specific primers (Appendix 
B).  Amplified rsh-rel was also digested and ligated into pBAD33 vector at the KpnI and 
PstI sites. The plasmid pBAD33::rsh-rel (Appendix A) was subsequently transformed into 
DH5-α first, followed by plasmid extraction from DH5-α background and transformation 
into E. coli BL21. The plasmid was confirmed by PCR using rsh-rel-specific primers 
(Appendix B). 
For RSH-REL purification, rsh-rel was amplified from pMMBneo::rsh expression 
vector using primers (Appendix B), digested and ligated at the NdeI and XhoI cut sites 
into pET24a vector fused with a hexa-histidine tag. The plasmid, pET24a::rsh-rel 
(Appendix A) was transformed into E. coli BL21 expression strain. Transformation was 
confirmed using gene-specific primers (Appendix B). The expression strain was 
eventually grown in LB-Kan50 supplemented with 0.5% casamino acid (CAA) and 0.5% 
glucose (GLU) at 37°C ON. The following day, the ON starter culture was spun at 4°C 
using a JA-12 rotor (Beckman Coulter) at 500 RPM for 30 mins. The pellet was 
resuspended in plain LB-Kan50 medium and allowed to grow till the cell density reached 
0.5 to 0.8 at 600 nm. At this point the cells were diluted down in fresh plain LB-Kan50 to 
bring the OD600 at ~0.14. When the new OD600 value was between 0.14 to 0.16, the 
temperature was dropped to 30°C and expression was induced using 0.5 mM IPTG ON 
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(16 to 20 hrs). After induction, cells were lysed by sonication in the lysis buffer composed 
of 10 mM Tris-HCl pH 7.8, 300 mM NaCl, 5 mM MgCl2, 50 mM NaH2PO4, 10% glycerol, 
0.5 mg/mL lysozyme, 10 mM imidazole, 0.25 mM DTT, and 5 mM PMSF after which the 
lysates were clarified by centrifugation and subsequently purified using HisPure Ni-NT 
resin (G-Biosciences) according to the manufacturer’s protocol. Like RSHCd purification, 
all RHS-REL purification buffers included 5 mM MgCl2. Purification fractions were run on 
a 4% stacking and 12% separating SDS-PAG via electrophoresis. Concentration of the 
elutant fraction (resolving in a clean band) was determined spectrophotometrically. 
Purified RSH-REL were stored at -80°C in 5 to 10 µL aliquots to be used for enzymatic 
assays.  
 
Growth curves  
Growth curve was performed using a 96-welled microtiter plate (BrandTech) after 
the induction of C. difficile rsh in E. coli DH5-α background. Log phase cultures of E. coli 
cells were inoculated in LB-Kan50 in the presence or absence of 0.5 mM IPTG inducer. 
The plate was incubated at 37⁰C shaking for a total of 12 hrs. Growth of induced vs 
uninduced cells were monitored every 30 mins. Growth curve assays following the 
induction of C. difficile rsh-rel in E. coli DH5-alpha background was also conducted in the 
same manner. Supplementation with nutrient sources, including CAA and GLU were 
initiated from time point 0 mins for both pMMBneo::rsh and pMMBneo::rsh-rel vector 
carrying strains in the presence of the 0.5 mM IPTG inducer.  
 
In vitro measurement of RSHCd synthetase activity using Thin layer 
chromatography (TLC) 
 RSHCd synthetase assays were conducted in buffer containing 10 mM Tris-HCl 
(pH 7.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT and 0.12 mM ATP (ATP at 
the working concentration of 0.6 mM can also be used). A 5X buffer stock was mixed with 
the indicated concentrations of GDP/GTP/ADP (0.2 – 0.6 mM), MgCl2 always 2X more 
than the concentration of GXP or AXP, and 1.0 μCi of γ-32P-ATP. The use of 32P-ATP 
radioisotope was presented as a proposal to and approved by the University’s Radiation 
Safety Office committee prior to experiment designing and conduction (Appendix L). 
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Pyrophosphate transfer reactions were initiated by adding RSHCd at a final concentration 
of 3.0 µM and a reaction volume of 10 µL. Post-incubation at 37°C for indicated time 
points, reactions were stopped by spotting 2 µL samples on PEI-cellulose plates, allowing 
the spots to dry. The plates were subsequently developed in 1.5 M KH2PO4 (pH 3.64 ± 
0.05) and autoradiographed using the Storm 860 Phosphorimager from GE Healthcare 
Life Sciences. RSHCd-catalyzed product signal was quantitated using ImageJ software 
as previously described (249). RSHCd synthetase activity was expressed as the 
percentage of 32P-ATP converted into inorganic phosphate (Pi) for alarmone synthesis 
(Appendix C).  
Allosteric feedback regulation of RSHCd by 5’-ppGpp-3’ was evaluated in the 
same manner in the presence of 0 to 10 µM of exogenous ppGpp (TriLink). Furthermore, 
the effect of different divalent metal cations as well as buffer pHs on RSHCd synthetase 
activity were also investigated under reaction conditions mentioned above. Metal 
cofactors studied included Mg2+, Mn2+, Co2+, Cu2+, Zn2+, Ni2+, Ca2+, and Fe2+ at the 
working concentration of 1.2 mM. Buffer pH studied included values of 5.0, 6.0, 7.5, 9.0, 
and 10.0. The effect of both metal cations and pH values on RSHCd pyrophosphoryl 
transfer activity was assayed at least three times. Post-incubation, the reaction mixtures 
were spotted on PEI-cellulose plates to perform the standard one-dimensional TLC 
assay.  
 
High-performance liquid chromatography (HPLC) 
Instrumentation for all HPLC analyses included the use of a dual-pump Ultra-High-
Performance Liquid Chromatograph system with ultraviolet detectors (Schimazdu). The 
analytical column used for running nucleotide samples was a strong anion exchange 
DNAPacTM PA100 (4 x 250 mm) column with a guard column (4 x 50 mm) from 
ThermoScientific. HPLC mobile phase buffer A and B was composed of 50 mM KH2PO4 
and 500 mM KH2PO4 and 500 mM Na2SO4, respectively. The buffers were adjusted to a 
neutral pH (7.00 ± 0.09) using HPLC grade concentrated orthophosphoric acid and 
potassium hydroxide. The following sections include a detailed procedure for the use of 




A. Nucleotide standards run  
Nucleotide standards, including GDP (Alfa Aesar), GTP (BioBasic), and GMP 
(BioWorld) at the concentration of 20 µM were separated using a gradient elution at the 
flow rate of 1.0 mL/min and absorbance at 252 nm. Total run duration was set at 22 mins 
per sample.  
 
B. Sample preparation for the analysis of intracellular (pp)pGpp in RSH-REL expressing 
E. coli cells using HPLC  
For analysis of intracellular (pp)pGpp in RSH-REL-induced E. coli cells, ON starter 
cultures of E. coli strain carrying either empty vector pBAD33 or pBAD33::rsh-rel were 
inoculated in LB medium treated with 10 µg/mL chloramphenicol. Cultures were allowed 
to grow till OD600 reached ~0.5. At mid log phase, cells were induced with 0.5% arabinose 
(ARA) for 3 hrs at 30°C. Post-induction, cell densities were remeasured (OD600 1.1 – 1.3) 
followed by spinning the cells at the maximum speed using a JS 5.3 rotor (Beckman 
Coulter). The supernatants were discarded appropriately, and cell pellets were stored in 
-20°C ON. The following day, pellets were thawed and resuspended in extraction buffer 
composed of MeOH/ acetonitrile/ Millipore water at the ratio of 40:40:20 with 0.1 N formic 
acid by vigorous shaking or vortexing. The pellets were incubated in the extraction buffer 
at -20°C for 30 mins by positioning the conical tubes upright. The resuspensions were 
subsequently transferred into new Eppendorf tubes on ice and cell debris were pelleted 
by centrifugation at 13,000 RPM for 5 mins at 4°C using a benchtop centrifuge. Post-
centrifugation, ~200 µL of the extractions were recovered which underwent neutralization 
with 4 µL of 15% NH4HCO3 (pH 7.0 – 7.7) per 100 µL of sample. After neutralization, 
samples were filter sterilized with 0.45 µm filter units and speed vacuumed for over 30 
mins. Samples were finally diluted in Millipore water and stored in -20°C ON prior to 
running through an anion exchange column.  
For HPLC, a gradient elution was set up where the concentrations of mobile phase 
Buffers A and B were changed accordingly for a total run duration of 31 mins per sample. 
Samples were separated at a flow rate of 1.5 mL/min and absorbance at 260 nm was 




C. Analysis of in vitro RSHCd and RelQBs synthetase reactions using HPLC 
  RSHCd synthetase activity was separately conducted in a buffer composed of 10 
mM Tris-HCl (pH 7.5 ± 0.02), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT, 0.12 
mM ATP (ATP up to 0.6 mM can also be used), 0.2 or 0.6 mM GXP, and 1.2 mM MgCl2. 
Reactions were started by adding RSHCd at a final concentration of 3.0 µm and incubated 
at 37°C on a portable heat block for a total duration of 30 mins. After 30 mins, ~100 µL 
samples were transferred into a VIVA SPIN 500 spin column (Corning) with a MWCO of 
30 KDa and spun at 12,000 times gravity (X g) for 5 mins at 20°C. The filtrates were saved 
in a new Eppendorf tube and stored in -20°C ON to run through the anion exchange 
column the next day.  
Likewise, RelQBs synthetase activity was separately conducted in a buffer 
composed of 10 mM Tris-HCl (pH 7.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM 
DTT, 0.12 mM ATP, 0.2 mM GDP or GTP, 5 mM MgCl2, and 3.0 µM RelQBs. Reactions 
were incubated at 37°C on a portable heat block for 30 mins. Post-30 mins, ~45 µL 
samples were transferred into a VIVA SPIN 500 spin column (Sartorius) with a MWCO of 
10 KDa and spun at 12,000 X g for 5 mins. The filtrates were saved in a new Eppendorf 
tube and stored in -20°C ON to run through the anion exchange column the next day. 
Notably, all samples were run on the HPLC system using a gradient elution profile where 
absorbance at 252 nm was used to detect enzyme-catalyzed (pp)pGpp alarmones.  
 
C. Analysis of in vitro RSHCd hydrolase reactions using HPLC 
 RSHCd hydrolysis activity was conducted against a buffer containing 50 mM Tris-
HCl (pH 7.52), 25 mM ammonium acetate, 10 mM KCl, 1 mM DTT, 0.2 mM ATP, 0.1 mM 
exogenous 5’-ppGpp-3’ (Trilink), and 0.2 mM MnCl2 in a mini plastic vial. Reactions were 
initiated by adding RSHCd at a final concentration of 0.6 µM into a dialysis tubing with a 
MWCO of 12 to 14 KDa (Spectra/Pro) and incubated at 37°C. The whole reaction was 
conducted within an incubator (Thermofisher) set at 37°C for a total duration of 4 hrs in a 
manner similar to the standard dialysis procedure. At 0 and 4 hrs time points, ~20 µL 
samples were drawn from the hydrolase reaction mixture outside of the membrane tubing 
and pipetted into mini HPLC-grade vials (AQ Brand) to run through the anion exchange 
46 
 
column at 1.0 mL/min flow rate. Absorbance at 260 nm was used to detect the reduction 
in ppGpp signal between 0 and 4 hrs of reaction incubation.  
 
LiCl-based extraction of radiolabeled nucleotides for RSHCd hydrolysis activity  
RSHCd pyrophosphate transferase reaction was conducted separately in the order 
mentioned above and separated on a PEI-cellulose plate. The plate was left to dry after 
which the retention factor of RSHCd-catalyzed product was manually calculated. 
Radioactive strips corresponding to the radiolabeled spots was subsequently cut from the 
plate using sterile scissors. The strips were then immersed in 15 mL of 4 M LiCl into a 50 
mL conical tube. The strips were incubated in the LiCl solution for 15 mins at room 
temperature. The solution was then filter sterilized using a 45 mm, 0.2 µm filter. The pH 
of the solution was measured and adjusted to 7.24 with concentrated formic acid and 
ammonium hydroxide. After acid-base neutralization, the solution was aliquoted into 1.5 
mL Eppendorf tubes (9X) and spun at 4,000 X g using the benchtop centrifuge. Following 
centrifugation, the precipitates were washed with 95% ethanol (5 mL total) to remove 
residual LiCl. The ethanol washed-radioactive nucleotides were centrifuged for 5 mins at 
4,000 X g and finally suspended in Millipore water to store in -20°C for further use.  
 
Measurement of in vitro RSHCd hydrolysis activity using TLC  
In vitro hydrolase assay was conducted in a buffer containing 10 mM Tris-HCl (pH 
7.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT and 0.12 mM ATP. A 5X buffer 
stock was mixed with ~0.5 µL of radiolabeled LiCl-extracted nucleotide product in the 
presence of 1.2 mM MnCl2. The use of 32P-ATP for the synthetase and hydrolase 
reactions was approved by the University’s Radiation Safety Office committee (Appendix 
L). Reactions were initiated by adding RSHCd at a final concentration of 3.0 µM and a 
total reaction volume of 10 µL. Reactions were stopped by spotting 2 µL samples on a 
PEI-cellulose plate, allowing the spots to dry for at least 10 mins. The plate was 
subsequently developed in 1.5 M KH2PO4 (pH 3.64). The plate was exposed to the 
phosphor cassette for at least 4 hrs and autoradiographed using the Storm 860 




Isothermal Titration Calorimetry (ITC) 
ITC analyses were conducted using an ITC200 Micro-Calorimeter from Malvern. 
300 µL of purified RSHCd was added onto the cell component of the instrument and the 
syringe was filled by 40 µL of GXP ligand. Protein and ligand were prepared in the same 
buffer composed of 10 mM Tris-HCl (pH 7.5), 5mM ammonium acetate, 1.2 mM MgCl2, 
0.2 mM DTT, 0.012 mM ATP, and 2 mM KCl. 1.2 µM protein and 12 µM ligand 
concentrations were used in the interaction analysis experiments at 37⁰C. ITC 
experiments were repeated at least three times where the heat of dilution obtained 
through the titration of ligand into the reference solution was used as a blank and 
subtracted from all binding curves attained in the presence of RSHCd and GXP. The data 
obtained were fitted using a single-binding-site model by Origin Software. The same 
software was also used for peak integration and thermodynamics calculation.  
RESULTS  
 
C. difficile has conserved (pp)pGpp metabolism genes 
The complete genome sequence of C. difficile strain R20291 has been searched 
for homologs to the conserved (pp)pGpp synthetase domain of RelA/SpoT-like proteins 
in diverse bacteria. The analysis has identified two putative open reading frames, rsh 
(KEGG ID, CD2633) in an operon with predicted beta-lactamase gene and a gene for 
tRNA metabolism, D-aminoacyl-tRNA deacylase dtd (148). C. difficile R20291 also 
encodes a conserved SAS, relQ (KEGG ID, CD1607) in a predicted operon with a putative 
beta-lactamase gene (148). As both rsh and relQ share predicted operons with yet to be 
characterized beta-lactamase like proteins, it can be suggested that the proteins may 
confer bacterial tolerance in C. difficile to beta-lactam family of antibiotics such as 
ampicillin and penicillin (Fig. 8A) (147). The product of rsh is a putative Rel/SpoT homolog 
(RSHCd) with two conserved N-terminal synthetase and hydrolase domains and ACT and 
TGS C-terminal regulatory domains (Fig. 8B) (147). C. difficile RelQ (RelQCd) is a 
proposed single-domain small alarmone synthetase (Fig. 8B). Based on our 
bioinformatics analysis, both rsh and relQ genes are completely conserved between the  














Figure 8. (pp)pGpp metabolism in C. difficile. (A) Operons of predicted (pp)pGpp 
metabolism genes (blue) and beta-lactamase like proteins encoding gene (pink). (B) 
Domain organization of predicted (pp)pGpp metabolism. Figure adapted from Pokhrel 





Figure 9. Alignment of amino acid sequences of the catalytic synthetase domain 
RSHCd with the primary sequence of other RSH family enzymes. Alignment of 
RSHCd and RelQCd with RelP/RelQ/SAS enzymes from B. subtilis, E. faecalis, S. 










           Alignment of the amino acid sequence of RSHCd with those of known proteins 
belonging to the RSH superfamily of enzymes revealed that the sequences exhibit high 
similarities, particularly to the substrate binding and product coordination regions of the 
N-terminal synthetase domain (Fig. 9) (147). Many functionally significant and charged 
amino acid residues, including D264, Y308, E323, G240, H342, and A335 from S. 
equisimilis RelA (RelSeq; GenBank accession no. X72832) are conserved in RSHCd, 
suggesting that the enzymes share functional, and presumably structural homology (Fig. 
9) (147,159,168). Several hydrophobic amino acid residues found in the synthetase 
domain of B. subtilis Rel/RSH (GenBank accession no. U86377), which are predicted to 
coordinate Relacin binding to the active site, are also conserved in the RSHCd synthetase 
domain (Table 2) (147,168). The great percentage identity and similarity between RSHCd 
and B. subtilis RSH suggests that RSHCd can potentially be inhibited by Relacin in a 





Table 2.  
Sequence alignment summary between RSHCd synthetase domain with its 
relatives. RSHCd synthetase domain sequence shares high % identity and similarity 
with those of RelA and RSH/Rel encoded by S. equisimilis and B. subtilis, respectively. 
Table adapted from Pokhrel et al. 2020. 
 
 
 % Identity % similarity 
S. equisimilis RelA  43.6 62.9 






Expression of RSHCd causes partial growth arrest in E.  coli 
           Precedent studies have revealed that the intracellular accumulation of (pp)pGpp, 
as a result of amino acid starvation, leads to a delayed bacterial growth phenotype in 
exponentially growing E. coli cells (242,250). Upon the IPTG-dependent induction of full-
length C. difficile rsh, we also observed a partial growth inhibition of exponentially growing 
E. coli cells (Fig. 10) (147). The observed inhibition of E. coli growth suggests that RSHCd 
mediates the production and cytoplasmic accumulation of (pp)pGpp while also inducing 
native E. coli stringent response. We found that the partial growth arrest of cells due to 
the overaccumulation of (pp)pGpp can be rescued through supplementation with CAA 
(Fig. 10B) (147). This shows that C. difficile potentially responds to amino acid starvation 
via activation of the stringent response, followed by RSH-mediated (pp)pGpp synthesis, 














Figure 10. Overexpression of RSHCd partially arrests bacterial growth. Growth 
curves of E. coli strain carrying either empty pMMBneo vector (A) or IPTG-inducible 
rsh-ligated pMMBneo expression vector (B) in plain LB medium or LB supplemented 





RSHCd exclusively utilizes GDP to produce magic spot in vitro 
           The enzymatic activity of full-length RSHCd has also been studied to confirm that 
the enzyme is a (pp)pGpp synthetase (248). Hexa-histidine-tagged C. difficile R20291 rsh 
has been expressed in E. coli and its product purified using nickel affinity chromatography 
and SDS-PAG electrophoresis in the presence of 5 mM MgCl2 (Fig. 11) (248). We found 
that failure to include MgCl2 results in the loss of protein activity even upon including the 
metal cation in the activity buffer, indicating that the divalent cation plays a crucial role in 
protein folding and stability in addition to enzyme catalysis. To confirm the synthetase 
activity of RSHCd, radiolabeled y-32-PATP has been utilized to directly monitor the 
transfer of a radiolabeled pyrophosphate group from ATP to the non-radiolabeled GDP 
substrate (248). Thin layer chromatography has been used subsequently to separate and 
quantify radiolabeled alarmones using autoradiograms (248). Nearly five decades ago, 
E. coli responding to amino acid starvation lead to the production of molecules, which in 
TLC autoradiograms “magically” appeared as spots that weren’t synthesized by non-
starving bacterial cells (242,251). Since the molecules hadn’t yet been characterized to 
be the derivatives of GDP and GTP, researchers began denoting the spots of the 
autoradiograms as “magic spot”. We also denote the RSHCd-produced alarmones 
collectively as the magic spot in this dissertation. For quantification purpose, magic spot 
signal was presented as a percentage of the total radioactive signal (Fig. 13 and 14B, 
Appendix C) (248). By doing so, we ensured for data reproducibility and prevented the 
introduction of random noises (which can be caused from pipetting errors and/or 
radioactive decay) in our analyses (Appendix C) (248).  
           Based on the primary sequence of RSHCd N-terminal synthetase domain, the 
enzyme contains the well conserved RXKD domain (Fig. 9). Consistent with precedent 
observations regarding the effect of increasing metal ion concentrations on basal RelSeq 
and RelMtb synthetase activity, we found that RSHCd also exhibits reduced magic spot 
synthesis in the presence of higher Mg2+ concentrations (Fig. 12) (247). This finding 
suggests that RSHCd depends on a single-divalent cation mechanism to synthesize the 
magic spot. Furthermore, inhibition of enzyme catalysis at higher Mg2+ concentrations 
also suggests that the RXKD motif of RSHCd negatively impacts GDP binding of the 
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protein while potentially causing a conformational change in the predicted synthetase 






Figure 11. Purification of full-length RSHCd. Coomassie-stained SDS-PAG showing 
lysate (L) and clarified lysate (CL) of induced BL21 strain carrying the expression vector 
as well as flow-through (FT), wash 1 (W1), wash 2 (W2), and elution fractions 1 (E1) 
and 2 (E2) after nickel affinity purification. RSHCd is ~85 KDa in molecular weight 
(dashed black circle). Adapted from Pokhrel et al. 2018.  
 




Figure 12. Effect of increasing concentrations of Mg2+ on RSHCd-mediated magic 
spot synthesis. Reaction was incubated at 37°C for 60 mins with 0.6 mM GDP, 3.0 
µM RSHCd, 0.12 mM ATP, and indicated concentrations of MgCl2. TLC assay was 
performed to quantitate magic spot synthesis. One-Way ordinary ANOVA analysis with 
Turkey’s multiple comparisons test. Adjusted * P 0.0253. Error bars indicate standard 






























Figure 13. A typical autoradiogram of TLC assay. PEI-cellulose plate depicting the 
32P-ATP spots, magic spots, and spot origin or location of a reaction carried out using 
purified RSHCd in the presence of GDP substrate. NP denotes no protein. Adapted 






Figure 14. Functional characterization of RSHCd. (A) Absolute signal intensities of 
32P-ATP and the magic spot as a function of time. (B) Magic spot synthesis is 






Interestingly, the RXKD motif of RSHCd appears to have no influence on the 
enzyme’s substrate preference as is the case for RelSeq and RelMtb (151,247). Unlike 
RelSeq and RelMtb, RSHCd does not utilize GTP to synthesize pppGpp (Fig. 15) (147). 
Notably, GTP appears to stimulate ATP hydrolysis by RSHCd, which corresponds to the 
robust inorganic phosphate (Pi) spots in the autoradiogram, suggesting that the enzyme 
recognizes the substrate but cannot accommodate the triphosphate form of the nucleotide 
in its active site to enable pyrophosphate transfer (147). Furthermore, SAS enzymes from 
E. faecalis and B. subtilis can also utilize GMP to produce pGpp, but RSHCd does not 
utilize GMP either, demonstrating high specificity for GDP (Fig. 15) (147,152,168).  
The finding that RSHCd does not utilize GTP despite carrying the highly conserved 
RXKD motif in its synthetase domain was further explored. RSHCd was incubated with a 
mixture of GDP and GTP at the ratio of either 1:1 or 1:2 in the presence of ATP. Reaction 
products were subsequently separated using TLC. Based on the TLC autoradiogram, 
RSHCd failed to utilize GTP at equimolar concentration of GDP and at an excess 
concentration of GTP in the same reaction mixture (Fig. 16) (147). Furthermore, 
commercially available GMP, GDP, and GTP nucleotide standards were also run 
separately through an anion exchange column in the HPLC system. We found that the 
GTP peak resolves in the chromatogram completely devoid of contaminants and 
derivative compounds (Fig. 17) (147). This suggests that the inability of RSHCd to utilize 

















Figure 15. Analysis of substrate preference and utilization of RSHCd. TLC 
autoradiogram of in vitro RSHCd transferase activity using different substrates. RSHCd 
readily transfers radioactive pyrophosphate from 32P-ATP to GDP but cannot utilize 
GMP or GTP as a substrate. ATP hydrolysis appears to increase Pi levels in the 








Figure 16. TLC autoradiogram of in vitro RSHCd transferase activity at different 
GDP:GTP ratio. In vitro transferase reaction using equimolar concentration of GDP and 
GTP (0.15 mM each) and 2X more GTP (0.2 mM) than GDP (0.1mM) keeping the total 
substrate concentration equivalent to 0.3 mM. NP denotes no protein. Adapted from 




Biochemical characterization of RSHCd synthesis activity 
We found RSHCd to exclusively utilize GDP, therefore, we next measured the 
kinetic constant (Km) for the RSHCd-mediated (pp)pGpp synthetase reaction. The 
synthesis reaction that was assayed involved the incubation of RSHCd at 3.0 µM with 
0.12 M ATP and 1.0 µCi 32P-ATP in the presence of various concentrations of GDP. 
Based on our reactions, the ability of RSHCd to convert GDP and excess radioactive ATP 
to the magic spot increases with increasing concentrations of GDP (Fig. 18A and 18B) 
(147). As a magic spot synthetase that only utilizes GDP for a substrate, we found that 
RSHCd binds GDP with a Km of 95 µM (Fig. 18C), which is physiologically relevant to the 
levels of GDP (< 128 µm) in the cytoplasm of exponentially growing E. coli cells (147,252).  
 
 
Figure 17. HPLC chromatogram of GTP, GDP, and GMP standards. Standards were 
run separately at the concentration of 20 µM as 252 nm readout. Adapted from Pokhrel 







Furthermore, ppGpp and pppGpp is a positive allosteric regulator of magic spot 
synthesis catalyzed by E. coli RelA and B. subtilis SAS, respectively (150,253). In E. coli, 
rapid production of ppGpp resulting in the activation of a positive feedback response is 
postulated to concurrently activate a fast-coordinated response that is mediated by the 
SpoT enzyme (253). As a strong (pp)pGpp hydrolase, E. coli SpoT serves as a threshold 
filter that controls cells from committing to full stringency during the SR cascade (253). 
Since RSHCd is a putative bifunctional enzyme with an intact synthetase and hydrolase 
domains, we investigated whether its synthetase activity (in the presence of GDP) is 
allosterically regulated by the ppGpp product. Upon incubation of RSHCd with GDP, ATP, 
and increasing concentrations of exogenous 5’-ppGpp-3’ (Trilink), we found that the 
magic spot synthesis activity of RSHCd is not regulated by a positive feedback 











Figure 18. Biochemical characterization of RSHCd. (A) Conversion of radiolabeled 
ATP to magic spot increases with a corresponding increase in GDP concentrations. (B) 
Nonlinear fit of velocity vs [GDP]. (C) Lineweaver-Burk plot of RSHCd activity. Km of 






Figure 19. Evaluating allosteric regulation of RSHCd. RSHCd activity in the 
presence of increasing concentrations of exogenous 5’-ppGpp-3’. Enzyme activity at 
different 5’-ppGpp-3’ concentrations were compared by One-Way ANOVA analysis of 































RSHCd synthetase activity is unaffected by pH or the type of metal ion cofactor 
  Like several biochemically characterized long RSH enzymes, RSHCd is an overall 
basic protein with an isoelectric point of 8.81 (147,160,254). RSHCd synthesizes magic 
spot, presumably ppGpp, in the presence of GDP at a buffer pH of 7.5 (147,248). Notably, 
a pH of 7.5 is a value that corresponds to the pH range (7.1 - 7.5) of the normal colonic 
perimucosa (147,255). To investigate the effect of environmental pH on the substrate 
utilization of RSHCd, in vitro pyrophosphate transfer reactions were carried out separately 
in various buffer pH values, including 5.0, 6.0, 7.5, 9.0, and 10.0. (Fig.  20). We found that 
RSHCd synthesizes magic spot at all buffer conditions studied but fails to utilize GTP at 
any tested pH value (Fig. 20) (147). This finding suggests that RSHCd cannot bind to or 
accommodate GTP regardless of the titration status or the ionic strength of the SD amino 




















Figure 20. Effect of pH on RSHCd synthetase activity. TLC autoradiograms (A) 
showing the accumulation of magic spot in the presence of GDP or GTP at any given 
pH value. Graphical representation of the GDP autoradiogram (B) demonstrating that 
RSHCd utilizes GDP without exhibiting any pH specificity. Magic spot synthesis at 
various pH values was compared to that at pH 7.5 by One-Way ANOVA.  n.s., not 












Pyrophosphokinases and nucleic acid-metabolizing enzymes need metal cofactor(s) to 
coordinate negative charge(s) for enzymatic reactions (147). Magnesium is abundantly 
present in the bacterial cytoplasm (~100 mM) and is the most utilized ion for nucelotidyl 
transfer reactions (147,256). Previous studies have shown that Mg2+ is employed by 
RelMtb and RelSeq for the optimal synthesis of (pp)pGpp in vitro (159,160,243,257). 
Recently, Methylobacterium extorquens RSH was shown to synthesize pppGpp more 
efficiently in the presence of Co2+ than Mg2+ (147,258). The catalytic palm domain of 
human DNA polymerase b bears structural kinship with the active site of RelSeq 
synthetase domain (147,159,247). According to Vashistha et al., human Polb can use 
Zn2+, Mn2+, and Co2+ along with Mg2+ to catalyze primer extension (147,259,260). 
Notably, Zn2+, Mn2+, and Co2 have an ionic radius similar to that of Mg2+ (147,259,260). 
Ca2+ has an ionic radius that is significantly larger than that of Mg2+ and does not enable 
primer extension, suggesting that the human Polb exhibits selectivity for specific metal 
cofactors (260).  
To investigate the metal cofactor selectivity of RSHCd, we performed in vitro 
pyrophosphate transfer reactions in the presence of different divalent cations (Fig. 21) 
(147). Of the eight metals tested, including Mg2+, Mn2+, Co2+, Cu2+, Fe2+, Zn2+, Ni2+, and 
Ca2+, only Cu2+ significantly yet modestly reduced RSHCd-driven magic spot synthesis 
(Fig. 21) (147). This suggests that the enzyme readily employs a wide array of structurally 
diverse cations for a cofactor to catalyze pyrophosphate transfer (147). We postulate that 
the substitution of Mg2+ with different cations becomes most relevant to C. difficile under 
environmental condition(s) where specific metal ions are depleted and/or during 









Figure 21. Effect of divalent metal cations on RSHCd synthetase activity. TLC 
autoradiogram (A) showing the accumulation of magic spot in the presence of GDP or 
GTP in the presence of different metal ion cofactors at a buffer pH of 7.5. Graphical 
representation of the GDP autoradiogram (B) demonstrating that RSHCd utilizes GDP 
without exhibiting any metal ion specificity. Levels of magic spot synthesis were 




RSHCd binds GTP with poor affinity 
To further investigate the lack of GTP utilization by RSHCd, we examined the 
interaction of RSHCd with GDP and GTP using isothermal titration calorimetry (147). 
Based on our ITC data, we found that RSHCd binds to GDP and GTP with an association 
constant of 31.9 M-1 (Fig. 22) and 25.1 M-1 (Fig. 23), respectively (147). This finding 
indicates that RSHCd interacts with GTP despite failing to catalyze the synthesis of 
pppGpp. During exponential growth, bacterial cells maintain GTP at concentrations 
ranging from 900 to 1,100 µM, a 2 to 10-fold excess compared to the concentrations of 
GDP (147,252,261,262). During stationary phase onset, both ATP and GTP are rapidly 
depleted, with ATP levels recovering more faster from the conversion of guanosine 
nucleotides to (pp)pGpp (252,262). Despite interaction, we found the binding affinity of 
RSHCd for GTP to be lower than that for GDP (147). During stationary phase, the 
physiological concentrations of GDP is relatively higher than that of GTP, indicating that 
RSHCd can preferentially utilize GDP as a substrate due to its abundancy and availability 
(147). Notably, we found RSHCd to bind GTP at a protein to substrate ratio of 1:10 (147). 
However, failure to utilize GTP to produce pppGpp was observed at a much larger protein 
to substrate ratio of 1:200 (147). Nevertheless, these results suggest that RSHCd may 
transiently bind to GTP at different stages of bacterial growth, but the consistent 
abundancy of GDP in the bacterial cytoplasm potentially enables the enzyme to readily 
respond to the substrate for enzyme catalysis (147). Furthermore, the “K” value from our 
ITC data represents the association constant computed from a single-site-binding model 
(Fig. 22 and 23) (147). We observed that the K value of RSHCd for GDP is lower than the 
Km value of 95 µM quantitated through TLC (147). We hypothesize that the observed 
variation in K values is arising from nonspecific interaction of GDP with the C-terminal 









Figure 22. Interaction analysis of RSHCd with GDP. Isothermal titration calorimetry 
thermogram (top) and Wiseman plot (bottom) of RSHCd interaction with GDP at 37°C. 
The upper panel shows the raw data for titration of GDP with RSHCd, and the lower 
panel shows the integrated heats of binding obtained from the raw data. The data were 
fitted to a single-binding model.  Each value is the average of three repeat experiments 
and the standard deviation ± are shown. RSHCd binds to GDP at a K value of 31.9 M-






Figure 23. Interaction analysis of RSHCd with GTP. Isothermal titration calorimetry 
thermogram (top) and Wiseman plot (bottom) of RSHCd interaction with GTP at 37°C. 
The upper panel shows the raw data for titration of GTP with RSHCd, and the lower 
panel shows the integrated heats of binding obtained from the raw data. The data were 
fitted to a single-binding model.  Each value is the average of three repeat experiments 
and the standard deviation ± are shown. RSHCd binds to GTP at a K value of 25.1 M-





RSH-REL lacks regulation by the HD and CTD of full-length RSHCd 
As mentioned previously, the C-terminal regulatory domains of long RSH enzymes 
control the opposing hydrolase and synthetase activity of the N-terminal region (159,160). 
In E. coli (pp)pGpp synthesis is negatively regulated by the CTD either by mediating RelA 
oligomerization or via intramolecular interaction with the enzyme’s N-terminal domain 
(160,263,264). However, upon binding to uncharged (non-aminoacyl) tRNA in complex 
with ribosomes, CTD positively regulates RelA-mediated (pp)pGpp synthesis (264). 
RelSeq and RelMtb NTD are also positively regulated by the enzymes’ CTD in the 
presence of uncharged tRNAs such that (pp)pGpp synthesis increases when uncharged 
tRNAs are bound to a complex of ribosome + mRNA (160,243). Interestingly, regulation 
of the Rel/RSH hydrolase domain, capable of hydrolyzing the small molecule alarmones, 
also appears to involve the CTD in diverse bacterial species. Fang et al. demonstrated 
that the ACT domain present in Rhodobacter capsulatus Rel, along with S. equisimilis 
Rel, B. subtilis Rel and E. coli SpoT bind branched-chain amino acids to stimulate its 
hydrolysis activity (166). Very recently, Shin and colleagues solved the atomic structure 
of the interaction between valine and the ACT domain of RelMtb using NMR, confirming 
the role of the CTD of bifunctional RelMtb in the positive allosteric regulation of (pp)pGpp 
hydrolysis (265).  
 In order to determine whether RSHCd synthetase domain activity is regulated by 
the RSHCd CTD, we designed and cloned a truncation construct of RSHCd called RSH-
REL, which is a monofunctional synthetase derivative of the full-length RSHCd (Fig.  
24A). Overexpression of RSH-REL appeared to be extremely toxic to E. coli even in the 
absence of the IPTG inducer, suggesting that the enzyme is hyperactive (Fig. 24B) (147). 
It is so active that trace transcription of rsh-rel from an uninduced, leaky promoter results 
in sufficient RSH-REL protein product to produce inhibitory/potent levels of magic spot 
(147). RSH-REL-driven toxicity can be partially rescued by supplementation with 1% CAA 
and is further enhanced by the additional supplementation with 1% GLU (Fig. 24B) (147). 
The finding that full-length RSHCd slows E. coli growth while RSH-REL completely 
arrests it suggests that (pp)pGpp toxicity is modulated by the presence of and the activity 







Figure 24. Cloning and overexpression of RSH-REL. (A) Schematic representation 
of full-length RSHCd (1-735 amino acid residues) alongside the truncation construct; 
RSH-REL (amino acid residues 113–388). The theoretical molecular weight of the 
construct is provided (~33 KDa). Growth of E. coli cells carrying pMMBneo::rsh-rel 
vector in LB medium supplemented with Casamino acids (LB-CAA), glucose (LB-GLU) 





RSH-REL produces magic spot in vitro 
To confirm the functionally of RSH-REL enzyme, recombinant RSH-REL was 
purified using metal affinity chromatography. We found that the protein runs at a higher 
molecular weight (MW) (between 40 and 45 KDa) on a 4% stacking, 12% separating 
SDS-PAG (Fig. 25A). This finding suggests that the enzyme could be undergoing post-
translational modification such as glycosylation and phosphorylation or the protein is 
interacting with potential binding partners, contributing to its increased weight. Peptide 
amino acid composition has been directly linked to the difference between SDS-PAGE-
displayed MW and the theoretical MW of enzymes. Guan et al. demonstrated that the 
difference in MW of several enzymes is linearly correlated with the percentage of acidic 
amino acid that fits the equation y = 276.5x - 31.33 (where x represents the percentage 
of D and E amino acids combined, and y represents the average ΔMW per amino acid 
residue) (266). Based on the equation, y = 0 when x = 11.3% in which case the observed 
MW on an SDS-PAG is identical to the enzyme’s theoretical MW (266). RSH-REL 
constitutes approximately 16% acidic amino acids in its primary sequence and with the 
application of the “y = 276.5x - 31.33” equation, it can be inferred that the band size 
discrepancy is not due to PTM. The calculated ΔMW (~5 KDa) also corresponds to the 
approximate added weight to the theoretical MW of RSH-REL enzyme (Fig. 25A). Like 
full-length RSHCd, RSH-REL enzyme utilizes GDP and ATP to produce the magic spot 
but appears to be incapable of utilizing GTP (Fig. 25B). Furthermore, expression of RSH-













Figure 25. Overexpression, purification, and functional characterization of RSH-
REL. (A) 4%, 12% SDS-PAGE gel image of purified RSH-REL protein. Lanes 1 through 
10 were loaded with marker (L), clarified lysate (CL), prepped CL, flow-through (FT), 
CL FT2, wash 1 FT, wash 2 FT, wash 3 FT, elute 1 (E1), and elute 2 (E2). (B) TLC 
autoradiogram of RSH-REL protein utilizing GDP for reaction catalysis. (C) HPLC 
chromatogram of 5’-ppGpp-3’ detected in exponentially growing E. coli cells expressing 
RSH-REL in the presence of the IPTG inducer. Filtered cell extracts post-induction were 
run through a strong anion exchange column at the flow rate of 1.5 mL/min. Sample 




RSHCd HD requires activation by biological effectors of the CTD 
The differential regulation of the synthetase and hydrolase domain activities in 
bifunctional S. aureus Rel (RelSau), RelSeq and RelMtb has been characterized 
(160,164,243). Like E. coli, the synthetase domain activity of RelMtb is activated in the 
presence of uncharged tRNAs alone or from an imbalance in the ratio of uncharged 
tRNAs to charged tRNAs, which is characteristic of cytoplasmic amino acid depletion 
(243). But in vitro synthetase activity significantly increases in the presence of and upon 
complex formation of RelMtb with ribosome, uncharged tRNA, and mRNA (243). 
Similarly, the synthetase domain of RelSeq, an enzyme exhibiting a net specific activity 
strongly in favor of (pp)pGpp degradation, is also activated in a stalled ribosome-
dependent manner (159,160). The CTD of RelSeq is directly involved in the reciprocal 
regulation of the two opposing activities in the NTD of RelSeq (160). Free RSHCd 
optimally utilizes GDP to produce basal levels of magic spot at Mg2+ concentrations 
approximately 2-fold higher than the concentration of GDP substrate (147,248).  
To investigate how the opposing synthesis and hydrolysis activities of RSHCd are 
differently regulated, we evaluated the hydrolase activity of RSHCd. The hydrolase assay 
involved the extraction and use of radiolabeled magic spot (product of a separate 
pyrophosphate transfer reaction) as a substrate, Mn2+ metal cofactor, and full-length 
RSHCd for pyrophosphohydrolase catalysis. Based on literature evidence, Mn2+ optimally 
coordinates (pp)pGpp to the hydrolase domain of long RSHs (160,243). For instance, 
RelSeq in the presence of Mn2+ optimally catalyzes (pp)pGpp hydrolysis at 2 to 3-fold 
molar excess over the total concentration of nucleotide substrate at pH values ranging 
from 7.2 to 9.5 (160). However, we found RSHCd to exhibit a net synthesis activity in 
isolation (Fig. 26). The failure to hydrolyze the magic spot to yield inorganic 
pyrophosphate (PPi), suggests that the hydrolase domain requires regulation by 
branched-chain amino acids and/or yet to be characterized biological effector(s) of 
alarmone metabolism. Analysis of in vitro RSHCd pyrophosphohydrolase activity through 
HPLC also resulted in a modest reduction of the exogenous ppGpp signal after 4 hrs of 
reaction incubation, further suggesting that the hydrolase domain of RSHCd requires 
regulation by the CTD, presumably via interaction of the ACT domain with branched 










Figure 26. Characterization of in vitro RSHCd hydrolase activity using TLC. 
Autoradiogram of RSHCd hydrolase activity with Mn2+, full-length RSHCd, and 
radiolabeled magic spot. Radiolabeled magic spots were extracted using Li2+ from a 
separate synthetase reaction. Failure to detect the hydrolysis product in the 
autoradiogram suggests that the reaction requires effectors of the CTD domain to 













Figure 27. Analysis of in vitro RSHCd hydrolase activity via HPLC. HPLC 
chromatogram comparing 5’-ppGpp-3’ signal between 0 and 4 hrs of RSHCd-mediated 
hydrolysis reaction in vitro. Reaction mixture after 0 and 4 hrs of incubation were run 
separately through a strong anion exchange column at the flow rate of 1.0 mL/min. 




RSHCd produces triphosphate product in the presence of GDP 
 The unique finding that RSHCd utilizes only GDP for a substrate was further 
evaluated through the functional characterization of RelQ from B. subtilis. RelQBs is a 
small alarmone synthetase that shares the conserved synthetase fold with the long RSH/ 
Rel enzyme. Unlike monomeric Rel/RSH proteins, RelQBs forms highly symmetric 
homotetramers and binds ATP and GXP in a sequential order to catalyze pyrophosphate 
transfer (150). A unique feature of the RleQBs homotetramer is the presence of a cleft in 
its center that enables the binding of two allosteric pppGpp molecules (150). Cell wall 
antibiotics and perturbations of cell envelope from alkaline stress induce B. subtilis relQ 
expression, leading to a strong accumulation of (pp)pGpp, which can be detected via high 
performance liquid chromatography-coupled mass spectrometry (168,198).  
Recently, Fung et al. demonstrated that the expression of gene encoding RelQBs 
also results in the accumulation of 5’-pppApp-3’ in addition to (pp)pGpp in vivo (267). The 
increase in the levels of these alarmones are dramatically suppressed in a synthetase 
mutant strain of RelQBs (SASD87G), suggesting that the accumulation of multiple 
alarmones apart from (pp)pGpp are also dependent on the magic spot synthesis activity 
of RelQBs (267). Of the multiple alarmones, pGpp is the most strongly induced small 
alarmone nucleotide for several reasons (267). Firstly, ppGpp is rapidly degraded to pGpp 
by the NuDiX family hydrolase, NahA (156). Secondly, RelQBs is capable of directly 
producing pGpp through the utilization of GMP for a substrate as ΔnahA strains 
accumulate lower but detectable levels of pGpp (156). Fung et al. also reported that the 
accumulation of diverse alarmones corresponds with changes in the levels of intracellular 
purine nucleotide (267). Rapid depletion of GTP is postulated to occur from the inhibition 
of GMP kinase by pGpp, suggesting that (pp)pGpp target de novo purine biosynthesis 
enzymes (156,267). Based partially on the purification protocol established in Fang et al. 
2018 as well as direct consultations with the first author of the publication, we purified 
RelQBs from an E. coli expression strain and performed in vitro pyrophosphate transfer 
reactions to subsequently run reaction products through an anion exchange column in 
the HPLC system (Fig. 28) (166). We also incubated RelQBs and RSHCd separately with 
GMP, GDP, GTP or ADP (RSHCd only), 1.0 µCi γ-32P-ATP, and ATP at 37°C to 
subsequently perform one-dimensional TLC assay (Appendix D). As expected, RelQBs 
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synthetized pGpp, ppGpp, and pppGpp from GMP, GDP and GTP, respectively 
(Appendix D). RSHCd specifically utilized GDP to synthesize magic spot (Appendix D). 
However, RSHCd-produced magic spot ran parallelly with RelQBs-produced pGpp as 
depicted in the autoradiograms, indicating that RSHCd is not producing ppGpp alarmone 
(Appendix D). To confirm that RSHCd-mediated catalysis is yielding a triphosphate 
product rather than a tetraphosphate product using GDP as the substrate, we tested the 
ability of RSHCd to utilize ADP (Appendix D). B. subtilis RelQ can utilize ADP as a 
substrate to yield 5’-diphsophate-adenosine-3’-diphosphate (5’-ppApp-3’), which migrate 
similar distances to guanosine-three phosphate alarmones on a PEI-cellulose plate 
(258,267). The similarity in the retention factor or migration of ppApp with guanosine-
three phosphate molecules is due to the steric hindrance imposed by or the higher mass 
of the guanosine base in comparison to the adenosine base. Since mobility of molecules 
in TLC is dependent on its molecular weight as much as its affinity for the stationary 
phase, and since RSHCd does not utilize GMP, we hypothesized that RSHCd uses ADP 
to produce ppApp (248). Contrary to our hypothesis, we found that RSHCd fails to utilize 
ADP, confirming that RSHCd is producing guanosine-triphosphate alarmone in the 
presence of GDP under the experimental conditions used (Appendix D).  
Analysis of in vitro RSHCd and RelQBs-mediated (pp)pGpp synthesis via the 
highly sensitive HPLC technique also revealed that RSHCd produces a triphosphate 
alarmone that co-elutes with the GTP standard (Fig. 28). We postulate that the minor 
discrepancy in the retention times between RSHCd-produced alarmone and the GTP 
standards is due to slight variations in the pH value of the mobile phase buffers, which 
are prepared fresh and filter sterilized every time prior to sample running. The pH values 
of the mobile phase buffers can also change overtime if the buffers are stored at room 
temperature, which contributes to minor changes in the retention time of same 











Figure 28. Analysis of RelQBs and RSHCd-catalyzed pyrophosphoryltransferase 
reactions in vitro using HPLC. Reactions were conducted separately in the presence 
of the indicated substrate with either 3.0 µM RSHCd or RelQBs. The sample filtrates 
alongside the standards were run through a strong anion exchange column using a 
gradient elution at the flow rate of 1.0 mL/min. Absorbance at 252 nm as a readout is 
presented showing that RelQBs produces ppGpp and pppGpp from GDP and GTP, 
respectively. Whereas RSHCd produces triphosphate alarmones in the presence of 
GDP that co-elute with the GTP standard. This experiment was conducted by and 
chromatogram produced by Astha Pokhrel (Poudel et al. manuscript in preparation).  
82 
 
Members of the RSH superfamily synthesize (pp)pGpp and (p)ppApp via the 
transfer of a pyrophosphoryl group from ATP to the 3’-OH group of GXP and/or AXP 
(148,149,158). Under the experimental conditions used in our pyrophosphate transfer 
reactions, RSHCd appeared to produce triphosphate products in the presence of GDP 
(Appendix D and Fig. 28). Contrary to the fundamental reaction mechanism of RSH-
catalyzed reactions to produce (pp)pA/Gpp, RSHCd synthesizes magic spot with a 
guanosine entity bound to three phosphate groups even when GDP is the substrate. 
Therefore, based on our TLC and HPLC data, we currently hypothesize that RSHCd is 
producing a three-phosphate alarmone using GDP as a substrate in an ATP-dependent 
manner via non-canonical mechanism(s). The enzyme catalysis is potentially driven by 
the initial hydrolysis of GDP to GMP followed by the addition of a pyrophosphate moiety 
from ATP to the 3’-OH of GMP.  
We believe that RSHCd itself could be responsible for the hydrolysis of GDP, which 
the enzyme utilizes to produce putative 5’-pGpp-3’ for two reasons. One, purification of 
RSHCd from E. coli cells can result in the copurification of contaminant GDPases that 
hydrolyze GDP during pyrophosphoryltransferase reactions. But the use of hexa-histidine 
specific nickel affinity purification technique followed by a stringent protein dialysis 
procedure out rules the possibility of contamination by native E. coli GDPases. Two, the 
notion that RSHCd is either directly producing GTP from GDP in the presence of 
radiolabeled ATP or a byproduct of ppGpp synthesis reaction appears to hold untrue in 
this case. Sobala et al. demonstrated that M. extorquens RSH (RSHMex) produces 
ppGpp and pppGpp in the presence of ATP and GDP or GTP, respectively, in addition 
with γ-32P-GTP (258). According to their findings, γ-32P-GTP migrates slowly on PEI-
cellulose plates than pGpp and ppGpp when run in 0.85 M KH2PO4 mobile phase buffer 
(258). We found that RSHCd-synthesized magic spot co-migrates with RelQBs-
synthesized pGpp in 1.5 M KH2PO4. Furthermore, RSHCd does not produce ppGpp in 
the presence of GDP unlike RSHMex. This suggests that RSHCd carries an intrinsic 
GDPase activity and is able to synthesize the magic spot via non-conventional 
mechanism(s). Furthermore, E. coli GppA and NuDiX family hydrolases degrade pppGpp 
and ppGpp to ppGpp and pGp, respectively (176,179,180). This means that even if 
RSHCd were contaminated with native E. coli hydrolases that metabolize (pp)pGpp, the 
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contaminants would not yield radiolabeled pGpp products that are clearly visible as spots 
in our autoradiograms.  
SUMMARY  
 
Here we show that the full-length RSH homolog of C. difficile exhibits a strict 
utilization preference for GDP in vitro (147). The enzyme may transiently bind GTP but 
failure to produce pppGpp suggests that the enzyme is unable to accommodate a 
pyrophosphate transfer from ATP to GTP (147). Furthermore, the enzyme also fails to 
utilize GMP and ADP for a substrate but readily utilizes GDP at a wide range of 
environmental pHs without demonstrating any metal cofactor specificity (147). We 
previously concluded that the full-length enzyme produces ppGpp in the presence of GDP 
substrate (147,248). However, our more recent in vitro pyrophosphotransferase reactions 
using RelQBs as a positive control and full-length RSHCd indicate that the latter enzyme 
is in fact producing a triphosphate alarmone. HPLC analyses using an anion exchange 
column to separate and resolve RSHCd and RelQBs-catalyzed products further revealed 
that the alarmone synthesized by RSHCd co-elutes with the GTP standard, confirming 
that the protein is catalyzing the synthesis of small alarmone triphosphate nucleotide in 
the presence of GDP. This finding is unique as it indicates that RSHCd produce magic 
spot via non-conventional route(s), not previously reported in the analyses of other RSH-
family enzymes. Furthermore, we postulate that the alarmone synthesis activity of RSHCd 
is regulated by the hydrolase domain and/or the CTD. Expression of RSH-REL is 
extremely toxic to bacterial growth and just like its full-length counterpart, RSH-REL can 
only produce magic spot in the presence of GDP. Additionally, we were able to detect 
intracellular ppGpp upon expression of RSH-REL in E. coli cells. Based on our TLC assay, 
however, RSH-REL does not produce ppGpp. Therefore, we believe that the intracellular 
ppGpp extracted and detected using HPLC is actually due to the production and 
accumulation of ppGpp by E. coli cells as a consequence of growth phase-induced 
nutrient starvation and cytoplasmic changes (Fig. 25C). ppGpp is a more potent effector 
of the SR in stressed E. coli cells, indicating that the bacteria produce detectable levels 
of ppGpp (178).  
84 
 
 We also speculate that the HD of RSHCd requires regulation by the CTD, 
presumably via interaction with branched-chain amino acids. Based on the mobility of 
RelQBs-produced pGpp (where GMP is the substrate) and RSHCd-produced magic spot 
(where GDP is the substrate) in our TLC autoradiograms, we believe that RSHCd 
exclusively synthesizes pGpp. Nonetheless, analysis of RSHCd catalyzed magic spot 
using more sensitive techniques such as LC-MS along with the structural analysis of the 
magic spot through 31Phoshporus NMR will also deem essential in confirming the 


























Long RSH enzymes are transcriptionally regulated, with transcription increasing 
during late exponential phase or stationary phase, or upon induced nutrient deprivation 
by inhibitors of biosynthetic pathways (147,158,182-184). The specific nutrients whose 
limitation triggers RSH-mediated (pp)pGpp synthesis vary between bacterial species 
(158,182,183,185). In E. coli, the SR is triggered by amino acid starvation, which results 
in RelA-mediated (pp)pGpp synthesis. Interestingly, fatty acid starvation and iron 
limitation specifically induce E. coli SpoT-dependent accumulation of (pp)pGpp and 
ppGpp, respectively (268,269). In B. subtilis, the SR is also stimulated in response to lipid 
starvation (185). Since Gram-positive organisms typically encode one or two SASs in 
combination with a long RSH enzyme, the SASs in B. subtilis are transcriptionally 
regulated during bacterial growth phase where relQ expression is upregulated during 
exponential phase and relP expression is upregulated in the late exponential phase 
(158,168). Furthermore, genes encoding S. aureus RelQ and RelP are also regulated at 
the transcriptional level by vancomycin, exposure to ethanol and alkaline shock 
(158,199).  
Clostridioides difficile genome encode a monofunctional RelQ and a bifunctional 
RSH (147). We have shown that full-length RSHCd produces putative pGpp, not ppGpp 
in the presence of GDP substrate via yet to be determined mechanism(s). To investigate 
whether the extracellular signals that regulate C. difficile rsh transcription include bacterial 
stationary phase onset, nutrient limitation, and exposure to antibiotics, we have employed 
highly sensitive and quantitative molecular tools such as quantitative reverse 
transcriptase-PCR (qRT-PCR) and a fluorescent translational reporter (147). Through 
qRT-PCR, we have analyzed the mRNA transcript levels of C. difficile rsh and relQ at 
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different phases of bacterial growth to find that rsh transcription is positively regulated by 
stationary phase onset (147). Unlike rsh, relQ transcription is not affected by growth 
phase, suggesting that C. difficile relQ expression is potentially induced by factors that 
cause cell wall stresses (147). Notably, bacterial stationary growth phase is associated 
with many adverse conditions, including nutrient limitation, accumulation of waste and 
metabolic byproducts and alterations in environmental pH (270). To evaluate whether 
nutrient limitation during bacterial stationary phase onset contributes to the positive 
regulation of C. difficile rsh transcription, we have used qRT-PCR to study rsh and relQ 
mRNA transcript fold-change in bacterial cells cultured in different media conditions, 
including regular Brain heart infusion medium supplemented with 5% yeast extract 
(BHIS), spent BHIS, and phosphate buffered saline (PBS). In this case, growth of C. 
difficile 630Derm strain in regular BHIS corresponded with normal growth conditions, 
whereas spent medium represented nutrient limited growth conditions. Based on our 
analysis, we found that C. difficile rsh is positively regulated by starvation stress, 
suggesting that nutrient limitation is one of many factors that triggers the stringent 
response in this pathogen.  
Previous studies have also employed antibiotics as a stress inducer in 
Clostridioides difficile, notably, without directly demonstrating rsh and relQ transcriptional 
regulation. For example, Emerson et al. demonstrated that exposure of C. difficile 630 
strain to amoxicillin, clindamycin, and metronidazole results in the general upregulation 
of numerous transcriptional and translational machineries (271). Microarray analyses 
revealed that amoxicillin upregulates rpoB, rpoC and rpoA (encoding components of the 
RNA polymerase) and ribosomal protein-encoding genes, along with tRNA synthetases 
and genes encoding tRNA-associated enzymes (271). Transcripts of putative ppGpp 
metabolizing enzymes are also significantly upregulated upon exposure to amoxicillin and 
clindamycin (271). Furthermore, expression of genes encoding bacterial cell wall proteins 
and those involved in peptidoglycan synthesis pathways are induced by ampicillin, 
clindamycin, metronidazole, and mainly amoxicillin (271). Interestingly, components of 
the secretion apparatus (secE, secY, and secA2) are also upregulated by these 
antibiotics, suggesting that C. difficile alters the composition of its cell wall to withstand 
the pressures exerted by and to reduce the penetration of antibiotics (271). Notably, 
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changes in the cell wall composition in response to antibiotics confer intermediate 
vancomycin resistance in S. aureus, suggesting that antibiotics cause changes in 
bacterial transcriptional profiles, leading to the development of virulence traits such as 
antibiotic tolerance (271,272).  
To investigate whether antibiotics play a role in the transcriptional regulation of C. 
difficile rsh and relQ, we utilized an anaerobic fluorescent transcriptional reporter 
incorporating the oxygen-independent flavoprotein phiLOV2.1 (147,273). We placed the 
phiLOV2.1 gene under the control of the rsh and relQ promoter regions from 630Derm 
and R20291 strains to monitor rsh and relQ transcription in two genetic variants of C. 
difficile upon exposure to sublethal concentrations of clindamycin and metronidazole 
(147). We found that the activity of the magic spot synthetase promoters in the presence 
of clindamycin is stimulated in a strain-specific manner (147). We also found that rsh 
transcription is positively regulated by exposure to metronidazole in the hypervirulent 
R20291 background, suggesting that the transcriptional regulation of full-length rsh in 
Clostridioides difficile is a general response to antibiotic stresses rather than a response 
to the inhibition of a specific synthetic pathway (147). Since the use of clindamycin is 
associated with risk factor development for CDI and metronidazole is losing clinical 
significance for CDI treatment, we postulate that the expression of rsh upon exposure to 
these antibiotics contributes to C. difficile tolerance and survival in the host.  
In summary, this chapter focuses on elucidating environmental stimuli that 
positively regulate rsh gene transcription, resulting in the cytoplasmic accumulation of 
putative pGpp. All aspects of this chapter previously appeared as an article in the 
reference (147). The rights and permission to use the materials of the publication is given 
in Appendix M. Figure numbers and formats have been modified from the publication.  
METHODS AND MATERIALS 
 
Plasmid and strain construction  
The plasmid pRF185::phiLOV2.1 (provided by Gillian Douce, University of 
Glasgow), containing the phiLOV2.1 gene under the control of the tetracycline-inducible 
promoter Ptet, was digested with BamHI and KpnI to remove the original promoter 
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(Appendix A). The predicted promoters upstream of rsh (CD630_27440 and 
CDR20291_2633) and relQ (CD630_03450 and CDR20291_0350) were amplified from 
630Δerm and R20291 genomic DNA using promoter-specific forward and reverse primers 
(Appendix B). Prsh (promoter upstream of rsh) was amplified separately from 630Δerm 
and R20291 genomic DNA, while PrelQ (promoter upstream of relQ) which is fully 
conserved between the two strains, was amplified only from 630Δerm background. The 
primers introduced cut sites for BamHI and KpnI, which were used to digest the amplified 
promoters. The promoters were subsequently ligated into the digested 
pRF185_phiLOV2.1 plasmid to yield Prsh630Δerm::phiLOV2.1, PrshR20291::phiLOV2.1, and 
PrelQ630Δerm::phiLOV2.1 plasmids (Appendix A). These plasmids were PCR verified for 
promoter insertion using vector-specific as well as promoter-specific primers (Appendix 
B). The reporter plasmids were then individually transformed into competent E. coli 
HB101 cells (NEB) carrying the helper plasmid pRK24. HB101 with pRK24 were 
conjugated with C. difficile 630Δerm and R20291 strains as described in details 
elsewhere (119). Prsh630Δerm::phiLOV2.1 and PrshR20291::phiLOV2.1 were conjugated into 
their isogenic background strains and PrelQΔerm::phiLOV2.1 was mated into both C. difficile 
strains. After conjugation, transconjugants were selected on BHIS agar treated with 10 
µg/mL thiamphenicol and 100 µg/mL kanamycin (E. coli sensitive). Finally, 
transconjugants were verified by PCR using both promoter-specific and vector-specific 
primers (Appendix B).  
 
Promoter activity analysis using fluorescent phiLOV reporter constructs 
  C. difficile strains containing phiLOV reporter plasmid (Appendix A) were grown 
anaerobically at 37°C in BHIS-Tm10 for 12 to 16 hrs. To monitor growth phase-dependent 
promoter activity of rsh and relQ genes, ON cultures of 630Derm were inoculated at the 
ratio of 1:20 into fresh BHIS-Tm10 media the next day and grown with OD measured at 
600 nm. Samples were collected when cultures reached the OD600 of 0.8 (exponential 
phase) and 1.2 (stationary phase onset). When cultures at the final volume of 3 mL 
reached the target OD600 values, cell numbers in each sample for fluorescence 
measurements were normalized to cell culture OD of 0.20 at 600 nm. To monitor 
antibiotic-induced promoter activity, ON starter cultures were inoculated 1:50 into fresh 
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BHIS-Tm10 media containing metronidazole and clindamycin at the indicated 
concentrations and grown for ~2 hrs (Appendix E). OD600 was recorded for each sample 
to monitor growth. To minimize variations in fluorescence signal from background cellular 
autofluorescence, cell numbers in each sample were equalized on collection in the 
manner reported elsewhere (273). Each sample was collected at a volume that would 
give a cell count equivalent to 3 mL of the culture with the lowest OD600. After collection, 
cells were pelleted in a microcentrifuge and suspended in 400 µL of reduced 1X PBS 
within the anaerobic chamber. Duplicate 200 µL samples were also aliquoted into a clear-
bottomed black 96-wells microplate (ThermoFisher Scientific) for the purpose of 
measuring sample fluorescence intensity. Sample fluorescence and sample OD630 were 
measured using 440/30 excitation and 508/20 nm emission filters on a plate reader from 
BioTek. The instrumental parameters for all fluorescence measurements included a 
sensitivity limit of 65. Fluorescence measurements were blanked against 1X PBS and 
were reported as E508/A630 absorbance units (AU).  
 
Bacterial strains and growth conditions 
Appendix A lists the bacterial strains and plasmids used herein. C. difficile 
630Δerm and R20291 were grown at 37°C in tryptone yeast (TY) medium or in BHIS, as 
indicated. The strains were grown in an anaerobic chamber (Coy Laboratory Products, 
Grass Lake, MI) with an atmosphere of 85% N2, 10% CO2, and 5% H2. Bacterial strains 
carrying the respective phiLOV2.1 plasmid were maintained in 10 µg/mL thiamphenicol 
(Alfa Aesar), and 50 or 100 µg/mL kanamycin (Bio Basic Canada Inc). To study the effect 
of antibiotics on the promoter activity of rsh and relQ genes, 0.3 µg/mL metronidazole 
(Beantown Chemical) or 16 µg/mL clindamycin (Tokyo Chemical Industry) was used. The 
sublethal concentrations of the antibiotics used are included in Appendix E.  
 
RNA isolation and real-time quantitative PCR  
Total RNA from C. difficile 630Δerm cultured in BHIS was isolated as previously 
described (119). Primers were designed using the PrimerQuest tool from IDT DNA 
technologies. Samples for RNA isolation were collected when cultures reached OD600 of 
0.8, 1.2 and 1.6 (stationary phase). Samples were also collected after culturing in spent, 
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plain BHIS media and PBS. Complementary DNA (cDNA) samples were prepared from 
200 ng RNA using random hexamers and the Tetro cDNA synthesis kit (Bioline). Real-
time PCR reactions were performed with 2 ng of cDNA template using the SensiMix SYBR 
and fluorescein kit (Bioline). Primers (Appendix B) were designed using PrimerQuest tool 
from IDT DNA. The rpoC mRNA transcript was measured and used as an internal control 
for normalization. Controls with no reverse transcriptase were also included for all 
templates and primer sets. For data analysis, the standard 2-ΔΔCt 	method was employed 
with normalization to rpoC and at OD600 of 0.8. 
RESULTS 
 
C. difficile rsh transcription is induced by stationary-phase onset 
Transcription of relA/rsh gene in E. coli and several stringent response mounting 
organisms is induced by nutrient limitation during the onset of stationary phase of growth. 
To confirm that C. difficile rsh transcription is also regulated by bacterial growth phase, 
we have examined the transcript levels of rsh and relQ at cell culture optical densities 
(OD600) of 0.8, 1.2, and 1.6, corresponding to exponential growth, stationary phase onset, 
and stationary phase, respectively (147). qRT-PCR-based analysis revealed that rsh 
transcription increases ~3-fold when cells leave the exponential growth phase and 
remains elevated in the stationary phase (Fig. 29A). In the contrary, relQ transcription is 
unaffected by bacterial growth phase, suggesting that transcription of C. difficile rsh is a 
response to changes in bacterial growth once the cells enter into the stationary phase, 
which is characterized by many adverse conditions (Fig. 29A) (147). We also utilized our 
phiLOV-based transcriptional reporter strain (630Derm) to examine the transcriptional 
regulation of C. difficile rsh in response to stationary phase onset. Strains carrying the 
respective fluorescent transcriptional reporter were grown at OD600 of 0.8 and 1.2 (147). 
Supporting our qRT-PCR data, we found rsh promoter activity to be induced by ~3-fold 
upon onset of stationary phase (Fig. 29B) (147). Notably, the promoter activity from the 
tetracycline-inducible control and from PrelQ appeared to be unaffected by growth phase, 
suggesting that C. difficile relQ does not respond to growth phase but potentially to cell 





Figure 29. Stationary phase onset stimulates C. difficile rsh transcription. (A) qRT-
PCR analysis shows that rsh mRNA levels increase by ~3-fold upon stationary phase 
onset, representative of bacterial OD600 of 1.2. (B) The fluorescent phiLOV 
transcriptional reporter also shows a 3-fold increase in the promoter activity of rsh 
between exponentially growing cells and cells entering stationary phase at an OD600 




rsh transcription is stimulated by nutrient limitation  
To evaluate nutrient limitation as a candidate for the activation of the stringent 
response in C. difficile, we used qRT-PCR to compare the mRNA transcript levels of rsh 
and relQ in cells cultured either in plain BHIS, spent BHIS, or PBS media. When cultured 
in spent media, we found rsh gene transcription to be positively regulated with ~10-fold 
increase in the transcript levels compared to those from cells cultured in plain BHIS media 
(Fig. 30). We also found that relQ transcription is unchanged in spent media, suggesting 
that nutrient limitation induces the stringent response in Clostridioides difficile via 





Figure 30. Nutrient limitation induces C. difficile rsh transcription. qRT-PCR 
analysis shows that transcription levels of rsh increases by ~10-fold when C. difficile 
cells are cultured in spent medium, representative of nutrient limitation or starvation 
condition. relQ transcription in unaffected by nutrient limitation. Multiple t test 
comparison between BHIS and spent BHIS. ** P 0.001220. This experiment and figure 
























rsh and relQ transcription is induced by antibiotic stress 
Adeo et al. demonstrated that antibiotic stress induces the stringent response in 
methicillin-resistant S. aureus, contributing to the pathogen’s antibiotic tolerance 
phenotype (274). To confirm that antibiotic-induced stress regulates C. difficile rsh and 
relQ transcription, we used the phiLOV2.1 reporter to monitor the transcription of rsh and 
relQ upon treatment with sublethal concentration of clindamycin and metronidazole 
(Appendix E) (147). Notably, rsh promoters that control the expression of the rsh gene 
are differentiated by a single purine substitution in the 630Derm and R20291 genomes, 
whereas the relQ promoters are 100% identical in both genetic variants of the pathogen 
(Fig. 31) (147). Therefore, we constructed two translational reporters in which the 
phiLOV2.1 gene was placed under the control of rsh promoter from both 630Derm and 
R20291 strains (147). As expected, we found that the promoter activity in the tetracycline-
inducible negative control was unaffected by clindamycin in both genetic variants (Figure 
32A) (147). But the activity of rsh and relQ promoters was increased in a strain-specific 
manner from clindamycin exposure (Fig. 32A) (147). The rsh promoter activity was 
uninduced by clindamycin exposure in the 630Derm background while demonstrating a 
50% increase in promoter activity in the R20291 background (Fig. 32A) (147). relQ 
promoter activity, on the other hand, was upregulated 2.8-fold in 630Derm background 
but remained uninduced in R20291 (Fig. 32A) (147). To investigate if magic spot 
synthesis can also be stimulated by exposure to metronidazole, we repeated this assay 
by exposing cells to sublethal concentration of metronidazole (Appendix E). The 
tetracycline-inducible control promoter was uninduced by metronidazole treatment. 
Interestingly, both rsh and relQ promoter activities remained unaffected by metronidazole 
exposure in the 630Derm background (Fig. 32B) (147). However, rsh promoter activity 
increased by 80% in the R20291 background, while relQ promoter showed no activity 
(Fig. 32B) (147). These findings suggest that the epidemic strain responds to stress 
induced by different types of antibiotic via upregulation of rsh gene expression. The non-
epidemic strain, on the other hand, does not respond to metronidazole via rsh or relQ 










Figure 31. Sequence alignment of the upstream promoter regions. The sequence 
of promoters used in the (A) Prsh and (B) PrelQ translational reporters are provided. A 
purine base substitution in the promoter sequences of rsh between R20291 and 






Figure 32. C. difficile rsh and relQ transcription is induced by antibiotic stress.  
PhiLOV2.1 transcriptional reporter activity after two hours of exposure to 16 μg/mL 
clindamycin (A) and 0.3 μg/mL metronidazole (B) in the C. difficile 630Δerm and 
R20291 genetic backgrounds. Fluorescence activity normalized by cell density in the 
presence and absence of antibiotics was compared by Two-Way ANOVA. n.s., not 





The stringent response is a ubiquitous stress signaling in bacteria, which is 
regulated by different combinations of RSH superfamily enzymes (158). These enzymes 
are in turn differentially regulated by factors, including nutrient limitation or starvation, 
antibiotic and alcohol exposure, alkaline shock and oxidative stress (149,158). Regulation 
of RSH/SAS-mediated (pp)pGpp signaling occurs either at the transcriptional level or 
post-translational level (158). Long RSH enzymes are known to be transcriptionally 
regulated by stationary growth phase and nutrient limitation induced by inhibitors of 
biosynthetic pathways such as mupirocin and serine hydroximate (269). We have 
identified that stationary phase onset and nutrient limitation also induce C. difficile rsh 
transcription (147). Furthermore, we have identified antibiotic exposure as a stimulus that 
positively regulates C. difficile rsh transcription in a strain- and stress-dependent manner 
(147). The non-epidemic 630Δerm and epidemic strain R20291 appear to exhibit different 
transcriptional responses to clindamycin and metronidazole (147). Notably, R20291 
contains an intact ermB gene that renders the strain resistant to erythromycin (147). 
Therefore, we postulate that the presence of an intact ermB gene in R20291 potentially 
influences the strain’s perception of antibiotic-induced stress and phenotypes (147). 
Nevertheless, clindamycin and metronidazole have distinct mechanism of antimicrobial 
action against pathogens, suggesting that C. difficile rsh transcription could be the 
predominant and a general response to extracellular stress caused by different classes 













EFFECTS OF DISRUPTING THE STRINGENT RESPONSE IN CLOSTRIDIOIDES 
DIFFICILE STRESS SURVIVAL 
OVERVIEW 
 
Transcriptional regulation of rsh (and relQ in some) is not the only mechanism by 
which bacterial cells mediate (pp)pGpp signaling. The activity of other intracellular 
proteins can also influence alarmone levels in response to post-translational regulation 
by extracellular stimuli (275,276). Furthermore, stringency or stress response in bacteria 
doesn’t always involve (pp)pGpp alarmones as the key pleiotropic effector for 
reprogramming cellular processes (277). Therefore, it is critical to define RSH’s 
contribution, independently from RelQ’s, in the accumulation of putative pGpp as well as 
the biological consequences of the alarmones in stressed C. difficile cells. It is also 
important to determine whether (pp)pGpp signaling stimulates C. difficile virulence traits 
such as antibiotic resistance, sporulation, and toxin production, even biofilm formation. 
One such way to determine the contribution of (pp)pGpp in C. difficile physiology during 
stresses is by disrupting alarmone synthesis via RSH inhibitors such as Relacin and/or 
by suppressing rsh and relQ genes at the transcriptional and translational level.  
As mentioned previously, SASs in Gram-positive bacteria are known to respond to 
cell wall stressors, including β-lactam family of antibiotics, heat, and alkaline shock (158). 
Based on our fluorescent translational reporter assays, transcription of C. difficile relQ is 
not induced by bacterial stationary phase onset or nutritional depletion in the environment. 
We also found that C. difficile relQ responds to clindamycin and metronidazole antibiotics 
in a strain-specific manner (147). Notably, both clindamycin and metronidazole are 
cytoplasmic antibiotics that inhibit bacterial protein synthesis and DNA replication, 
respectively. Given that Gram-positive SASs respond to cell wall/envelope stresses, we 
postulate that C. difficile relQ is transcriptionally regulated by ampicillin exposure and/or 
is responsible for alarmone-driven bacterial beta-lactam tolerance. On the other hand, 
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positive transcriptional regulation of C. difficile rsh appears to be a general response of 
the bacteria when exposed to different classes of antibiotic, suggesting that rsh 
transcription contributes to general antibiotic tolerance in C. difficile R20291 variant (147).  
To determine the significance of rsh and rsh translation in C. difficile survival during 
antibiotic stress, we have employed an RNA-based gene-silencing tool called RNA 
interference (RNAi) that suppresses the molecular translation of targeted genes (68,147). 
Through this tool, we have induced the expression of antisense RNA (asRNA) 
complementary to the 5’untranslated region (5’UTR) of the rsh mRNA in the epidemic 
R20291 strain using genomic and molecular cloning techniques described elsewhere 
(68). We found that induction of the asRNA specific to the mRNA of C. difficile rsh using 
a sublethal concentration of anhydrotetracycline (Appendix F) suppresses R20291 
accumulation upon exposure to metronidazole (147). While the observed effect on 
bacterial accumulation is modest, we believe that rsh plays a direct role in C. difficile 
metronidazole tolerance and survival.  
Due to the role of (pp)pGpp in bacterial survival and virulence factors production, 
compounds targeting RSH enzymes and (pp)pGpp alarmones have been screened, 
developed, and characterized (233,235,236,240,278-280). The ppGpp structural analog, 
Relacin competitively inhibits the activity of most full-length RSH family synthetases 
(233,235). The compound reduces (pp)pGpp accumulation, stationary phase onset and 
survival, biofilm formation, and sporulation in Bacillus species (233). Notably, Relacin 
does not affect the activity of SAS family synthetases or inhibit in vivo (pp)pGpp 
accumulation in E. coli, indicating that anti-stringent response inhibitors are not 
universally effective (233). To study the inhibitory effects of Relacin on RSHCd magic 
spot synthesis activity in vitro and in vivo, we have conducted pyrophosphate transfer 
reactions in the presence of increasing concentrations of Relacin (147). We found that 
Relacin inhibits the magic spot synthesis activity of RSHCd in a dose-dependent manner 
(147). We also found that Relacin independently has no discernible effect on the 
accumulation of C. difficile R20291 in vivo, however, the compound increases bacterial 
antibiotic susceptibility to both clindamycin and metronidazole (147). This suggests that 
Relacin is active against RSHCd during antibiotic-induced stringent response mechanism 
in Clostridioides difficile.  
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In summary, this chapter focuses on the effects of disrupting the RSH-mediated 
stringent response mechanism in C. difficile antibiotic stress tolerance and survival. All 
aspects of this chapter previously appeared as an article in the reference (147). The rights 
and permission to use the materials of the publication is given in Appendix M. Figure 
numbers and formats have been changed unless stated otherwise in the figure legends. 
METHODS AND MATERIALS  
 
Overexpression and purification of C. difficile RSH  
Restriction enzymes and DNA ligase used in this study were purchased from New 
England Biolabs. Phusion DNA polymerase for polymerase chain reactions was 
purchased from ThermoFisher Scientific. rsh (CDR20291_2633) was amplified from the 
genomic DNA of C. difficile R20291 using primers (Appendix A) that added a C-terminal 
hexa-histidine tag, ligated into the pMMBneo expression vector at the KpnI and PstI 
restriction sites, and transformed into E. coli BL21. The plasmid was confirmed by PCR 
using rsh gene-specific primers (Appendix B). 
E. coli expression strain carrying pMMBneo vector ligated with hexa-histidine 
tagged rsh was grown in LB-Kan50 at 37°C to an OD of 0.16 to 0.25 at 600 nm (if OD600 
reached above this range, cell cultures were diluted into fresh LB-Kan50 at the desired 
OD value), at which point the temperature was dropped to 30°C and expression was 
induced using 0.5 mM IPTG  for 16 hrs. Cells were lysed by sonication while suspended 
in the lysis buffer composed of 10 mM Tris-HCl (pH 7.8), 300 mM NaCl, 5 mM MgCl2, 50 
mM NaH2PO4, 10% glycerol, 0.5 mg/mL lysozyme, 10 mM imidazole, 0.25 mM DTT and 
5 mM PMSF. Post-lysis buffer treatment, the lysates were clarified by centrifugation and 
subsequently transferred to a gravity column filled with HisPure Ni-NTA resin (G-
Biosciences). Protein purification was conducted according to the manufacturer’s 
protocol. Notably, all purification buffers included 5 mM MgCl2 which was found to be 
critical for protein stabilization and purification. Purified RSHCd was dialyzed ON at 4°C 
against a dialysis buffer composed of 15.7 mM Tris-HCl (pH 7.6), 471.9 mM NaCl, 15.69 
mM MgCl2, 1.57 mM DTT, 1.5 mM PMSF, and 15.7% glycerol. Concentration of the 
100 
 
protein was determined spectrophotometrically. Protein aliquots were stored at -80°C for 
subsequent use.  
 
In vitro measurement of RSHCd synthetase activity  
Synthetase assays in the presence of Relacin (a gift from Sigal Ben-Yehuda, 
Hebrew University of Jerusalem) were conducted in a buffer composed of 10 mM Tris-
HCl (pH 7.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT and 0.12 mM ATP. A 5X 
buffer stock was mixed with the indicated concentrations of GDP (0.2 to 0.6 mM), with 
covarying MgCl2, 1.0 μCi of γ-32P-ATP (approval to use 32P isotope is presented in 
Appendix L), and concentrations of Relacin ranging from 0 to 5 mM (233). Reactions were 
initiated by adding RSHCd at a final concentration of 0.6 µM and a reaction volume of 10 
µL. Reactions were stopped by spotting 2 µL samples on a PEI-cellulose plate, allowing 
the spots to dry. The plates were subsequently developed in 1.5 M KH2PO4 (pH 3.64) and 
autoradiographed using the Storm 860 phosphorimager (GE Healthcare Life Sciences). 
Magic spot signal was quantitated using ImageJ software. RSHCd activity was reported 
as the percentage of magic spot produced.  
 
Construction of RNAi strains  
The vector pMSPT (Appendix A) was a gift from Dr. Julian G. Hurdle (Texas A&M 
University). It was used to express anhydrotetracycline (ATc)-inducible asRNA to the 
mRNA of C. difficile rsh. The pMSPT vector we received was derived by cloning a paired 
termini region (synthesized by GenScript) into pUC57 at BamHI/SacI sites of pRPF185 
as reported elsewhere (68). Antisense fragments were designed and synthesized to span 
~50 base pairs (bp) upstream and downstream of the start codon in order to mimic 
naturally occurring bacterial asRNAs that block translation upon binding to the ribosome 
binding site (RBS). The antisense fragment synthesized by GenScript was amplified using 
gene-specific primers (Appendix B), digested, and cloned into the SphI/ XhoI sites of 
empty pMSPT vector. The derived construct or plasmid, termed as pMSPT::as_rsh 
(Appendix A) contained the gene with its own RBS expressed from the Ptet promoter. 
The plasmid was subsequently PCR verified for antisense gene insertion using vector-
specific primers (Appendix B). The RNAi plasmid and the empty vector plasmid were both 
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individually electroporated into E. coli HB101 cells (NEB) carrying the helper plasmid, 
pRK24. HB101 with pRK24 were conjugated with C. difficile R20291 strains as described 
elsewhere (119). Transconjugants were selected on BHIS agar supplemented with 15 
µg/mL thiamphenicol and 100 µg/mL kanamycin. Finally, transconjugants were verified 
by PCR using C. difficile relQ gene-specific and pMSPT vector-specific primers (Appendix 
B). C. difficile relQ primers were used in colony PCR to confirm that the transconjugants 
were C. difficile, whereas the vector-specific primers were used to confirm the success of 
the conjugation process.  
 
Bacterial strains and growth conditions  
Appendix A lists the bacterial strains and plasmids used herein. C. difficile R20291 
strain was grown at 37°C in TY medium or BHIS medium, as indicated. The strain was 
grown in an anaerobic chamber (Coy Laboratory Products, Grass Lake, MI) with an 
atmosphere of 85% N2, 10% CO2, and 5% H2. Wild type R20291 strain as well as bacterial 
strains carrying the pMSPT::as_rsh or pMSPT empty plasmid were maintained using the 
following antibiotics in the indicated concentration: 15 µg/mL thiamphenicol (Alfa Aesar), 
50 or 100 µg/mL kanamycin (Bio Basic Canada Inc), 0.075 or 0.3 µg/mL metronidazole 
(Beantown Chemical), or 16 µg/mL clindamycin (Tokyo Chemical Industry) as indicated 
in Appendix E.  
 
End-point growth/ cell accumulation assay using R20291 and RNAi strains   
ON starter cultures of wild type R20291 strain was inoculated 1:50 into fresh TY 
medium and grown till OD600 ~0.8 (exponential phase). At this point, using a 96-welled 
microtiter plate, the starter cultures were added to reduced TY medium treated with 2 mM 
Relacin, with or without 16 µg/mL clindamycin or 0.3 µg/mL metronidazole from time point 
0 min. The plate was subsequently incubated anaerobically at 37°C for 12 to 18 hrs. Post-
incubation, the plates were taken out of the anaerobic chamber and OD630 was measured 
using a plate reader (BioTek) to measure cell accumulation.  
For the RNAi strains, growth following the induction of asRNA to the mRNA of C. 
difficile rsh was performed by using the standard media dilution technique using a 96-
welled microtiter plate. To determine the sublethal concentration of ATc to use for 
102 
 
inducing as_rsh without inhibiting bacterial growth and viability, increasing concentrations 
of ATc were added to BHIS medium in the absence of antibiotics (Appendix F). Plate was 
incubated for 24 hrs after which the sublethal concentrations of ATc that partially inhibited 
growth was recorded (Appendix E). The concentration of ATc (0.5 µg/mL) that moderately 
inhibited growth was further used to induce as_rsh in assays where the growth of 
unstressed vs stressed strains using 0.075 µg/mL metronidazole was monitored after 12 
hrs of anaerobic incubation at 37°C in BHIS medium treated with 15 µg/mL thiamphenicol.  
RESULTS  
 
Relacin inhibits RSHCd synthetase activity in vitro and reduces bacterial antibiotic 
survival in vivo 
Relacin inhibits (pp)pGpp synthesis in B. subtilis and D. radiodurans by 
competitively binding to the SD active site of the bifunctional RSH enzymes in vitro (233). 
Upon incubating purified RSHCd with GDP, ATP, and increasing concentrations of 
Relacin, we found that Relacin also inhibits RSHCd synthetase activity in a dose-
dependent manner in vitro (Fig. 33) (147). Notably, Relacin appears to inhibit RSHCd 
pyrophosphoryltransferase activity in millimolar concentrations consistent with its 
efficacious dose against other RSH/REL enzymes, indicating that the molecule itself is 
not a promising candidate to use in the clinical settings for the management of CDI (147). 
We also investigated the effects of Relacin on the accumulation of R20291 cells over a 
period of 12 hrs (147). We treated cells with 2 mM Relacin in the absence of any stringent 
response inducing factors and found that Relacin does not affect bacterial survival under 
normal growth conditions (Fig. 34A) (147). Interestingly, when R20291 cells are 
pretreated with 16 µg/mL clindamycin or 0.3 µg/mL metronidazole, the compound 
appears to increase bacterial susceptibility to both antibiotics (147). The intracellular 
accumulation of (pp)pGpp causes a delayed growth phenotype in bacterial cells and puts 
cells in a state of quiescence, which notably, contributes to bacterial antibiotic tolerance 
(242). We found that treatment with clindamycin and metronidazole appears to suppress 
R20291 accumulation overtime, which could be due to the production and intracellular 
accumulation of the putative pGpp alarmones (Fig. 34B and 34C). But bacterial 
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accumulation was further suppressed in the presence of Relacin, suggesting that the 
molecule specifically targets RSHCd during the stringent response cascade in C. difficile 











Figure 33. Relacin affects RSHCd synthetase activity in vitro. Relacin inhibits the 
activity of RSHCd in a dose-dependent manner. Activity at each Relacin concentration 
was compared to that in the 0 mM Relacin condition by ordinary One-Way ANOVA. * P 
0.0173, * P 0.0279, *** P 0.0009, **** P 0.0004. Adapted from Pokhrel et al. 2020. 
 



















Figure 34. Effect of disrupting RSH-regulated stringent response mechanism in 
C. difficile antibiotic survival. (A) Relacin alone has no impact on the ON 
accumulation of C. difficile R20291. Cell density after overnight growth was compared 
with and without Relacin by ordinary One-Way ANOVA. (B-C) 18 hrs cell density in the 
presence of sublethal clindamycin (B) and metronidazole (C) with and without Relacin. 
The cell density of antibiotic treated samples with and without Relacin were compared 
by Unpaired t test. n.s., not significant, * P < 0.05, ** P < 0.01, *** P < 0.001. Adapted 





rsh plays a role in bacterial antibiotic tolerance and survival in vivo 
Due to the observed modest effect of Relacin on metronidazole treated 
hypervirulent R20291 strain, we investigated the significance of RSH for C. difficile 
survival during metronidazole-induced stress. We induced the expression of asRNA 
specific to the mRNA of rsh using our pMSPT::as_rsh vector carrying R20291 RNAi strain 
(Appendix A) (147). Induction of the asRNA has previously been shown to deplete mRNA 
transcript levels and to knock down translation in C. difficile (68,147). Upon silencing rsh 
translation in vivo in the epidemic strain pre-treated with sublethal concentration of 
metronidazole, we found R20291 accumulation to be dramatically suppressed overtime 
(Fig. 35) (147). This suggests that rsh and its gene product contribute to the accumulation 
and survival of C. difficile cells during metronidazole-induced stress (147). We also 
postulate that rsh confers metronidazole tolerance in C. difficile, further establishing that 






 The stringent response governs virulence traits and phenotypes in many 
organisms, including biofilm production, spore formation, virulence factor expression, and 
survival of pharmacological and immune stresses (149). We have found that Relacin is 
effective at inhibiting RSHCd synthetase activity in a dose-dependent manner in vitro 
(147). While Relacin does not have any effect against bacterial accumulation and survival 
under normal growth conditions, we found that inhibition of RSHCd synthetase activity, 
mediated by Relacin, amplifies the potency of both metronidazole and clindamycin 
against C. difficile R20291 strain (147). Notably, we found the effect of Relacin on 
antibiotic efficacy to be modest (147). Furthermore, we found Relacin to be effective 





Figure 35. Significance of rsh in antibiotic stress survival. Knock down of C. difficile 
rsh gene with ATc inducer (0.5 µg/mL) negatively impacts the accumulation of R20291 
strain in the presence of metronidazole (0.075 µg/mL). The cell densities of antibiotic 
treated samples with and without ATc were compared by ordinary One-Way ANOVA. 





















molecule is not a suitable candidate for clinal use in managing CDI. Furthermore, knock 
down of R20291 rsh gene in the presence of metronidazole substantially reduced 
bacterial accumulation, confirming that rsh translation and subsequent production of 
putative pGpp is required for C. difficile to respond to and survive antibiotic stress in the 


































 Clostridioides difficile is an obligate anaerobic pathogen that persists as dormant 
spores in the aerobic environment (13). Once ingested by the host, the pathogen 
germinates into rapidly reproducing vegetative cells that can secrete toxins (13). The 
clinical spectrum of C. difficile infection ranges from asymptomatic colonization to life-
threatening pseudomembranous colitis, toxic megacolon, sepsis and death (13). CDI is 
defined when patients experience symptomatic diarrhea and test positive for C. difficile 
toxin A and/or B or the presence of toxin-producing strains in the stool (6,42). 
Pseudomembranous colitis or colonic histopathological characteristics revealed by 
endoscopy also defines CDI (6,7,281). But bacterial colonization without the onset of 
symptoms, which still leads to disease progression remains an unclear aspect of C. 
difficile pathogenesis. Studies have revealed that C. difficile colonizes between 0 to 17.5 
% of healthy individuals without causing clinical signs of CDI (6,282,283). Notably, a high 
prevalence of asymptomatic colonization is found in institutionalized patients, particularly 
with underlying medical conditions, or in health-care workers (6,284-286). Furthermore, 
asymptomatic colonization can also be found in infants and neonates, mainly during the 
first four weeks of life (6,287). Analysis of PCR ribotypes have shown that individuals from 
different age groups are colonized with identical toxigenic strains of C. difficile without 
showing any clinical signs of CDI (288,289). Whether symptomatic or asymptomatic, 
colonization of C. difficile, nevertheless, serves as a reservoir of the pathogen and a mean 
of bacterial transmission from one host to another (6).  
 One of the key mechanisms regulating C. difficile colonization in the host is the 
disruption of the indigenous microbiota community (42). The intestinal microbiota is a 
complex ecosystem consisting of numerous bacterial species (6). In healthy adults, the 
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intestinal microbiota is predominantly constituted of species belonging to the 
Bacteroidetes and Firmicutes phyla, with roles in metabolism, nutritional function, 
maturation of the immune system, and conferring host colonization resistance to enteric 
pathogens (6,42,290). Due to the beneficial contributions of the indigenous microbiota to 
the host, disruption or dysbiosis of the microbiota community negatively impacts 
microbiota structure and functions (6). Consequently, host colonization resistance is 
attenuated, resulting in the germination, growth, and rapid multiplication of C. difficile 
within the host intestine (6). Factors such as diet, geography, antibiotic use, and the 
development of gastrointestinal complications influence microbiota diversity between 
individuals (6,291).   
 Antibiotic exposure (especially cephalosporins, penicillins, and fluoroquinolones) 
is the primary risk factor for CDI development and is postulated to increase host 
susceptibility to CDI by disrupting the intestinal microbiota community (6,292,293). The 
impact of antibiotic administration on the host microbial structure and composition has 
been studied extensively. CDI patients exhibit changes in the gut microbiota composition, 
including a significant decrease in Bacteroidetes family species with an increase in the 
members of the Proteobacteria such as Pseudomonadales (6,42). Within the Firmicutes 
phylum, CDI patients report a decrease in butyrate producing Ruminococcacea and 
Lachnospiraceae, Bacteroidaceae, and Clostridia cluster IV and XIVa with a 
corresponding increase in Lactobacillales (42,294). In animal models of infection, prior 
clindamycin exposure has confirmed the findings for human patients and demonstrated 
a decrease in the abundance of commensal species (295). Similarly, animal models 
lacking pre-antibiotic treatment fail to exhibit the debilitating symptoms of CDI, 
presumably owing to an undisrupted microbiota community (42,295,296). Changes in the 
gut microbiota of asymptomatic carriers of C. difficile are less defined but studies have 
shown that there is a comparable decrease in microbial diversity and species structure in 
both CDI and asymptomatic carrier groups in contrast to the healthy group (42,297). 
Interestingly, the structure of the microbial communities are strikingly different among CDI 
patients and asymptomatic carriers (42). Indigenous microbiota of the carrier group is 
dominated by Firmicutes and Bacteroidetes, suggesting that the composition of 
microbiota in this group resembles that of healthy individuals (42,297). Studies using 
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murine models of infection also support the findings that colonization with certain bacterial 
taxa such as Lachnospiraceae prevents the progression of CDI from symptomatic or 
asymptomatic colonization (42,298).  
 Apart from altering the native microbiota structure and composition, antibiotic 
treatment also induces substantial changes in the gut metabolome. The intestinal 
microbiota is responsible for fermenting carbohydrates and amino acids into short chain 
fatty acids (SCFAs) (299,300). Furthermore, the microbiota metabolizes lipids, amino 
acids, and proteins, ensuring a balanced colonic health that affects the growth and 
survival of enteric pathogens (300,301). However, antibiotic-induced disruption of the 
normal microbiota results in a metabolic environment that largely favors the colonization 
and spread of enteric pathogens. Theriot et al. reported that cefoperazone treatment in 
murine models increases the concentration of primary bile acids, including taurocholate, 
taurocholenate sulphate, and tauroursodeoxycholate, with a corresponding decrease in 
secondary bile acid, deoxycholate (300). To establish colonization, C. difficile spores must 
germinate into vegetative cells using primary bile acids as germinant. Therefore, 
antibiotic-induced increase in the concentrations of primary bile acid promotes C. difficile 
germination in animal models, further indicating that antibiotics disrupt members of the 
commensal microbiota with roles in the metabolism of primary bile acids into secondary 
bile acids, which inhibit C. difficile growth (44,45,300). Theriot et al. also reported that 
cepfoperazone treatment increases the level of sugar alcohols and carbohydrates in 
murine models, including mannitol, sorbitol, arabitol, xylitol, ribitol, gluconate, sucrose, 
raffinose, stachyose, galactose, lactate, and fructose (300). The reported increase in the 
levels of carbohydrates and alcohols coincided with a decrease in free short-chain fatty 
acids, including acetate, propionate, butyrate and valerate, suggesting that indigenous 
microbiota-mediated fermentation of carbohydrates is decreased from antibiotic exposure 
(300). Upon testing the ability of C. difficile to utilize these sugars and alcohols both 
independently and in conjugation with murine cecal contents, it was revealed that C. 
difficile successfully germinates and outgrows in a niche that is rich in these metabolites 
(300).  
 According to Theriot et al., antibiotic treatment also increases the concentration of 
N-acetylneuraminic acid (NEU5A) or sialic acid in the gut (300). NEU5A is a branched 
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carbohydrate and a component of the O-glycosylated MUC2 core protein, which is largely 
constituted by mucins of the intestinal mucus (302). C. difficile adheres to gut mucins in 
vitro and has been observed within the mucus of mice and humans in vivo, suggesting 
that C. difficile colonizes the intestinal mucus  (302-309). In addition to NEU5A, the mucin 
is O-glycosylated with GlcNAc, N-acetylgalactosamine, galactose, and fucose 
(302,310,311). These O-glycosylated carbohydrates are degraded and released as free 
glycans via hydrolase enzymes encoded by mucin-degrading native species 
(302,311,312). Notably, free glycans serve as nutrients to the commensal microbes as 
well as to colonic enteric pathogens, including V. cholerae, C. jejuni, and S. typhimurium 
that swim towards the intestinal mucus to compete with and outnumber the native 
microbiota community (302,313-316). Like many motile bacteria, these organisms 
regulate their motility in response to nutrients by controlling the activity of motor 
complexes that rotate their flagella. According to Courson et al., long periods of flagellar 
rotation cause unidirectional runs, whereas transient changes in rotational direction 
causes tumbles that reorient cells to run in new directions (317). Furthermore, sustained 
runs cause bacterial dispersal, but frequent tumbles reduce run lengths and confine cells 
in one region of the niche or locality (317). The speed of flagellar rotation can also 
influence bacterial dispersal (317). Nevertheless, bacteria alter their tumbling frequency 
and/or velocity to control their motility towards a more concentrated source of nutrients or 
chemoattractants (317). Notably, C. difficile also readily responds to nutrient availability 
in the niche. Sporulation, toxin production, and metabolism of c-di-GMP in this organism 
are influenced by the nutrient composition of the bacterial growth medium (317-319).  
Like many motile intestinal pathogens, C. difficile produce flagella and can swim 
through liquid and semi-solid media (119,317). This bacterium also moves on solid 
surfaces with the aid of TFP (111,317). To investigate if nutrients regulate C. difficile 
R20291 motility, we have designed and constructed portable rose cell chambers that can 
be used in any inverted microscope under aerobic conditions (317). At the single-cell 
level, we found that free NEU5A glycans reduce bacterial swim velocity and displacement 
without affecting bacterial tumbling frequency (317). Since NEU5A is associated with C. 
difficile colonization in vivo, we postulated that the reduction in bacterial motility and 
biofilm formation by R20291 may be coordinately regulated by the same signaling 
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mechanism(s). Biofilm is a virulence factor that enables bacteria to resist stresses from 
antibiotics and host immune system. Very recently, Engevik et al. demonstrated that C. 
difficile RT027 strain chemotaxes toward and adheres to MUC2 of the intestinal mucus 
layer in murine models (302). Chemotaxis is defined as the directed movement of bacteria 
in response to chemical gradients that facilitate movement toward and away from 
favorable and unfavorable conditions, respectively. According to Engevik et al., NEU5A 
is the least preferred chemoattractant for C. difficile followed by GlcNAc, and mannose 
(302). However, culturing of C. difficile cells in a minimal medium supplemented with each 
monosaccharide as the primary source of carbon demonstrated that all mucin sugars 
facilitate bacterial growth, resulting in a delayed stationary phase-onset (302). Based on 
Engevik et al., mannose is the most preferred chemoattractant exhibiting maximal 
bacterial growth. But supplementation of a growth medium made from the cecal contents 
of gnotobiotic mice (also depleted in amino acids and carbohydrates) with GlcNAc and 
NEU5A has previously been reported to enable C. difficile division (317,320). These 
findings show that C. difficile respond to unchained NEU5A as a food source.  
Engevik and group additionally reported that C. difficile interacts with mucus-
associated and mucin-degrading microbes within biofilms such as Bacteroides, 
Ruminococcus, and Akkermansia in the antibiotic-treated gut (302). Given that C. difficile 
does not code for glycosyl hydrolases responsible for cleaving O-glycosylated mucin 
components, the pathogen depends on glycosyl hydrolases-encoding species to utilize 
free monosaccharides, suggesting that mucin degradation is a crucial step in the mucosal 
colonization and growth of C. difficile (302). To investigate whether C. difficile R20291 
directly assembles as biofilm in the presence of high NEU5A concentration, we conducted 
the standard plate-based biofilm assays requiring crystal violet staining. Based on our 
analyses, C. difficile R20291 forms biofilm in BHIS medium independently of a GLU, 
GlcNAc, and NEU5A gradient. However, the strain appears to produce significantly robust 
single-species biofilm at 32 mM NEU5A, suggesting that NEU5A-specific motility 
suppression of the hypervirulent strain may be regulated by signaling network(s) that also 
inversely regulate biofilm formation.  
In summary, this chapter focuses on evaluating nutrient-regulated motility 
stimulation and/or suppression of C. difficile R20291 strain. Antibiotic-induced shifts of 
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the colonic microbiome and metabolome create a niche suitable for C. difficile 
germination, growth and colonization (300). Therefore, this chapter focuses on nutrient-
dependent colonization mechanisms adopted by C. difficile which ultimately contribute to 
virulence and/or transmission. Several aspects of this chapter, including the methods and 
materials section previously appeared as an article in the reference (317). The rights and 
permission to use the materials of the publication is given in Appendix M. Figure numbers 
and formats have been modified from the actual publication unless stated otherwise in 
the figure legends. 
METHODS AND MATERIALS  
 
Bacterial strains and growth conditions  
C. difficile strain R20291 was grown in BHIS medium in an anaerobic chamber at 
37°C maintained at an atmosphere composed of 85% N2, 10% CO2, and 5% H2. Migration 
assays were performed in BHIS and BHIS with 0.3% agar in the presence of GLU, ARA, 
or NEU5A at the indicated concentrations. Growth curves were performed in BHIS 
supplemented with the indicated metabolites to a final concentration of 32 mM and 
inoculated at the ratio of 1:20 with ON cultures of R20291. Doubling times were calculated 
using the Prism (GraphPad) software and the non-linear curve fits to the exponential 
growth equation Y = Y0*expo (K*X) where Y0 denotes the initial optical density, Y is the 
measured optical density, and X is time. Doubling times were determined by fitting the 
data between 0 and 5 hours in order to exclude entry of bacterial cells into the stationary 
phase of growth.  
 
Macroscopic motility assays  
Macroscopic motility assays were carried out in supplemented or unsupplemented 
BHIS medium with 0.3% agar. ARA, GLU, or NEU5A was added to the molten agar to the 
indicated final concentration. Plates were prepared outside of the anaerobic chamber and 
left to dry ON, then transferred to the anaerobic chamber to equilibrate for at least 24 
hours prior to use. Sterilized and O2 reduced toothpicks were used for inoculation of 
individual colonies of R20291 into the motility agar. Each toothpick was used to stab a 
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soft agar (which was divided into two even sections using a sharpie on the plate base) 
twice to allow for duplicate measurements. Migration or bacterial swarm diameters were 
measured manually using a ruler after 12 and 24 hrs of incubation at 37°C. The mean 
diameters and standard deviations of four biologically independent samples measured in 
duplicate (total of 8) were reported. One biological replicate had to be excluded from the 
24 hrs plain BHIS condition because cell populations grew into each other, spread across 
the agar, and made measurements of motility impossible.  
 
Rose cell imaging chamber construction  
As mentioned elsewhere, sealed rose cell chambers with gas impermeable 
gaskets were constructed for the imaging of anaerobic bacteria using an aerobic 
microscope (321). Aluminum top and bottom plates with imaging windows and 25 mm 
square glass coverslips were prepared for use with a Nikon Ti-E inverted microscope. 
Screw holes were milled into each corner of the top and bottom aluminum plates. Gaskets 
were cut from 3 mm thick rubber with a central circular or square opening (18 mm 
diameter). The screw holes in the gaskets were aligned to those in the aluminum chamber 
plates. Before use, all components of the rose cell chambers were sterilized in 10% 
bleach followed by rinsing in deionized water. The components were left to dry prior to 
use.   
 
Sample preparation for imaging  
Starter cultures of C. difficile R20291 were grown ON in BHIS medium. These 
cultures were diluted 1:50 and allowed to grow for ~3 hrs the following day so that the 
cells will have entered exponential growth phase. 150 µL of dilution culture was then 
mixed with fresh BHIS medium and nutrient supplement at desired concentrations for a 
total sample volume of 1,500 µL. Within the chamber, the sample was injected through 
the bottom port of the chamber through the rubber gasket using a 1 mL syringe until all 
gas escaped from the top needle. After sample injection, both top and bottom needles 
were removed, allowing the holes in the rubber gasket to seal on its own. The edges of 
the imaging chamber were parafilmed and removed from the anaerobic chamber, sprayed 
with 10% bleach and 70% ethanol for sterilization purpose before imaging. Microscopy 
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Live-cell, time-lapse differential interference contrast microscopy was performed 
on a Nikon Ti-E inverted microscope equipped with Nikon Perfect Focus System, 
apochromat TIRF 60X Oil Immersion Objective Lens (numerical aperture of 1.49), a 
condenser (numerical aperture of 0.52), pco.edge 4.2 LT sCMOS camera, and SOLA SE 
II 365 Light Engine along with complementary DIC components. Stage temperature was 
maintained at 36.5oC ± 0.5oC to monitor bacterial motility at 37oC using a Nevtek Air 
Stream microscope stage warmer and a microscope enclosure prepared in house. 100 
µs exposures at a frame rate of 10 frame/sec for 10 seconds was used to record movies 
of bacterial motility. Three biologically independent samples were imaged in each medium 
condition; 600 X 600-pixel windows were imaged at three randomly selected locations 
per sample. The first ten cells that entered the field of view were analyzed.  
 
Decontamination of the rose cell chambers  
After each imaging experiment, the microscope stage and sample holder were 
wiped with 10% bleach and 70% ethanol. The parafilm wrap was peeled off the rose cell 
chamber and placed into biohazard waste bin. The sample chamber was submerged in 
a 50% bleach solution and disassembled. All components of the chamber were allowed 
to soak in the bleach solution for at least 10 mins. Glass coverslips were gently removed 
and discarded as biohazardous waste. Aluminum and rubber components were rinsed 
with deionized water and then soaked in ~117 mM sodium thiosulfate for at least 30 mins 
to neutralize bleach. Components were subsequently washed with ethanol and dried prior 
to reusing.  
 
Single-cell analysis 
Image analysis was performed using a bunch of Nikon Elements imaging Suite 
and the ImageJ software. The line segment tool was used in ImageJ to measure 
unidirectional run of each bacterial cell over time from which the velocity and 
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displacement factors were calculated. Each reorientation was considered the peak as 
well as the end of a run but the start of a new one. Only runs whose beginnings and ends 
took place within the field of view and the plane of focus were considered for motility 
measurements. For each cell, the run lengths, run durations, and number of tumbles were 
recorded. Swimming velocity was calculated by dividing displacement by time.  
 
Plate-based, single-species biofilm assay  
ON cultures of C. difficile R20291 were diluted 1:100 into fresh buffered BHIS (38.7 
mM NaH2PO4 and 11.3 mM Na2HP04 at pH 7.43 ± 0.05) media. A total of 2 mL samples 
per well was deposited in 24-well polystyrene non-treated plates (Costar, USA) with 0 
mM, 4 mM, 8 mM, 16 mM, and 32 mM of GLU, NEU5A and GlcNAc. The 24-well plates 
were always reduced for at least 72 hrs prior to setting up single-species biofilm assays. 
The stock solution of each metabolite was prepared as a 10X stock in plain BHIS media, 
filtered sterilized, and stored in aliquots in –20 °C for long-term use. Prior to plate set up, 
buffered BHIS, plain BHIS and 10X stock solutions of all sugar metabolites were taken 
into the chamber to reduce overnight. Post-set up, the plates were incubated at 37°C 
within the anaerobic chamber for at least 48 hours. Once incubation was complete, the 
plates were taken out of the anaerobic chamber and placed on a portable rack. Spent 
media from the plates were subsequently removed via pipetting and wells were gently 
washed once with filter sterilized 1X PBS. Biofilms were air dried for 5 to 10 mins and 
stained with crystal violet (CV; 0/1% w/v) for 30 mins. CV stain was removed through 
pipetting after which the wells were washed twice with PBS then air-dried for ~10 mins. 
Dye bound to the biofilm biomass was solubilized with 70% reagent alcohol and the 
absorbance, corresponding to the biofilm biomass, was measured at 570 nm with a plate 
reader (BioTek). When necessary, the solubilized CV dye was diluted for all readings to 
remain in the linear range of the spectrophotometer. Autoclaved BHIS and same media 
condition with different sugar metabolite was used for blanking in the assays. Biofilm 
assays using NaCl were conducted in the same manner at the indicated concentrations 







C. difficile regulates motility in a nutrient-specific manner  
The C. difficile genome encodes a predicted methyl-accepting chemotaxis protein 
(CDR20291_0463) within a putative chemotaxis operon (CDR20291_0458 to 
CDR20291_0467), suggesting that the bacteria could regulate flagella-dependent motility 
to respond to unknown nutrients (317). The levels of NEU5A increases in animal models 
as a result of cefoperazone-induced dysbiosis of the gut microbiome and metabolome 
(300). To investigate if NEU5A regulates the motility of C. difficile R20291, we inoculated 
individual colonies of the strain into BHIS medium with 0.3% agar that has a level of 
viscosity comparable to that of the intestinal mucus and measured bacterial dispersal 
from the site of inoculation (317,322-324). We performed these macroscopic motility 
assays because available nutrients that bacteria can metabolize suppress motility by de-
motivating bacteria to seek new territories. We found that BHIS medium supplemented 
with 1% of any metabolite reduces R20291 dispersal post-12 hrs of incubation (Fig. 36A) 
(317). Notably, NEU5A appeared to reduce migration of inoculated colonies from the 
inoculum site most dramatically (Fig. 36A) (317). 
 Supplementation of BHIS medium with arabinose also reduced motility of R20291 
after 12 hrs of incubation (Fig. 36A) (317). This shows that the addition of substrates that 
are not metabolizable to the bacteria still contributes to motility suppression at earlier 
timepoints, potentially due to the impact of high carbohydrate concentration on the 
osmolarity of the medium (317,325). After 24 hrs of growth, however, migration through 
the agar in the presence of arabinose had no effect on the swarm diameter, suggesting 
that the bacteria eventually adapt to the nutrient-independent effects of the medium 
supplemented with ARA (Fig. 36B) (317). Nonetheless, by including arabinose in our 
motility analyses, we have controlled for the possibility of observing an osmolarity 
response of cells vs nutrient-derived response in the presence of GLU and NEU5A. 
Hence, supplementation with 1% GLU and NEU5A reduces migration by 22% and 69%, 
respectively, after 24hrs of incubation, suggesting that the presence of metabolically 
accessible nutrients in the niche inhibits C. difficile dispersal (Fig. 36B) (317).  
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 To ensure that the observed motility differences from supplementation with 1% 
monosaccharide were not due to differences in the molar concentrations of each 
supplement tested, we remeasured bacterial swarm diameters on soft agar supplemented 
with 32 mM ARA and 32 mM GLU (where 32 mM concentration corresponds to 1% 
NEU5A) (Fig. 36C and 36D) (317). As expected, neither ARA nor GLU at 32 mM caused 
any significant motility suppression post-12 and 24 hrs of incubation (Fig. 36C and 36D) 
(317). This suggests that the inhibition of bacterial swarming on the soft agar is specific 

















Figure 36. C. difficile motility through soft agar is regulated by nutrients. (A, B) 
Migration of C. difficile R20291 through BHIS, 0.3% agar supplemented with 1% ARA, 
GLU or NEU5A. (C, D) Migration of R20291 through BHIS, 0.3% agar supplemented 
with 32 mM of ARA or GLU. Swarm diameters were measured post-12 (A, C) and 24 
(B, D) hrs of inoculation. Measurement of four biologically independent swarms per 
condition (X2). Motility in each medium was compared to migration in BHIS-agar by 
Unpaired t-test; n.s., not significant, * P < 0.05, ** P < 0.01, **** P < 0.0001. (E) 
Representative images of C. difficile R20291 24 hrs after inoculation. Adapted from 
Courson et al. 2019. 
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To confirm that motility suppression regulated by NEU5A or suppression of migration of 
C. difficile R20291 on the soft agar is not due to bacterial growth inhibition, we monitored 
bacterial growth in the presence of various monosaccharides at 32 mM concentration 
over the course of 12 hrs (317). We found that none of the monosaccharides slowed 
growth in liquid culture, confirming that the observed effect of nutrient supplementation in 
the motility agar (Fig. 36E) is due to motility suppression rather than suppression of cell 
division and growth (Fig. 37A) (317). The calculated doubling times of R20291 in BHIS 
supplemented with the indicated sugar are comparable to each other (Table 3). The 
findings that the bacteria exhibit a normal growth phenotype in the presence of all sugars 
studied at 32 mM concentration but substantially reduces motility in response to NEU5A, 
suggest that C. difficile R20291 senses nutrient availability in the niche and reduces its 


















Figure 37. C. difficile growth in the presence of different sugars at 32 mM 
concentration. (A) Growth curves in medium supplemented with either 32 mM ARA, 
GLU or NEU5A are comparable to the growth of the bacteria in plain BHIS medium. (B) 
Growth curve as in (A) showing how the doubling times were calculated between 0 and 















Table 3.  
C. difficile replicates normally in the presence and/or lack of different 
metabolites. Doubling times of C. difficile R20291 in BHIS with 32 mM supplementation 
of either ARA, GLU or NEU5A. Doubling times were calculated between 0 and 5 hrs of 
growth in plain BHIS or BHIS supplemented with the respective metabolite. Adapted 






Doubling time (hrs) 
Plain BHIS 1.74 
+ 32 mM ARA 1.54 
+ 32 mM GLU 1.59 




Imaging of live C. difficile R20291 cells using home-built portable rose cell 
chambers  
Based on our macroscopic motility assays, NEU5A specifically suppresses 
R20291 motility or swarming from the initial site of inoculation on a soft agar. To verify 
this finding on the single-cell level, we have utilized a rose cell chamber (317). The use 
of a rose cell chamber involves assembling a gas impermeable rubber gasket with a 
central hole that is sandwiched immediately between two glass cover slips followed by 
two aluminum plates at the top and bottom (Fig. 38A) (317). The rubber gasket is pierced 
with two standard needles, one that allows gas and fluid exchange to occur with the 
surrounding and another that allows for venting displaced air along with sample injection 
into the assembled chamber (317). Assembled chambers are reduced in the anaerobic 
chamber (although time consuming, the chamber can be assembled within the anaerobic 
chamber itself) and injected with liquid culture after which the needles are removed to 
allow the bacterial culture to be sealed inside of the rose cell chamber (317). The chamber 
is then placed on an aerobic inverted microscope and maintained at 37°C (317). By doing 
so, we found that within this device, C. difficile R20291 can grow and multiply normally 
overtime (317) (Fig. 38B). As depicted in the figure, growth is indicated by an increase in 
bacterial cell density as a function of time (Fig. 38B). We recorded images at various time 
points while the cells grew and found that after 6 hrs, bacteria continued swimming and 
multiplying, confirming that the home-built rose cell chambers preserve R20291 growth 



















Figure 38. Extended live-cell microscopy of C. difficile R20291 using a rose cell 
chamber. (A) Side view of rose cell chamber assembly. (B) Cell division and growth of 
R20291 within the imaging chamber in BHIS medium. Panels show the time course in 
which the cells were incubated at 37°C within the chamber. Scale bar indicated at 10 




Analysis of C. difficile R20291 motility at the single-cell level 
To measure motility in BHIS media supplemented with increasing concentrations 
of NEU5A, we recorded fast time-lapse videos (317). To prepare cultures for imaging, ON 
cultures of R20291 were diluted 1:50 into fresh BHIS media and allowed to grow for ~3 
hrs, letting cells to reach late lag or early exponential phase of growth (317). Chambers 
were subsequently injected with BHIS supplemented with indicated concentrations of 
NEU5A (0, 10, 16, 25, and 32 mM) and 1:10 dilutions of the early exponential phase 
culture (317). To quantify bacterial motility within the chamber, we measured net 
displacement, unidirectional run length, and velocity during unidirectional runs of at least 
ten randomly selected cells within each movie (317). We found that supplementation with 
10 mM NEU5A exhibited no significant effect on displacement, while 16 mM NEU5A 
caused a modest but significant increase in bacterial displacement (Fig. 39A) (317). At 
32 mM concentration, however, bacterial displacement was significantly inhibited (Fig. 
39A). At 25 mM, NEU5A reduced net displacement by 20% from 88.4 µm to 71.0 µm, and 
at 32 mM, NEU5A further reduced displacement. The motility videos used for the 
quantification of displacement are included in Courson et al. and that the link to the videos 
is included in Appendix G.  
 To verify if reduction in displacement caused by increasing NEU5A concentrations 
is due to reduction in bacterial swimming speeds, we calculated the flagella-dependent 
swimming velocities of each cell (317). We measured run velocity only during 
unidirectional runs even if that required us to include multiple frames of movement in the 
same direction (317). We found that NEU5A reduced swimming velocity at concentrations 
higher than 25 mM since 10 mM and 16 mM NEU5A had no significant effect on velocity 
(Fig. 39B) (317). Supplementation of BHIS medium with 25 mM and 32 mM NEU5A 
reduced velocity from 21.3 µm/sec to 15.8 µm/sec and 75% to 5.4 µm/sec, respectively 









Figure 39. NEU5A reduces net displacement and velocity. (A) Net displacement (B) 
linear swimming velocity of R20291 during unidirectional runs within 10 sec in BHIS 
with indicated concentrations of NEU5A. Means and standard deviations of 49-146 cells 
are shown per condition. One-Way ANOVA analysis of variance comparing 
displacement and velocity of cells in supplemented media to those in plain BHIS. 
Turkey’s multiple comparison test., n.s., not significant; **** P < 0.0001. Adapted from 




Analysis of C. difficile R20291 motility via the tumbling mechanism  
To quantify bacterial motility within the rose cell chamber, we also measured 
bacterial tumbling frequency of cells within each movie (317). Notably, reducing 
swimming velocity is not the only mechanism that bacteria employ to limit dispersing away 
from regions of high nutrient concentration or availability in the niche (317). Bacteria can 
stay closer to nutrient-rich sites by increasing flagella-dependent tumbling (317). To 
determine if C. difficile also alters its tumbling frequency in the presence of high NEU5A 
concentration, we quantified the reorientations of individual cells in the movies (317). We 
reported the number of tumbles per second of recorded motility because not all the cells 
analyzed managed to stay within-frame for the full 10 secs exposure duration (317). Upon 
doing so, we found that the average tumble frequency was not affected by 
supplementation with NEU5A at any concentrations tested (Fig. 40A) (317). The majority 
of cells did not tumble and supplementation with NEU5A appeared to make no difference 
in the observed trait (Fig. 40A) (317). Of the subset of cells that tumbled and were 
analyzed separately to study the effect of NEU5A, we found that NEU5A decreases 
tumbling frequency rather than increasing it (317). Tumbling cells in all medium conditions 
tumbled at the rate of 0.1-0.25 times/sec (Fig. 40B) (317). Only 7.3% of cells incubated 
in 32 mM NEU5A tumbled more than 0.25 times/sec in comparison to 10-20% of cells 
that tumbled in other media (Fig. 40B) (317). The average reorientation frequency of 
tumbling cells in 32 mM NEU5A was 0.22 tumbles/sec, which notably was lower than 0.32 
tumbles/sec in plain BHIS or in any of the other media conditions supplemented with lower 
NEU5A concentrations (Fig. 40C) (317). These findings suggest that C. difficile R20291 
senses high NEU5A concentration in the niche as is the case post-antibiotic treatment, 





Figure 40. NEU5A has no effect on C. difficile R20291 tumbling. (A) Tumble 
frequency of C. difficile R20291 in BHIS supplemented with indicated concentrations of 
NEU5A. Tumble counts were normalized by the duration of each cell’s motility to control 
for cells that left the field of view during 10 secs exposure. (B) Percentage of the total 
cells exhibiting the indicated number of tumbles/secs in each condition is given. (C) 
Normalized frequency of cells that show a non-zero rate of tumbling. Turkey’s multiple 




High NEU5A concentration regulates biofilm formation by C. difficile R20291  
Since flagellum-dependent motility and TFP-mediated biofilm formation are 
inversely regulated by c-di-GMP in C. difficile, we investigated the impact of high NEU5A 
concentration in bacterial biofilm formation. We hypothesized that NEU5A serves as a 
potential signal in the host during C. difficile infection that regulates intracellular c-di-GMP 
pool and the associated physiological responses. Using plate-based biofilm assays, we 
found that C. difficile R20291 forms relatively more biofilm in media supplemented with 
NEU5A, GlcNAc, and GLU metabolites than in unsupplemented medium (Fig. 41). 
Notably, the bacteria formed single-species biofilm in the presence of both GLU and 
GlcNAc regardless of the monosaccharide concentrations (Fig. 41). However, the 
bacteria produced significantly more biofilm biomass at the highest NEU5A concentration 
tested (Fig. 41). This suggests that C. difficile responds to NEU5A abundancy and 
availability in the niche by producing biofilms above the threshold levels.  
Previous studies have demonstrated that C. difficile 630 forms higher amounts of 
biofilm in BHIS supplemented with fermentable sugar such as GLU, fructose, and ribose 
in the presence of stress-causing insults (326). Since we were evaluating the impact of 
glucose in bacterial biofilm formation to determine if there is a correlation between motility 
suppression and sessile biofilm production in response to nutrients, we did not include 
glucose in our biofilm media. According to Dapa et al., both glucose and 0.3 M NaCl 
induce biofilm formation by 630 and R20291 strains where 0.3 M NaCl slightly inhibits 
biofilm production in caparison to 100 mM GLU (127). Consistent with literature evidence, 
we found that C. difficile R20291 form biofilm in the presence of increasing concentrations 
of NaCl (Fig. 42A), however, 32 mM NEU5A causes R20291 to produce more biofilm than 
does 0.3 M NaCl (Fig. 42B). Observed significant loss of biofilm during PBS washes led 
to this measurement which, notably, under-reports the amount of biofilm actually 
produced by R20291 in the presence of 32 mM NEU5A. Higher ionic strengths reduce 
the repulsion between a bacterial cell and a material surface, and that osmotic stress 
caused by NaCl promotes biofilm formation in Gram-positives such as Staphylococcus 
species and Listeria monocytogenes (327). The finding that C. difficile R20291 forms 
more biofilm in 32 mM NEU5A than in 0.3 M NaCl suggests that while osmolytes generally 
induce biofilm formation, the bacteria is also responding to NEU5A as a nutrient. We have 
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shown that 32 mM NEU5A does not impact bacterial growth negatively but inhibits 
dispersal from the site of inoculation on a soft agar (317). We have also shown that higher 
NEU5A concentration suppresses displacement and swimming velocity without affecting 
bacterial tumbling (317). Together, these observations indicate that NEU5A is not a 







Figure 41. 32 mM NEU5A induces robust single-species biofilm formation by C. 
difficile R20291. Cultures of R20291 were incubated for 48 hrs at the indicated 
concentrations of NEU5A, GlcNAc, and GLU. Measurement of bacterial biomass using 
0.1% crystal violet staining and 570 nm absorbance readings demonstrated that 
R20291 forms significantly more biofilm at 32 mM NEU5A. Production of biofilm in BHIS 
is independent of a GlcNAc and GLU gradient. Two-way ANOVA multiple comparison 
(cell means regardless of rows and columns) analysis of biomass produced at different 
concentrations of the unchained mucin monosaccharides., n.s., not significant, *** P 
0.0003. Means and standard deviation of 6 biologicals are shown of two assays 











Figure 42. Effect of NaCl on biofilm production by C. difficile R20291. (A) Biofilm 
formation kinetics by R20291 in the presence of NaCl at the indicated concentrations 
using 0.1% CV staining procedure and measurement of biomass at 570 nm. Biofilm 
formation is comparable between 0 to 0.15 M non-sugar osmolyte but robust at 0.3 M 
NaCl. (B) R20291 produce biofilm in 32 mM NEU5A as well as in 0.3 M NaCl although 
at the population level, more independent biologicals produce more biomass in 32 mM 
NEU5A. Statistical significance determined by Unpaired t test., n.s., not significant, * P 
0.0355. Means and standard deviation of 6 total biologicals are shown for two separate 






C. difficile is responsive to nutrient availability in its niche and we have found that 
the bacteria suppresses its movement in a nutritionally favorable environment. When 
added to a soft agar growth medium supplemented with either GLU or NEU5A, C. difficile 
can reduce motility at the population level, suggesting that the bacteria is sensing these 
free monosaccharides as a food source (317). In the presence of the non-metabolizable 
sugar ARA, C. difficile R20291 fails to exhibit any effect on motility over 24 hrs, confirming 
that the observed motility response is specific to sugars metabolizable by the bacteria 
(317). Notably, the molar concentration required to reduce R20291 motility is higher for 
GLU (55 mM at 1%) than for NEU5A (32 mM at 1%) (317). Unlike GLU, NEU5A supplies 
nitrogen and carbon as nutrients. Therefore, it remains to be elucidated whether the 
pronounced effect on motility exerted by NEU5A is specific or is a general read-out of the 
bacterium’s global metabolic state (317). Since the organism codes for predicted 
chemotaxis gene products, we initially postulated that NEU5A-regulated motility 
suppression contributes to and/or is driven by bacterial directional motility in the presence 
of a NEU5A gradient (317). Engevik et al. recently demonstrated that C. difficile R20291 
prefer NEU5A the least among other mucin monosaccharides, including GLU and GlcNAc 
(302). This finding suggests that R20291 does not readily respond to a NEU5A gradient 
when a plethora of significantly relevant metabolites are abundant in the niche. Therefore, 
we presume that C. difficile R20291 responds to NEU5A gradient strictly under 
circumstances where the metabolite profiles of the host have been changed as a 
consequence of intestinal dysbiosis. Post-cefaperozone treatment, a negative fold-
change in GLU and GlcNAc have been reported in the gut of animal models, indicating 
that R20291 chemotaxis to NEU5A for survival when the levels of competing metabolites 
are low (300). Moreover, C. difficile R20291 may also reach NEU5A-rich sites 
independently of the chemotaxis mechanism (87).   
Planktonic cells initiate biofilm formation to either resist adverse environmental 
conditions or to stay put in nutritionally favorable environments to establish colonization 
and infection (328). Based on our findings, C. difficile reduces unidirectional motility at 
higher NEU5A concentrations (317). Therefore, we postulated that NEU5A induces 
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motility suppression of R20291 while promoting single-species biofilm formation in a 
highly coordinated fashion, potentially under the regulation of the same signaling 
mechanism(s) such as the c-di-GMP signaling. We found that C. difficile R20291 forms 
biofilm in the presence of all monosaccharides tested. However, the bacteria form 
significantly higher amounts of biomass in 32 mM NEU5A than in the same concentration 
of GLU or GlcNAc. C. difficile is known to form biofilm in the presence of 0.3 M NaCl, 
which causes osmolarity stress to the pathogen (127). Based on our data, biofilm 
production by R20291 is influenced by osmolarity as well as nutrient availability. Unlike 
biofilm formation, however, C. difficile motility is influenced specifically by metabolizable 



























This dissertation investigates the response of Clostridioides difficile to extracellular 
conditions.  The (pp)pGpp-mediated stress response is a globally conserved mechanism 
that bacteria and some eukaryotes employ to respond to extracellular stresses (149). We 
have shown that the C. difficile genome encodes a long bifunctional RSH and a 
monofunctional RelQ enzyme that are members of the RSH superfamily (147,248). 
RSHCd contains two catalytic domains in the N-terminal end and regulatory domains in 
the C-terminal end, with a potential role in the reciprocal regulation of the enzyme’s 
hydrolysis and synthesis activity (147). Unlike many of its Gram-positive RSH/Rel 
homologs, RSHCd does not bind GTP despite harboring the highly conserved RXKD 
motif in the amino acid sequence of its synthetase domain (147). The RXKD motif appears 
to influence RSHCd synthetase activity in the presence of high Mg2+ concentrations, 
suggesting that RSHCd-catalyzed pyrophosphate transfer reactions involve a single-
divalent cation mechanism. However, the motif does not influence RSHCd substrate 
preference and utilization in a manner similar to RelSeq and RelMtb. Both RelSeq and 
RelMtb prefer GTP and readily produce pppGpp, suggesting that guanosine 
pentaphosphate alarmone has a physiological relevance to several Gram-positive 
organisms during the stringent response (160,243). In the contrary, RSHCd poorly binds 
GTP and does not accommodate pyrophosphate transfer from ATP to GTP (147).  
 RSHCd exclusively utilizes GDP as a substrate to synthesize the magic spot in 
vitro (147). We have shown that RSHCd synthetase activity is robust in a wide range of 
environmental pHs and that the enzyme can utilize a diverse array of metal cofactors that 
are structurally and chemically distinct (147). The failure of RSHCd to utilize GTP at an 
equimolar concentration of GDP and an excess in the same substrate pool suggests that 
the enzyme strictly utilizes GDP (147). We previously identified the magic spot produced 
by RSHCd as ppGpp since the enzyme exclusively utilized GDP under the conditions 
used (147,248). However, using RelQBs as a positive control, which utilizes GMP to 
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synthesize pGpp, we found that RSHCd-catalyzed alarmone migrates similar distances 
on PEI-cellulose plates as RelQBs-produced pGpp. The comparable mobility of the magic 
spot produced by RSHCd and RelQBs, notably, using two distinct substrates, lead us to 
conclude that RSHCd is synthesizing a three-phosphate alarmone instead of ppGpp via 
non-canonical mechanism(s). Additionally, a time-course analysis of RSHCd synthetase 
activity using HPLC also demonstrated that the signal of the triphosphate product 
increases with an increase in the reaction time, suggesting that the enzyme is producing 
putative pGpp in the presence of GDP and ATP (Appendix H). Future structural analysis 
using 31Phosphorus NMR is necessary to confirm the identity of the triphosphate 
alarmone produced by RSHCd in the presence of GDP. Detection and quantification of 
alarmone accumulation in vivo is also imperative to establish that RSHCd produces pGpp 
via non-conventional mean(s). Like Bacillus species, C. difficile genome also encodes 
two putative NuDiX hydrolases that could potentially degrade pppGpp and ppGpp to 
pGpp, suggesting that C. difficile may synthesize the tetraphosphate and the 
pentaphosphate forms of magic spot under certain conditions (Appendix I).  
 To access the role of the CTD in regulating RSHCd synthetase activity, we have 
designed and cloned a synthetase-only gene called rsh-rel that codes for C. difficile RSH-
REL enzyme. We found that the overexpression of C. difficile rsh-rel completely shuts 
down bacterial growth compared to rsh, which only partially inhibits growth. This suggests 
that expression of RSH-REL, lacking regulation by an intact hydrolase domain and/or the 
CTD,  leads to the uncontrolled accumulation of the magic spot in bacterial cytoplasm 
(147). Notably, the toxicity associated with RSH-REL overexpression and subsequent 
magic spot production was attenuated by supplementing the bacterial growth medium 
with a combination of glucose and casamino acids (147). Like RSHCd, RSH-REL 
exclusively utilizes GDP to produce putative pGpp in vitro. We also examined the 
hydrolase activity of RSHCd in the presence of exogenous ppGpp and Mn2+ ion and found 
that RSHCd exhibits a relatively modest hydrolysis activity in isolation. Failure to detect 
hydrolysis product PPi via TLC suggests that the HD of RSHCd potentially requires 
activation regulation by branched-chain amino acids known to bind the ACT domain of 
several well-characterized Rel/RSH CTD (166).  
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 Although the SR is a ubiquitous stress signaling pathway, factors contributing to 
the transcriptional regulation of rsh in diverse species vary dramatically (158). We found 
that C. difficile rsh is transcriptionally regulated by bacterial stationary phase onset and 
nutrient limitation (147). We also found that rsh transcription in C. difficile R20291 is 
induced by exposure to clindamycin and metronidazole (147). Interestingly, Relacin 
inhibits RSHCd synthetase activity in vitro but exerts no effect on bacterial accumulation 
in vivo (147). Exposure to antibiotics partially suppresses C. difficile R20291 accumulation 
from the intracellular production of (pp)pGpp and activation of the SR. Notably, the 
treatment of antibiotic-exposed C. difficile with 2 mM Relacin appeared to further 
suppress bacterial accumulation or load, suggesting that Relacin inhibits bacterial 
accumulation during the SR, presumably by inhibiting RSHCd-mediated putative pGpp 
synthesis (147). We have also confirmed the significance of rsh and rsh translation to C. 
difficile R20291 using a gene-silencing tool. Our data demonstrated that rsh translation in 
response to metronidazole is involved in bacterial antibiotic stress tolerance and survival. 
Furthermore, we have directly examined the significance of rsh gene in C. difficile R20291 
virulence. Using ICelligence electrical cell impedance assay where R20291 and Madin-
Darby canine kidney (MDCK) cells were co-cultured in gold microelectrode wells, we have 
shown that induction of asRNA specific to the mRNA of C. difficile rsh increases the lag 
time of MDCK cells to transition from proliferating to nonviable cells (Appendix J). While 
the MDCK cells are eventually killed from C. difficile toxicity (bacterial toxins lead to 
disruption of the mammalian epithelium monolayers and subsequent detachment from 
the assay wells causing reduction in impedance) and nutrient limitation in the growth 
medium, the observed delay in MDCK detachment or death corresponding to higher 
cellular index in the inducer-treated group indicates that rsh directly contributes to 
pathogenesis in C. difficile R20291 strain (Appendix J).  
 Finally, this dissertation also investigated nutrient-regulated mechanisms 
contributing to C. difficile host colonization. C. difficile is responsive to nutrients in the 
environment and as a motile organism, the bacteria utilize its motility machineries to 
respond to attractants and repellents accordingly (110). Based on a study by Theriot et 
al., antibiotic exposure alters the colonic microbiome and metabolome, creating an ideal 
niche for C. difficile germination and growth (300). Unchained NEU5A becomes abundant 
137 
 
and readily available to the pathogen post-cefoperazone treatment in the gut, suggesting 
that the bacteria utilize this mucin monosaccharide as a food source (300). Furthermore, 
Ng et al. demonstrated that C. difficile 630 genome carries a NEU5A catabolic operon 
like S. typhimurium and can metabolize free NEU5A, promoting higher pathogen densities 
within the intestinal lumen of mouse models (329). We have found that C. difficile R20291 
suppresses its flagella-dependent motility at high NEU5A concentrations by decreasing 
bacterial displacement and swimming velocity (317). Notably, C. difficile does not 
attenuate motility by increasing its tumbling frequency (317). We hypothesized that the 
bacteria respond to NEU5A gradients in the host and maintain flagella-dependent 
chemotaxis to reach NEU5A-rich sites. However, a recent study demonstrated that 
NEU5A is one of the least preferred chemoattractants for C. difficile, indicating that 
R20291 cells respond to NEU5A gradient via chemotaxis only under conditions in which 
the levels of GLU and GlcNAc are substantially low (302).  
While the chemotaxis mechanism largely governs the net direction of movement 
of bacteria for approaching attractants, it is not the only way pathogens can sense and 
move toward favorable environments (87). For instance, enterohemorrhagic E. coli can 
sense butyrate via positive transcriptional regulation of flagellar gene synthesis, which in 
turn enhances flagellum-driven motility of the pathogen to reach the surface of the 
intestinal mucosa (87,330). Furthermore, V. cholerae can sense high bile concentration 
using a two-component sensing and response system, which increases bacterial motility 
from the intestinal lumen to the bile-rich locations (87,331). This suggests that C. difficile 
R20291 could potentially rely on system(s) apart from chemotaxis to reach NEU5A-rich 
sites. Upon arriving at the target sites, the bacteria suspend flagella-driven motility but 
may or may not use flagella for other roles, including adhesion and biofilm formation 
during C.  difficile infection. Purcell et al. reported that TFP contributes to biofilm formation 
by C. difficile in a c-di-GMP and class II_4 riboswitch-dependent manner (111). They also 
reported that c-di-GMP promotes TFP biosynthesis and surface motility, with the R20291 
strain exhibiting significantly higher pilA1 gene transcription corresponding to higher 
biofilm formation than 630/630Δerm strain (111). Since c-di-GMP represses flagellum-
mediated motility in C. difficile by down regulating the expression of genes in the ƒlgB 
operon (including sigD that positively regulates toxin gene expression) and facilitates 
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autoaggregation and biofilm formation, we hypothesized that R20291 form biofilm in the 
presence of high NEU5A concentration and that NEU5A may be one of the many signals 
that impact cytoplasmic c-di-GMP pool and signaling in this organism.  
Based on our quantification analyses using crystal violet assays and absorbance 
measurements at 570 nm, we found that C. difficile R20291 form biofilm in the presence 
of all sugar metabolites evaluated. Interestingly, R20291 cells appeared to form robust 
biofilm with significantly more biomass in the presence of 32 mM NEU5A than in GLU or 
GlcNAc at the same concentration. These findings indicate that C. difficile R20291 
maintains colonization in the host by responding to NEU5A abundancy through robust 
single-species biofilm formation. However, the bacteria do not respond the same way to 
the same concentration of GLU and GlcNAc. Furthermore, our plate-based assays also 
revealed that biofilm formation by C. difficile R20291 is induced by osmolarity, while 
motility of the strain is not dependent on factors or monosaccharides such as ARA that 
impact cellular osmolarity. Overall, these findings indicate that motility suppression and 
biofilm formation of R20291 caused by 32 mM NEU5A may be inversely regulated by the 
same regulatory network(s) such as the c-di-GMP signaling. Recently, glucose-6-
phopshate was shown to serve as a signal for P. aeruginosa SagS system to activate its 
motile-sessile switch function in a c-di-GMP-dependent manner (332). Glucose-6-
phosphate increases diguanylate cyclase NicD expression, resulting in the corresponding 
increase in bacterial attachment and biofilm formation (332). Overall, this finding 
demonstrates the feasibility of our current hypothesis that NEU5A, much like glucose-6-
phosphate, serves as a signal to induce R20291 biofilm formation via the c-di-GMP 
signaling network.  
Using portable rose cell chambers to image bacterial aggregation upon incubation 
in buffered biofilm medium supplemented with 32 mM NEU5A, we have found that C. 
difficile R20291 form long chains of replicating cells (Appendix K) in a manner similar to 
B. subtilis during the production of ECM and biofilm formation (333). Notably, the chains 
appear to be longer when R20291 culture is treated with 0.3 M NaCl, with visibly fewer 
spores (Appendix K). We postulate that the deviation in cellular aggregation pattern and 
spore formation is attributable to the differential regulation of cell behaviors in the 
presence of a stress-inducing osmolyte versus a growth-facilitating food source. Future 
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characterization of R20291 biofilm architecture and matrix composition at 32 mM NEU5A 
using CLSM and TEM will provide more knowledge about the significance of this 
monosaccharide to C. difficile host colonization and pathogenesis. Furthermore, 
transcriptomic analyses with and without 32 mM NEU5A will provide mechanistic insights 
into the inverse regulation of motility and biofilm formation by R20291. We believe that 
the expression of genes involved in the biosynthesis of flagella (those in the F3 regulon 
and sigD) and/or genes regulating flagellar motility (ƒliC, ƒliD) along with those involved 
in chemotaxis will be downregulated in NEU5A-derived R20291 biofilms with a concurrent 
upregulation of TFP biosynthesis and assembly genes (such as pilA1 and pilB1) (127). 
To determine if c-di-GMP signaling directly regulates the observed motility suppression 
and biofilm formation traits in C. difficile R20291 at elevated NEU5A concentrations, 
transcriptional profiling of genes encoding c-di-GMP cylases, class I and II riboswitches, 
and phosphodiesterases through microarray analyses or more advanced RNA 
sequencing technology will be useful. Additionally, we postulate that spo0A, with role(s) 
in biofilm formation and attachment by C. difficile and C. perfringens will be differentially 
expressed in R20291 biofilms ± 32 mM NEU5A (127). spoOA gene encodes SpoOA, the 
master regulator of sporulation in Bacillus and Clostridium species such that spoOA 
deletion attenuates biofilm formation (127,132). Upregulation of spoOA in R20291 
biofilms at high NEU5A concentrations will suggest that NEU5A potentiates C. difficile 
pathogenesis by promoting sporulation and dissemination. While the role of c-di-GMP 
signaling in C. difficile sporulation remains to be elucidated, positive regulation of spoOA 
gene expression in R20291 biofilms in the presence of concentrated NEU5A will further 
denote that NEU5A serves as a signal during host microbial dysbiosis that primes C. 
difficile to sporulate rather than produce toxins.  
As a concluding remark, we have shown the contributions of the stringent response 
mechanism in Clostridioides difficile tolerance and survival of extracellular stresses, 
providing significant implications toward the screening and/or designing of RSHCd-
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SUMMARY OF STRAINS AND PLASMIDS USED  
 
Name Description Reference 
Escherichia coli 
DH5α F- φ80lacZΔM15 Δ(lacZYA-
argF) U169 recA1 endA1 
hsdR17, phoA supE44 thi-1 





BL21 fhuA2 [lon] ompT gal [dcm] ΔhsdS NEB 
HB101  NEB 
HB101 pRK24 HB101 transformed with pRK24  273 
RT1255  pMMBneo::R20291_rsh-His6 in 
DH5α 
248 




630  Wild type   
630∆erm Wild type 630 lacking erythromycin 
resistance gene ermB 
108 
R20291  Wild type   
CEP18  pRF185::phiLOV2.12.1 in R20291 147 
CEP19  pRF185::phiLOV2.12.1 in 630∆erm 147 
CEP21 PrelQ630∆erm::phiLOV2.12.1 in 
R20291 
147 
CEP22 Prsh630∆erm::phiLOV2.12.1 in 
630∆erm 
147 
CEP23 PrelQ630∆erm::phiLOV2.12.1 in 
630∆erm 
147 




pMMBneo Low copy expression vector, Ptac, 
neo cassette, KanR 
147 
pRF185 tetR 273 
pMMBneo::R20291_rsh-His6 R20291 rsh ligated into KpnI/PstI 






rel amplified from R20291 rsh and 
ligated into KpnI/PstI sites of 
pMMBneo  
147 
pRF185::phiLOV2.12.1 phiLOV2.1 downstream of 
tetracycline-inducible promoter 
ligated into BamHI/KpnI sites of 
pRF185 
273 
PrelQ630∆erm::phiLOV2.12.1 Predicted promoter upstream of 
630∆erm  relQ amplified and 
ligated into BamHI/KpnI sites of 
pRF185::phiLOV2.12.1 
147 
Prsh630∆erm::phiLOV2.12.1 Predicted promoter upstream of 
630∆erm  rsh amplified and ligated 






Predicted promoter upstream of 
R20291  rsh amplified and ligated 
into BamHI/KpnI sites of 
pRF185::phiLOV2.12.1 
147 
pMSPT Low copy expression vector 68 
pMSPT::as_rsh Antisense RNA to the mRNA of 
Cdrsh ligated into the SphI/XhoI 
sites of pMSPT  
147 
pBAD33 Low copy expression vector   
pBAD33::rsh-rel rsh-rel amplified from full-length 
rsh and ligated into KpnI/PstI sites 
of pBAD33 
147 
pET24a High copy expression vector  
pET24a::rsh-rel rsh-rel amplified from full-length 














SEQUENCES OF PRIMERS USED 
Name  Sequence (5’ to 3’) 









pRF185_F CTGGACTTCATGAAAAACTAAAAAAAATATTG 147 















relQ_F CAAGAATTCCACTATGGAGCTTGTAATCA 147 
relQ_R  CAAGGATCCCATATTGCTCACCCTTTATTTG 147 
pMSPT_F CTAAAGGGCAAAAGTGAGTATGG 147 
pMSPT_R GACGAGCAAGGCAAGACC 147 
rsh_as_F GGTATGCATGCTGCATAAAC 147 
rsh_as_R CCTAGCTCTCGAGACCAAC 147 
rshREL_F KpnI CAGGTACCATGAAAGAAGAAACTCAATCTG  147 





GACCATATGAAAGAAGAAACTCAATC This study  
pET24a::rsh-
rel_R 







































relQ_qF CATTGCGGGTTCAAAGGAAAT  
 
147 





APPENDIX C  
SIGNAL QUANTIFICATION USING A TLC AUTORADIOGRAM  
 
 
Signal quantification using a TLC autoradiogram. Regions of interest (ROIs) defining 
the total, 32P-ATP, and magic spot signal are shown for a blank lane and an 
experimental lane. Signal intensity within each blank ROI is subtracted from the 
experimental value, and the 32P-ATP and the magic spot signals are normalized to the 
total signal using the equations given to present the percentage of the total radioactive 
signal attributable to ATP hydrolysis and magic spot or putative 5’-pGpp-3’ alarmone 




Total signal = 4 – 1  
32P-ATP signal = 5 – 2  
Magic spot signal = 6 – 3  
%Magic spot signal = (6 – 3) / (4 - 1) 
Initial spot  




RSHCd PRODUCES PUTATIVE TRIPHOSPHATE ALARMONES 
 
Autoradiograms of in vitro pyrophosphate transfer reactions catalyzed by RSHCd and 
RelQBs in the presence of GMP, GDP, GTP, and ADP (RSHCd only). RelQBs utilizes 
GMP, GDP, and GTP to produce 5’-pGpp-3’, 5’-ppGpp-3’, and 5’-pppGpp-3’, 
respectively. RSHCd is unable to utilize GMP, GTP, and ADP. When either protein is 
lacking in the incubation mixture (where NP denotes no protein), magic spot is not 
synthesized. RSHCd-produced magic spot migrates similar distance with RelQBs-
produced pGpp (black oval), suggesting that RSHCd-catalyzed magic spot could be 
pGpp. The first three autoradiograms (left to right) were produced by Asia Poudel and 












0.25X 4.00 0.075 
0.5X 8.00 0.15 
1X 16.0 0.30 
Sublethal concentrations of antibiotics metronidazole and clindamycin for C. difficile 
R20291 were determined using the standard minimum inhibitory concentration (MIC) 
technique. ON starter cultures of R20291 were inoculated 1:10 into fresh BHIS media 
treated with increasing concentrations of either antibiotic. Cells were incubated 
anaerobically at 37°C for 12 hrs to monitor cell accumulation and growth inhibition. The 
sublethal concentrations used in the study for four independent biologicals are shown. 
Adapted from Pokhrel et al. 2020. 
 




























Minimum inhibitory concentration for ATc against C. difficile RNAi strains were analyzed 
in BHIS plus thiamphenicol (15 µg/mL) medium with increasing concentrations of ATc. 
ON starter cultures of RNAi strains were inoculated into media at the ratio of 1:20 and 
incubated anaerobically at 37°C for 24 hrs to monitoring growth inhibition. The MIC 
against empty vector (pMSPT) and asRNA vector (pMSPT::as_rsh) expressing strains 
are shown for two biological replicates. 0.5 µg/mL was determined to be the sublethal 
concentration of ATc against both RNAi strains to be used for end-point cell 
accumulation assays. Adapted from Pokhrel et al. 2020.  
 
 











































TIME-COURSE ANALYSIS OF RSHCd ACTIVITY IN VITRO 
 
HPLC analysis of RSHCd-mediated three-phosphate alarmone production with 
increasing incubation time. Synthetase activity was performed in a buffer containing 10 
mM Tris-HCl (pH 7.5 ± 0.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT, 0.12 
mM ATP, 0.6 mM GDP, and 1.2 mM MgCl2. Reaction was initiated by adding RSHCd 
at a final concentration of 3.0 µM and incubated at 37°C on a portable dry bath for a 
total duration of 30 mins. At 10 mins intervals, ~45 µL samples were transferred into 
VIVA SPIN 500 spin column (Corning) with a MWCO of 30 KDa and spun at 12,000 X 
g for 5 mins at 20°C. Filterates/samples were run through a strong anion exchange 
column the following day along with a 20 µM 5’-ppGpp-3’ standard (Trilink) using a 
gradient elution profile. Absorbance at 252 nm was used to detect the standard (std) 
(blue peak) and the triphosphate compound at different time points. With increasing 
incubation time, there is an evident increase in the signal of putative pGpp as depicted 
in the chromatogram. This experiment was performed, and chromatogram produced by 









Protein sequence alignment of NahA (YvcI) homologs in different species including C. 
difficile strain 630. Multiple sequence alignment of YvcI homologs from B. subtilis 
(BSU_34780), B. anthracis (BA_5385), B. halodurans (BH_3570), and C. difficile 630 
(CD630_07050, CD630_12200, CD630_19840). Alignment was obtained with 
BoxShade Server-EMBnet (with consensus lines). Numbers on the sides of the 
sequences indicate the residue numbers in the corresponding proteins. Dark shading 
(black) represents identical amino acid residues among sequences being aligned, 
whereas light shading (grey) represents amino acid residues with matching polarity. 
Protein accession numbers were retracted from Yang et al. 2020.  




SIGNIFICANCE OF RSH GENE TO C. DIFFICILE TOXICITY 
 
Significance of rsh in C. difficile virulence examined in real-time using iCeLLigenceTM 
real-time cell analyzer (Agilent). The assays involved culturing 300 µL of MDCK cells 
(ATCC) in Dulbecco’s modified eagle medium (DMEM) from VWR in the wells of the 
16-well microtiter plates (with a gold microelectrode biosensor array) within a CO2 
incubator. Post-incubation, the apparatus was taken into the anaerobic chamber where 
MDCK cells were cultured in BHIS-Tm15 media with as_rsh expression vector carrying 
RNAi strain (R20291 variant), and with or without 0.5 µg/mL ATc. C. difficile toxicity was 
measured for a total of 72 hrs (5 mins interval for the first 24 hrs and 15 mins interval 
















Portable rose cell chamber was injected with 1:100 dilution of ON starter culture of 
R20291 cells in buffered BHIS medium diluted with 0.3 M NaCl. The chamber was 
parafilmed and placed on the stage of a Nikon Ti-E inverted microscope. Live-cell DIC 
microscopy was performed to image R20291 aggregation in the presence of 0.3 M NaCl 
over a period of 48 hrs. Stage temperature was maintained at 36.5°C ± 0.5°C using a 
Nevtek Air Stream stage warmer. Red arrows indicate chaining of replicating cells for 
single-species biofilm formation. C. difficile produce biofilm in response to osmolarity 
stress. Scale bar shown is 50 µm.  
 





Portable rose cell chamber was injected with 1:100 dilution of ON starter culture of 
R20291 cells in buffered BHIS medium diluted with 32 mM NEU5A. The chamber was 
parafilmed and placed on the stage of a Nikon Ti-E inverted microscope. Live-cell DIC 
microscopy was performed to image R20291 aggregation in the presence of 32 mM 
NEU5A over a period of 48 hrs. Stage temperature was maintained at 36.5°C ± 0.5°C 
using a Nevtek Air Stream stage warmer. Red arrow(s) indicate replicating cells making 
contacts with one another to form extended, notably shorter chains for the initiation of 
single-species biofilm formation than in 0.3 M NaCl. Magenta arrows indicate spores. 
Unlike biofilm produced by R20291 in the presence of NaCl, the biofilm community of 
R20291 in 32 mM NEU5A may be dominated by spores. Scale bar shown is 50 µm.  
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